BLASTP 2.2.20 [Feb-08-2009]


Reference: Altschul, Stephen F., Thomas L. Madden, Alejandro A. Schaffer, 
Jinghui Zhang, Zheng Zhang, Webb Miller, and David J. Lipman (1997), 
"Gapped BLAST and PSI-BLAST: a new generation of protein database search
programs",  Nucleic Acids Res. 25:3389-3402.

Reference for compositional score matrix adjustment: Altschul, Stephen F., 
John C. Wootton, E. Michael Gertz, Richa Agarwala, Aleksandr Morgulis,
Alejandro A. Schaffer, and Yi-Kuo Yu (2005) "Protein database searches
using compositionally adjusted substitution matrices", FEBS J. 272:5101-5109.

Query= model
         (115 letters)

Database: pdb.fasta 
           42,001 sequences; 9,620,218 total letters

Searching..................................................done



                                                                 Score    E
Sequences producing significant alignments:                      (bits) Value

gi|56554341|pdb|1W5Y|A Chain A, Hiv-1 Protease In Complex With F...   192   3e-50
gi|90109335|pdb|2FDE|A Chain A, Wild Type Hiv Protease Bound Wit...   191   5e-50
gi|443021|pdb|1HOS|A Chain A, Inhibition Of Human Immunodeficien...   191   5e-50
gi|157831402|pdb|1HVC|A Chain A, Crystal Structure Of A Tethered...   191   7e-50
gi|11513732|pdb|1G6L|A Chain A, 1.9a Crystal Structure Of Tether...   191   7e-50
gi|4558173|pdb|1ODY|A Chain A, Hiv-1 Protease Complexed With An ...   191   7e-50
gi|197724931|pdb|2R38|A Chain A, I84v Hiv-1 Protease Mutant In C...   191   7e-50
gi|197724933|pdb|2R3T|A Chain A, I50v Hiv-1 Protease Mutant In C...   191   7e-50
gi|443017|pdb|1HIV|A Chain A, Crystal Structure Of A Complex Of ...   191   7e-50
gi|126030406|pdb|2FLE|A Chain A, Structural Analysis Of Asymmetr...   190   1e-49
gi|493788|pdb|1AAQ|A Chain A, Hydroxyethylene Isostere Inhibitor...   190   1e-49
gi|6980896|pdb|1BV9|A Chain A, Hiv-1 Protease (I84v) Complexed W...   190   1e-49
gi|3114324|pdb|1AXA|A Chain A, Active-Site Mobility In Human Imm...   190   1e-49
gi|66360070|pdb|1RL8|A Chain A, Crystal Structure Of The Complex...   189   1e-49
gi|6729844|pdb|3TLH|A Chain A, Structural Studies Of Hiv And Fiv...   189   2e-49
gi|194368486|pdb|2QHC|A Chain A, The Influence Of I47a Mutation ...   189   2e-49
gi|231149|pdb|5HVP|A Chain A, Crystallographic Analysis Of A Com...   189   2e-49
gi|1942941|pdb|1TCX|A Chain A, Hiv Triple Mutant Protease Comple...   189   2e-49
gi|168988684|pdb|2Q64|A Chain A, Hiv-1 Pr Mutant In Complex With...   189   2e-49
gi|122921397|pdb|2O4L|A Chain A, Crystal Structure Of Hiv-1 Prot...   189   2e-49
gi|193506629|pdb|2Z54|A Chain A, The Influence Of I47a Mutation ...   189   2e-49
gi|6435759|pdb|1D4S|A Chain A, Hiv-1 Protease V82fI84V DOUBLE MU...   189   3e-49
gi|6980882|pdb|1BV7|A Chain A, Counteracting Hiv-1 Protease Drug...   189   3e-49
gi|1421455|pdb|1DIF|A Chain A, Hiv-1 Protease In Complex With A ...   189   3e-49
gi|1943546|pdb|1GNN|A Chain A, Hiv-1 Protease Mutant With Val 82...   188   3e-49
gi|6980900|pdb|1BWA|A Chain A, Hiv-1 Protease (V82fI84V) DOUBLE ...   188   3e-49
gi|1943544|pdb|1GNM|A Chain A, Hiv-1 Protease Mutant With Val 82...   188   4e-49
gi|21730861|pdb|1LV1|A Chain A, Crystal Structure Analysis Of Th...   188   4e-49
gi|3318945|pdb|1A9M|A Chain A, G48h Mutant Of Hiv-1 Protease In ...   188   4e-49
gi|4139495|pdb|1HVH|A Chain A, Nonpeptide Cyclic Cyanoguanidines...   188   4e-49
gi|90108773|pdb|2AZ8|A Chain A, Hiv-1 Protease Nl4-3 In Complex ...   188   5e-49
gi|158428675|pdb|2I4U|A Chain A, Hiv-1 Protease With Tmc-126 >gn...   188   5e-49
gi|3114315|pdb|1MER|A Chain A, Hiv-1 Mutant (I84v) Protease Comp...   188   5e-49
gi|122920942|pdb|2NPH|A Chain A, Crystal Structure Of Hiv1 Prote...   187   6e-49
gi|576147|pdb|1HEF|E Chain E, The Crystal Structures At 2.2 Angs...   187   6e-49
gi|2098471|pdb|1ODX|A Chain A, Hiv-1 Proteinase Mutant A71t, V82...   187   6e-49
gi|168988674|pdb|2PYM|A Chain A, Hiv-1 Pr Mutant In Complex With...   187   6e-49
gi|2098357|pdb|1HPO|A Chain A, Hiv-1 Protease Triple MutantU1032...   187   7e-49
gi|99031740|pdb|1ZSF|A Chain A, Crystal Structure Of Complex Of ...   187   7e-49
gi|1421550|pdb|1HVS|A Chain A, Structural Basis Of Drug Resistan...   187   8e-49
gi|158428677|pdb|2I4V|A Chain A, Hiv-1 Protease I84v, L90m With ...   187   8e-49
gi|168988682|pdb|2Q63|A Chain A, Hiv-1 Pr Mutant In Complex With...   187   8e-49
gi|12084485|pdb|1FB7|A Chain A, Crystal Structure Of An In Vivo ...   187   8e-49
gi|168988676|pdb|2PYN|A Chain A, Hiv-1 Pr Mutant In Complex With...   187   9e-49
gi|30749426|pdb|1LZQ|A Chain A, Crystal Structure Of The Complex...   187   9e-49
gi|2914186|pdb|1HXW|A Chain A, Hiv-1 Protease Dimer Complexed Wi...   187   1e-48
gi|90108775|pdb|2AZ9|A Chain A, Hiv-1 Protease Nl4-3 1x Mutant        186   1e-48
gi|3114319|pdb|1MET|A Chain A, Hiv-1 Mutant (V82f) Protease Comp...   186   1e-48
gi|3114321|pdb|1MEU|A Chain A, Hiv-1 Mutant (V82f, I84v) Proteas...   186   1e-48
gi|146387074|pdb|2P3B|B Chain B, Crystal Structure Of The Subtyp...   186   2e-48
gi|28373793|pdb|1MTB|A Chain A, Viability Of A Drug-Resistant Hi...   186   2e-48
gi|2624873|pdb|1AID|A Chain A, Structure Of A Non-Peptide Inhibi...   186   2e-48
gi|1421543|pdb|1HVR|A Chain A, Rational Design Of Potent, Bioava...   186   3e-48
gi|38492434|pdb|1MRX|A Chain A, Structure Of Hiv Protease (Mutan...   185   3e-48
gi|27573665|pdb|1IZI|A Chain A, Inhibitor Of Hiv Protease With U...   185   3e-48
gi|158429165|pdb|2NXD|A Chain A, Structure Of Hiv-1 Protease D25...   184   5e-48
gi|119389416|pdb|2F3K|A Chain A, Substrate Envelope And Drug Res...   184   5e-48
gi|1942083|pdb|1YTG|A Chain A, Siv Protease Crystallized With Pe...   184   6e-48
gi|14719532|pdb|1F7A|A Chain A, How Does A Symmetric Dimer Recog...   184   7e-48
gi|116667812|pdb|2HS2|A Chain A, Crystal Structure Of M46l Mutan...   184   9e-48
gi|99031669|pdb|1ZBG|A Chain A, Crystal Structure Of A Complex O...   184   9e-48
gi|171849052|pdb|3BVA|A Chain A, Cystal Structure Of Hiv-1 Activ...   184   1e-47
gi|14488620|pdb|1FGC|C Chain C, Structural Implications Of Drug ...   183   1e-47
gi|28373784|pdb|1MT7|A Chain A, Viability Of A Drug-Resistant Hi...   183   1e-47
gi|119389478|pdb|2FGU|A Chain A, X-Ray Crystal Structure Of Hiv-...   183   1e-47
gi|9955095|pdb|1DW6|C Chain C, Structural And Kinetic Analysis O...   183   2e-47
gi|163311028|pdb|3B80|A Chain A, Hiv-1 Protease Mutant I54v Comp...   183   2e-47
gi|88192086|pdb|2AOC|A Chain A, Crystal Structure Analysis Of Hi...   183   2e-47
gi|88192162|pdb|2AVQ|A Chain A, Kinetics, Stability, And Structu...   183   2e-47
gi|2624506|pdb|1DMP|A Chain A, Structure Of Hiv-1 Protease Compl...   182   2e-47
gi|116667810|pdb|2HS1|A Chain A, Ultra-High Resolution X-Ray Cry...   182   2e-47
gi|189096255|pdb|3D1Z|A Chain A, Crystal Structure Of Hiv-1 Muta...   182   2e-47
gi|88192157|pdb|2AVM|A Chain A, Kinetics, Stability, And Structu...   182   2e-47
gi|119389480|pdb|2FGV|A Chain A, X-Ray Crystal Structure Of Hiv-...   182   2e-47
gi|18655473|pdb|1K6C|A Chain A, Lack Of Synergy For Inhibitors T...   182   3e-47
gi|49258965|pdb|1SDV|A Chain A, Crystal Structures Of Hiv Protea...   182   3e-47
gi|4389373|pdb|1A94|A Chain A, Structural Basis For Specificity ...   182   4e-47
gi|14488614|pdb|1FG6|C Chain C, Structural Implications Of Drug ...   182   4e-47
gi|88192169|pdb|2AVV|A Chain A, Kinetics, Stability, And Structu...   182   4e-47
gi|2554747|pdb|3AID|A Chain A, A New Class Of Hiv-1 Protease Inh...   182   4e-47
gi|14488608|pdb|1FFF|C Chain C, Structural Implications Of Drug ...   181   4e-47
gi|9955098|pdb|1EBK|C Chain C, Structural And Kinetic Analysis O...   181   4e-47
gi|193885421|pdb|3D3T|A Chain A, Crystal Structure Of Hiv-1 Crf0...   181   4e-47
gi|22218898|pdb|1K2B|A Chain A, Combining Mutations In Hiv-1 Pro...   181   5e-47
gi|93278539|pdb|1Z8C|A Chain A, Crystal Structure Of The Complex...   181   6e-47
gi|134104295|pdb|2FXE|A Chain A, X-Ray Crystal Structure Of Hiv-...   181   7e-47
gi|90108667|pdb|2A1E|A Chain A, High Resolution Structure Of Hiv...   181   7e-47
gi|109157787|pdb|2G69|A Chain A, Structure Of Unliganded Hiv-1 P...   181   7e-47
gi|189096246|pdb|3CYW|A Chain A, Effect Of Flap Mutations On Str...   180   1e-46
gi|3891944|pdb|1BDR|A Chain A, Hiv-1 (2: 31, 33-37) Protease Com...   180   1e-46
gi|22218901|pdb|1K2C|A Chain A, Combining Mutations In Hiv-1 Pro...   180   1e-46
gi|119389008|pdb|2B60|A Chain A, Structure Of Hiv-1 Protease Mut...   180   1e-46
gi|3659988|pdb|1BDL|A Chain A, Hiv-1 (2:31-37) Protease Complexe...   179   2e-46
gi|58176641|pdb|1RPI|A Chain A, Crystal Structures Of A Multidru...   179   2e-46
gi|55669731|pdb|1SGU|A Chain A, Comparing The Accumulation Of Ac...   179   2e-46
gi|231033|pdb|4HVP|A Chain A, Structure Of Complex Of Synthetic ...   179   2e-46
gi|2554748|pdb|3AID|B Chain B, A New Class Of Hiv-1 Protease Inh...   179   3e-46
gi|3659990|pdb|1BDQ|A Chain A, Hiv-1 (2:31-37, 47, 82) Protease ...   178   3e-46
gi|195927280|pdb|2RKF|A Chain A, Hiv-1 Pr Resistant Mutant + Lpv...   178   5e-46
gi|160877756|pdb|2R5P|A Chain A, Crystal Structure Analysis Of H...   178   5e-46
gi|12084156|pdb|1C6X|A Chain A, Alternate Binding Site For The P...   178   6e-46
gi|146387071|pdb|2P3A|A Chain A, Crystal Structure Of The Multi-...   177   6e-46
gi|170785196|pdb|3BXR|A Chain A, Crystal Structures Of Highly Co...   177   1e-45
gi|1827895|pdb|1MTR|A Chain A, Hiv-1 Protease Complexed With A C...   177   1e-45
gi|169791925|pdb|1Q9P|A Chain A, Solution Structure Of The Matur...   174   5e-45
gi|90109333|pdb|2FDD|A Chain A, Crystal Structure Of Hiv Proteas...   174   6e-45
gi|195927282|pdb|2RKG|A Chain A, Hiv-1 Pr Resistant Mutant + Lpv...   173   1e-44
gi|146387075|pdb|2P3C|A Chain A, Crystal Structure Of The Subtyp...   173   2e-44
gi|90108777|pdb|2AZB|A Chain A, Hiv-1 Protease Nl4-3 3x Mutant I...   167   1e-42
gi|146387077|pdb|2P3D|A Chain A, Crystal Structure Of The Multi-...   164   5e-42
gi|122921400|pdb|2O4N|A Chain A, Crystal Structure Of Hiv-1 Prot...   163   1e-41
gi|90108779|pdb|2AZC|A Chain A, Hiv-1 Protease Nl4-3 6x Mutant >...   162   2e-41
gi|158428963|pdb|2JE4|A Chain A, Atomic-Resolution Crystal Struc...   162   3e-41
gi|7766825|pdb|1DAZ|C Chain C, Structural And Kinetic Analysis O...   160   7e-41
gi|22218895|pdb|1K1U|A Chain A, Combining Mutations In Hiv-1 Pro...   160   1e-40
gi|119389010|pdb|2B7Z|B Chain B, Structure Of Hiv-1 Protease Mut...   160   2e-40
gi|22218892|pdb|1K1T|A Chain A, Combining Mutations In Hiv-1 Pro...   159   2e-40
gi|197107260|pdb|3DCK|A Chain A, X-Ray Structure Of D25n Chemica...   159   3e-40
gi|158428936|pdb|2J9J|A Chain A, Atomic-Resolution Crystal Struc...   158   4e-40
gi|134104293|pdb|2FXD|A Chain A, X-Ray Crystal Structure Of Hiv-...   158   5e-40
gi|122921392|pdb|2O40|A Chain A, Crystal Structure Of A Chemical...   157   7e-40
gi|158428937|pdb|2J9J|B Chain B, Atomic-Resolution Crystal Struc...   156   1e-39
gi|157833815|pdb|1SIP|A Chain A, Alternative Native Flap Conform...   107   9e-25
gi|157836348|pdb|2SAM|A Chain A, Structure Of The Protease From ...   106   2e-24
gi|1942089|pdb|1YTI|A Chain A, Siv Protease Crystallized With Pe...   105   3e-24
gi|494588|pdb|1SIV|A Chain A, Three-Dimensional Structure Of A S...   105   5e-24
gi|157830152|pdb|1AZ5|A Chain A, Unliganded Siv Protease Structu...   103   2e-23
gi|443402|pdb|2MIP|A Chain A, Crystal Structure Of Human Immunod...   103   2e-23
gi|443054|pdb|1IVP|A Chain A, The Crystallographic Structure Of ...   101   7e-23
gi|4389337|pdb|1BAI|A Chain A, Structural Basis For Specificity ...    48   7e-07
gi|159162755|pdb|1NSO|A Chain A, Folded Monomer Of Protease From...    34   0.010
gi|134104445|pdb|2HAH|A Chain A, The Structure Of Fiv 12s Protea...    30   0.18 
gi|230182|pdb|1MVP|A Chain A, Structural Studies Of The Retrovir...    30   0.21 
gi|230722|pdb|2RSP|A Chain A, Structure Of The Aspartic Protease...    30   0.21 
gi|157831103|pdb|1FMB|A Chain A, Eiav Protease Complexed With Th...    28   0.88 
gi|2624458|pdb|2FIV|A Chain A, Crystal Structure Of Feline Immun...    27   2.1  
gi|6730067|pdb|5FIV|A Chain A, Structural Studies Of Hiv And Fiv...    27   2.2  
gi|2624481|pdb|3FIV|A Chain A, Crystal Structure Of Feline Immun...    27   2.2  
gi|6730050|pdb|6FIV|A Chain A, Structural Studies Of Hiv And Fiv...    27   2.4  
gi|1127270|pdb|1FIV|A Chain A, Structure Of An Inhibitor Complex...    27   2.5  
gi|213424552|pdb|3F1C|A Chain A, Crystal Structure Of 2-C-Methyl...    26   2.9  
gi|2780904|pdb|2HRP|P Chain P, Antigen-Antibody Complex >gnl|BL_...    26   3.0  
gi|159164133|pdb|2DIV|A Chain A, Solution Structure Of The Rrm D...    26   3.6  
gi|114793631|pdb|2CU9|A Chain A, Crystal Structure Of Histone Ch...    26   3.6  
gi|159163504|pdb|1X2L|A Chain A, Solution Structure Of The Cut D...    26   4.1  
gi|178847337|pdb|2VNU|D Chain D, Crystal Structure Of Sc Rrp44         25   6.9  

>gi|56554341|pdb|1W5Y|A Chain A, Hiv-1 Protease In Complex With
           Fluoro Substituted Diol- Based C2-Symmetric Inhibitor
 Chain B, Hiv-1 Protease In Complex With Fluoro Substituted Diol-
           Based C2-Symmetric Inhibitor
 Chain A, Hiv-1 Protease In Complex With Fluoro Substituted Diol-
           Based C2-Symmetric Inhibitor
 Chain B, Hiv-1 Protease In Complex With Fluoro Substituted Diol-
           Based C2-Symmetric Inhibitor
 Chain A, Hiv-1 Protease In Complex With Fluoro Substituted Diol-
           Based C2-Symmetric Inhibitor
 Chain B, Hiv-1 Protease In Complex With Fluoro Substituted Diol-
           Based C2-Symmetric Inhibitor
 Chain A, Hiv-1 Protease In Complex With Fluoro Substituted Diol-
           Based C2-Symmetric Inhibitor
 Chain B, Hiv-1 Protease In Complex With Fluoro Substituted Diol-
           Based C2-Symmetric Inhibitor
          Length = 110

 Score =  192 bits (487), Expect = 3e-50,   Method: Compositional matrix adjust.
 Identities = 94/99 (94%), Positives = 97/99 (97%)

Query: 17  PQITLYQRPLVTIKIGGQLKEALLKTGADDTVLEEMSLPGEWKPKLIGGIGGFIKVRQYD 76
           PQITL+QRPLVTIKIGGQLKEALL TGADDTVLEEMSLPG WKPK+IGGIGGFIKVRQYD
Sbjct: 12  PQITLWQRPLVTIKIGGQLKEALLDTGADDTVLEEMSLPGRWKPKMIGGIGGFIKVRQYD 71

Query: 77  QILIEICGHKAIGTVLVGPTPVNILGRNLLTQIGCTLNF 115
           QILIEICGHKAIGTVLVGPTPVNI+GRNLLTQIGCTLNF
Sbjct: 72  QILIEICGHKAIGTVLVGPTPVNIIGRNLLTQIGCTLNF 110


>gi|90109335|pdb|2FDE|A Chain A, Wild Type Hiv Protease Bound With
           Gw0385
 Chain B, Wild Type Hiv Protease Bound With Gw0385
          Length = 100

 Score =  191 bits (485), Expect = 5e-50,   Method: Compositional matrix adjust.
 Identities = 94/99 (94%), Positives = 97/99 (97%)

Query: 17  PQITLYQRPLVTIKIGGQLKEALLKTGADDTVLEEMSLPGEWKPKLIGGIGGFIKVRQYD 76
           PQITL+QRPLVTIKIGGQLKEALL TGADDTVLEEMSLPG WKPK+IGGIGGFIKVRQYD
Sbjct: 2   PQITLWQRPLVTIKIGGQLKEALLDTGADDTVLEEMSLPGRWKPKMIGGIGGFIKVRQYD 61

Query: 77  QILIEICGHKAIGTVLVGPTPVNILGRNLLTQIGCTLNF 115
           QILIEICGHKAIGTVLVGPTPVNI+GRNLLTQIGCTLNF
Sbjct: 62  QILIEICGHKAIGTVLVGPTPVNIIGRNLLTQIGCTLNF 100


>gi|443021|pdb|1HOS|A Chain A, Inhibition Of Human Immunodeficiency
           Virus-1 Protease By A C2-Symmetric Phosphinate Synthesis
           And Crystallographic Analysis
 Chain B, Inhibition Of Human Immunodeficiency Virus-1 Protease By A
           C2-Symmetric Phosphinate Synthesis And Crystallographic
           Analysis
 Chain A, X-Ray Crystallographic Studies Of A Series Of Penicillin-
           Derived Asymmetric Inhibitors Of Hiv-1 Protease
 Chain B, X-Ray Crystallographic Studies Of A Series Of Penicillin-
           Derived Asymmetric Inhibitors Of Hiv-1 Protease
 Chain A, X-Ray Crystallographic Studies Of A Series Of Penicillin-
           Derived Asymmetric Inhibitors Of Hiv-1 Protease
 Chain B, X-Ray Crystallographic Studies Of A Series Of Penicillin-
           Derived Asymmetric Inhibitors Of Hiv-1 Protease
 Chain A, X-Ray Crystallographic Studies Of A Series Of Penicillin-
           Derived Asymmetric Inhibitors Of Hiv-1 Protease
 Chain B, X-Ray Crystallographic Studies Of A Series Of Penicillin-
           Derived Asymmetric Inhibitors Of Hiv-1 Protease
 Chain A, Rational Design, Synthesis And Crystallographic Analysis
           Of A Hydroxyethylene-Based Hiv-1 Protease Inhibitor
           Containing A Heterocyclic P1'-P2' Amide Bond Isostere
 Chain B, Rational Design, Synthesis And Crystallographic Analysis
           Of A Hydroxyethylene-Based Hiv-1 Protease Inhibitor
           Containing A Heterocyclic P1'-P2' Amide Bond Isostere
 Chain A, Crystal Structure Of Hiv-1 Protease In Complex With
           Vx-478, A Potent And Orally Bioavailable Inhibitor Of
           The Enzyme
 Chain B, Crystal Structure Of Hiv-1 Protease In Complex With
           Vx-478, A Potent And Orally Bioavailable Inhibitor Of
           The Enzyme
 Chain A, A Check On Rational Drug Design. Crystal Structure Of A
           Complex Of Hiv-1 Protease With A Novel Gamma-Turn
           Mimetic
 Chain B, A Check On Rational Drug Design. Crystal Structure Of A
           Complex Of Hiv-1 Protease With A Novel Gamma-Turn
           Mimetic
 Chain A, Comparative Analysis Of The X-Ray Structures Of Hiv-1 And
           Hiv-2 Proteases In Complex With Cgp 53820, A Novel
           Pseudosymmetric Inhibitor
 Chain B, Comparative Analysis Of The X-Ray Structures Of Hiv-1 And
           Hiv-2 Proteases In Complex With Cgp 53820, A Novel
           Pseudosymmetric Inhibitor
 Chain A, Hiv-1 Protease Complexed With The Inhibitor Kni-272
 Chain B, Hiv-1 Protease Complexed With The Inhibitor Kni-272
 Chain A, Crystal Structure At 1.9 Angstroms Resolution Of Human
           Immunodeficiency Virus (Hiv) Ii Protease Complexed With
           L- 735,524, An Orally Bioavailable Inhibitor Of The Hiv
           Proteases
 Chain B, Crystal Structure At 1.9 Angstroms Resolution Of Human
           Immunodeficiency Virus (Hiv) Ii Protease Complexed With
           L- 735,524, An Orally Bioavailable Inhibitor Of The Hiv
           Proteases
 Chain A, Hiv-1 Protease Complex With U100313 ([3-[[3-[cyclopropyl
           [4-
           Hydroxy-2oxo-6-[1-(Phenylmethyl)propyl]-2h-Pyran-3-Yl]
           Methyl]phenyl]amino]-3-Oxo-Propyl]carbamic Acid
           Tert-Butyl Ester)
 Chain B, Hiv-1 Protease Complex With U100313 ([3-[[3-[cyclopropyl
           [4-
           Hydroxy-2oxo-6-[1-(Phenylmethyl)propyl]-2h-Pyran-3-Yl]
           Methyl]phenyl]amino]-3-Oxo-Propyl]carbamic Acid
           Tert-Butyl Ester)
 Chain A, Hiv-1 Protease (Wild Type) Complexed With U89360e
           (Inhibitor)
 Chain B, Hiv-1 Protease (Wild Type) Complexed With U89360e
           (Inhibitor)
 Chain A, Hiv-1 ProteaseU101935 COMPLEX
 Chain B, Hiv-1 ProteaseU101935 COMPLEX
 Chain A, Hiv-1 Protease In Complex With The Cyclic Sulfamide
           Inhibitor Aha006
 Chain B, Hiv-1 Protease In Complex With The Cyclic Sulfamide
           Inhibitor Aha006
 Chain A, Hiv-1 Protease In Complex With The Cyclic Urea Inhibitor
           Aha001
 Chain B, Hiv-1 Protease In Complex With The Cyclic Urea Inhibitor
           Aha001
 Chain A, Hiv-1 Protease-Inhibitor Complex
 Chain B, Hiv-1 Protease-Inhibitor Complex
 Chain A, Hiv-1 Protease-Inhibitor Complex
 Chain B, Hiv-1 Protease-Inhibitor Complex
 Chain A, Hiv-1 Protease-Inhibitor Complex
 Chain B, Hiv-1 Protease-Inhibitor Complex
 Chain A, Hiv-1 Protease-Inhibitor Complex
 Chain B, Hiv-1 Protease-Inhibitor Complex
 Chain A, Hiv-1 Protease-Inhibitor Complex
 Chain B, Hiv-1 Protease-Inhibitor Complex
 Chain A, Alternate Binding Site For The P1-P3 Group Of A Class Of
           Potent Hiv-1 Protease Inhibitors As A Result Of
           Concerted Structural Change In 80's Loop.
 Chain B, Alternate Binding Site For The P1-P3 Group Of A Class Of
           Potent Hiv-1 Protease Inhibitors As A Result Of
           Concerted Structural Change In 80's Loop.
 Chain A, Crystal Structure Of The Complex Of Hiv-1 Protease With A
           Peptidomimetic Inhibitor
 Chain B, Crystal Structure Of The Complex Of Hiv-1 Protease With A
           Peptidomimetic Inhibitor
 Chain A, Crystal Structure Of Hiv-1 Protease In Complex With
           Inhibitor, Aha024
 Chain B, Crystal Structure Of Hiv-1 Protease In Complex With
           Inhibitor, Aha024
 Chain A, Hiv-1 Protease With Cyclic Sulfamide Inhibitor, Aha047
 Chain B, Hiv-1 Protease With Cyclic Sulfamide Inhibitor, Aha047
 Chain A, Crystal Structure Of Hiv-1 Protease Complexed With A
           Hydroxyethylamine Peptidomimetic Inhibitor
 Chain B, Crystal Structure Of Hiv-1 Protease Complexed With A
           Hydroxyethylamine Peptidomimetic Inhibitor
 Chain A, Hiv-1 Protease In Complex With The Inhibitor Bea435
 Chain B, Hiv-1 Protease In Complex With The Inhibitor Bea435
 Chain A, Hiv-1 Protease In Complex With The Inhibitor Bea425
 Chain B, Hiv-1 Protease In Complex With The Inhibitor Bea425
 Chain A, Hiv-1 Protease In Complex With The Inhibitor Msl370
 Chain B, Hiv-1 Protease In Complex With The Inhibitor Msl370
 Chain A, Hiv-1 Protease In Complex With The Inhibitor Bea322
 Chain B, Hiv-1 Protease In Complex With The Inhibitor Bea322
 Chain A, Hiv-1 Protease In Complex With The Inhibitor Bea388
 Chain B, Hiv-1 Protease In Complex With The Inhibitor Bea388
 Chain A, Hiv-1 Protease In Complex With The Inhibitor Bea403
 Chain B, Hiv-1 Protease In Complex With The Inhibitor Bea403
 Chain A, Hiv-1 Protease In Complex With The Inhibitor Bea409
 Chain B, Hiv-1 Protease In Complex With The Inhibitor Bea409
 Chain A, Hiv-1 Protease In Complex With The Inhibitor Bea428
 Chain B, Hiv-1 Protease In Complex With The Inhibitor Bea428
 Chain A, Hiv-1 Protease In Complex With The Inhibitor Msa367
 Chain B, Hiv-1 Protease In Complex With The Inhibitor Msa367
 Chain B, Crystal Structure Of Hiv-1 Protease Complexed With
           Lopinavir.
 Chain A, Crystal Structure Of Hiv-1 Protease Complexed With
           Lopinavir.
 Chain A, Crystal Structure Of Hiv-1 Protease Complexed With Ldc271
 Chain B, Crystal Structure Of Hiv-1 Protease Complexed With Ldc271
 Chain A, Crystal Structure Of Hiv Protease Complexed With Lgz479
 Chain B, Crystal Structure Of Hiv Protease Complexed With Lgz479
 Chain A, Hiv-1 Protease In Complex With An Ethyleneamine Inhibitor
 Chain B, Hiv-1 Protease In Complex With An Ethyleneamine Inhibitor
 Chain A, Crystal Structure Of Hiv-1 Protease-Hup
 Chain B, Crystal Structure Of Hiv-1 Protease-Hup
 Chain A, 1.03 A Structure Of Hiv-1 Protease: Inhibitor Binding
           Inside And Outside The Active Site
 Chain B, 1.03 A Structure Of Hiv-1 Protease: Inhibitor Binding
           Inside And Outside The Active Site
 Chain A, Crystal Structure Of Hiv Protease Complexed With
           Arylsulfonamide Azacyclic Urea
 Chain B, Crystal Structure Of Hiv Protease Complexed With
           Arylsulfonamide Azacyclic Urea
 Chain A, Crystal Structure Of A Hiv-1 Protease In Complex With
           Peptidomimetic Inhibitor Ki2-Phe-Glu-Glu-Nh2
 Chain B, Crystal Structure Of A Hiv-1 Protease In Complex With
           Peptidomimetic Inhibitor Ki2-Phe-Glu-Glu-Nh2
 Chain A, Hiv-1 Protease In Complex With Asymmetric Inhibitor,
           Bea568
 Chain B, Hiv-1 Protease In Complex With Asymmetric Inhibitor,
           Bea568
 Chain A, Hiv-1 Protease In Complex With Symmetric Inhibitor, Bea450
 Chain B, Hiv-1 Protease In Complex With Symmetric Inhibitor, Bea450
 Chain A, Hiv Protease With Oximinoarylsulfonamide Bound
 Chain B, Hiv Protease With Oximinoarylsulfonamide Bound
 Chain A, Hiv-1 Protease In Complex With Pyrrolidinmethanamine
 Chain B, Hiv-1 Protease In Complex With Pyrrolidinmethanamine
 Chain A, Hiv-1 Protease In Complex With Amidhyroxysulfone
 Chain B, Hiv-1 Protease In Complex With Amidhyroxysulfone
 Chain A, Crystal Structure Of Hiv-1 Protease Complexed With A
           Product Of Autoproteolysis
 Chain B, Crystal Structure Of Hiv-1 Protease Complexed With A
           Product Of Autoproteolysis
 Chain A, Synthesis And Activity Of N-Axyl Azacyclic Urea Hiv-1
           Protease Inhibitors With High Potency Against Multiple
           Drug Resistant Viral Strains.
 Chain B, Synthesis And Activity Of N-Axyl Azacyclic Urea Hiv-1
           Protease Inhibitors With High Potency Against Multiple
           Drug Resistant Viral Strains.
 Chain A, Structure Of Hiv1 Protease And Akc4p_133a Complex.
 Chain B, Structure Of Hiv1 Protease And Akc4p_133a Complex.
 Chain A, Structure Of Hiv1 Protease And Hh1_173_3a Complex.
 Chain B, Structure Of Hiv1 Protease And Hh1_173_3a Complex.
 Chain A, Hiv-1 Protease In Complex With Inhibitor Aha455
 Chain B, Hiv-1 Protease In Complex With Inhibitor Aha455
 Chain A, Structure Of Hiv-1 Protease Bound To Atazanavir
 Chain B, Structure Of Hiv-1 Protease Bound To Atazanavir
 Chain A, P1' Extended Hiv-1 Protease Inhibitors Encompassing A
           Tertiary Alcohol In The Transition-State Mimicking
           Scaffold
 Chain B, P1' Extended Hiv-1 Protease Inhibitors Encompassing A
           Tertiary Alcohol In The Transition-State Mimicking
           Scaffold
 Chain A, P1' Extended Hiv-1 Protease Inhibitors Encompassing A
           Tertiary Alcohol In The Transition-State Mimicking
           Scaffold
 Chain B, P1' Extended Hiv-1 Protease Inhibitors Encompassing A
           Tertiary Alcohol In The Transition-State Mimicking
           Scaffold
 Chain A, P1' Extended Hiv-1 Protease Inhibitors Encompassing A
           Tertiary Alcohol In The Transition-State Mimicking
           Scaffold
 Chain B, P1' Extended Hiv-1 Protease Inhibitors Encompassing A
           Tertiary Alcohol In The Transition-State Mimicking
           Scaffold
 Chain A, The Three-Dimensional Structure Of The Aspartyl Protease
           From The Hiv-1 Isolate Bru
 Chain A, Hiv-1 Protease Complex With U095438 [3-[1-(4-Bromophenyl)
           Isobutyl]-4-Hydroxycoumarin
 Chain A, X-Ray Analysis Of Hiv-1 Proteinase At 2.7 Angstroms
           Resolution Confirms Structural Homology Among Retroviral
           Enzymes
 Chain A, Hiv-1 Protease In Complex With A Pyrrolidine-Based
           Inhibitor
 Chain B, Hiv-1 Protease In Complex With A Pyrrolidine-Based
           Inhibitor
 Chain A, Hiv-1 Protease In Complex With A Amino Decorated
           Pyrrolidine-Based Inhibitor
 Chain B, Hiv-1 Protease In Complex With A Amino Decorated
           Pyrrolidine-Based Inhibitor
 Chain A, Hiv-1 Protease In Complex With A Carbamoyl Decorated
           Pyrrolidine-Based Inhibitor
 Chain B, Hiv-1 Protease In Complex With A Carbamoyl Decorated
           Pyrrolidine-Based Inhibitor
 Chain A, Hiv-1 Protease In Complex With A Multiple Decorated
           Pyrrolidine-Based Inhibitor
 Chain B, Hiv-1 Protease In Complex With A Multiple Decorated
           Pyrrolidine-Based Inhibitor
 Chain A, Hiv-1 Protease In Complex With A Iodo Decorated
           Pyrrolidine- Based Inhibitor
 Chain B, Hiv-1 Protease In Complex With A Iodo Decorated
           Pyrrolidine- Based Inhibitor
 Chain A, Hiv-1 Protease In Complex With A Chloro Decorated
           Pyrrolidine-Based Inhibitor
 Chain B, Hiv-1 Protease In Complex With A Chloro Decorated
           Pyrrolidine-Based Inhibitor
 Chain A, Two-Carbon-Elongated Hiv-1 Protease Inhibitors With A
           Tertiary-Alcohol-Containing Transition-State Mimic
 Chain B, Two-Carbon-Elongated Hiv-1 Protease Inhibitors With A
           Tertiary-Alcohol-Containing Transition-State Mimic
 Chain A, Two-Carbon-Elongated Hiv-1 Protease Inhibitors With A
           Tertiary-Alcohol-Containing Transition-State Mimic
 Chain B, Two-Carbon-Elongated Hiv-1 Protease Inhibitors With A
           Tertiary-Alcohol-Containing Transition-State Mimic
 Chain A, Hiv-1 Protease In Complex With A Isobutyl Decorated
           Oligoamine
 Chain B, Hiv-1 Protease In Complex With A Isobutyl Decorated
           Oligoamine
 Chain A, Hiv-1 Protease In Complex With A Benzyl Decorated
           Oligoamine
 Chain B, Hiv-1 Protease In Complex With A Benzyl Decorated
           Oligoamine
 Chain A, Hiv-1 Protease In Complex With A Three Armed Pyrrolidine
           Derivative
 Chain B, Hiv-1 Protease In Complex With A Three Armed Pyrrolidine
           Derivative
 Chain A, Hiv-1 Protease In Complex With A Dimethylallyl Decorated
           Pyrrolidine Based Inhibitor (Hexagonal Space Group)
 Chain A, Hiv-1 Protease In Complex With A Dimethylallyl Decorated
           Pyrrolidine Based Inhibitor (Orthorombic Space Group)
 Chain B, Hiv-1 Protease In Complex With A Dimethylallyl Decorated
           Pyrrolidine Based Inhibitor (Orthorombic Space Group)
 Chain G, Hiv Protease Inhibitors With Pseudo-Symmetric Cores
 Chain H, Hiv Protease Inhibitors With Pseudo-Symmetric Cores
 Chain A, Hiv Protease Inhibitors With Pseudo-Symmetric Cores
 Chain B, Hiv Protease Inhibitors With Pseudo-Symmetric Cores
 Chain C, Hiv Protease Inhibitors With Pseudo-Symmetric Cores
 Chain D, Hiv Protease Inhibitors With Pseudo-Symmetric Cores
 Chain B, Hiv Protease, Pseudo-Symmetric Inhibitors
 Chain A, Hiv Protease, Pseudo-Symmetric Inhibitors
 Chain C, Hiv Protease, Pseudo-Symmetric Inhibitors
 Chain D, Hiv Protease, Pseudo-Symmetric Inhibitors
 Chain E, Hiv Protease, Pseudo-Symmetric Inhibitors
 Chain F, Hiv Protease, Pseudo-Symmetric Inhibitors
 Chain G, Hiv Protease, Pseudo-Symmetric Inhibitors
 Chain H, Hiv Protease, Pseudo-Symmetric Inhibitors
 Chain I, Hiv Protease, Pseudo-Symmetric Inhibitors
 Chain A, Hiv Protease, Pseudo-Symmetric Inhibitors
 Chain B, Hiv Protease, Pseudo-Symmetric Inhibitors
 Chain C, Hiv Protease, Pseudo-Symmetric Inhibitors
 Chain D, Hiv Protease, Pseudo-Symmetric Inhibitors
 Chain E, Hiv Protease, Pseudo-Symmetric Inhibitors
 Chain F, Hiv Protease, Pseudo-Symmetric Inhibitors
 Chain G, Hiv Protease, Pseudo-Symmetric Inhibitors
 Chain H, Hiv Protease, Pseudo-Symmetric Inhibitors
          Length = 99

 Score =  191 bits (485), Expect = 5e-50,   Method: Compositional matrix adjust.
 Identities = 94/99 (94%), Positives = 97/99 (97%)

Query: 17  PQITLYQRPLVTIKIGGQLKEALLKTGADDTVLEEMSLPGEWKPKLIGGIGGFIKVRQYD 76
           PQITL+QRPLVTIKIGGQLKEALL TGADDTVLEEMSLPG WKPK+IGGIGGFIKVRQYD
Sbjct: 1   PQITLWQRPLVTIKIGGQLKEALLDTGADDTVLEEMSLPGRWKPKMIGGIGGFIKVRQYD 60

Query: 77  QILIEICGHKAIGTVLVGPTPVNILGRNLLTQIGCTLNF 115
           QILIEICGHKAIGTVLVGPTPVNI+GRNLLTQIGCTLNF
Sbjct: 61  QILIEICGHKAIGTVLVGPTPVNIIGRNLLTQIGCTLNF 99


>gi|157831402|pdb|1HVC|A Chain A, Crystal Structure Of A Tethered
           Dimer Of Hiv-1 Protease Complexed With An Inhibitor
          Length = 203

 Score =  191 bits (484), Expect = 7e-50,   Method: Compositional matrix adjust.
 Identities = 94/99 (94%), Positives = 97/99 (97%)

Query: 17  PQITLYQRPLVTIKIGGQLKEALLKTGADDTVLEEMSLPGEWKPKLIGGIGGFIKVRQYD 76
           PQITL+QRPLVTIKIGGQLKEALL TGADDTVLEEMSLPG WKPK+IGGIGGFIKVRQYD
Sbjct: 105 PQITLWQRPLVTIKIGGQLKEALLDTGADDTVLEEMSLPGRWKPKMIGGIGGFIKVRQYD 164

Query: 77  QILIEICGHKAIGTVLVGPTPVNILGRNLLTQIGCTLNF 115
           QILIEICGHKAIGTVLVGPTPVNI+GRNLLTQIGCTLNF
Sbjct: 165 QILIEICGHKAIGTVLVGPTPVNIIGRNLLTQIGCTLNF 203



 Score =  186 bits (472), Expect = 2e-48,   Method: Compositional matrix adjust.
 Identities = 91/98 (92%), Positives = 97/98 (98%)

Query: 18  QITLYQRPLVTIKIGGQLKEALLKTGADDTVLEEMSLPGEWKPKLIGGIGGFIKVRQYDQ 77
           QITL+QRPLVTI+IGGQLKEALL TGADDTVLEEM+LPG+WKPK+IGGIGGFIKVRQYDQ
Sbjct: 2   QITLWQRPLVTIRIGGQLKEALLDTGADDTVLEEMNLPGKWKPKMIGGIGGFIKVRQYDQ 61

Query: 78  ILIEICGHKAIGTVLVGPTPVNILGRNLLTQIGCTLNF 115
           ILIEICGHKAIGTVLVGPTPVNI+GRNLLTQIGCTLNF
Sbjct: 62  ILIEICGHKAIGTVLVGPTPVNIIGRNLLTQIGCTLNF 99


>gi|11513732|pdb|1G6L|A Chain A, 1.9a Crystal Structure Of Tethered
           Hiv-1 Protease
          Length = 203

 Score =  191 bits (484), Expect = 7e-50,   Method: Compositional matrix adjust.
 Identities = 93/99 (93%), Positives = 97/99 (97%)

Query: 17  PQITLYQRPLVTIKIGGQLKEALLKTGADDTVLEEMSLPGEWKPKLIGGIGGFIKVRQYD 76
           PQ+TL+QRPLVTIKIGGQLKEALL TGADDTVLEEMSLPG WKPK+IGGIGGFIKVRQYD
Sbjct: 105 PQVTLWQRPLVTIKIGGQLKEALLDTGADDTVLEEMSLPGRWKPKMIGGIGGFIKVRQYD 164

Query: 77  QILIEICGHKAIGTVLVGPTPVNILGRNLLTQIGCTLNF 115
           QILIEICGHKAIGTVLVGPTPVNI+GRNLLTQIGCTLNF
Sbjct: 165 QILIEICGHKAIGTVLVGPTPVNIIGRNLLTQIGCTLNF 203



 Score =  187 bits (474), Expect = 1e-48,   Method: Compositional matrix adjust.
 Identities = 92/99 (92%), Positives = 96/99 (96%)

Query: 17  PQITLYQRPLVTIKIGGQLKEALLKTGADDTVLEEMSLPGEWKPKLIGGIGGFIKVRQYD 76
           PQ+TL+QRPLVTIKIGGQLKEALL TGADDTVLEEMSLPG WKPK+IGGIGGFIKVRQYD
Sbjct: 1   PQVTLWQRPLVTIKIGGQLKEALLDTGADDTVLEEMSLPGRWKPKMIGGIGGFIKVRQYD 60

Query: 77  QILIEICGHKAIGTVLVGPTPVNILGRNLLTQIGCTLNF 115
           QILIEICGHKAIGTVLVGPTPVNI+GRNLLTQIG TLNF
Sbjct: 61  QILIEICGHKAIGTVLVGPTPVNIIGRNLLTQIGMTLNF 99


>gi|4558173|pdb|1ODY|A Chain A, Hiv-1 Protease Complexed With An
           Inhibitor Lp-130
 Chain B, Hiv-1 Protease Complexed With An Inhibitor Lp-130
          Length = 99

 Score =  191 bits (484), Expect = 7e-50,   Method: Compositional matrix adjust.
 Identities = 93/99 (93%), Positives = 97/99 (97%)

Query: 17  PQITLYQRPLVTIKIGGQLKEALLKTGADDTVLEEMSLPGEWKPKLIGGIGGFIKVRQYD 76
           PQ+TL+QRPLVTIKIGGQLKEALL TGADDTVLEEMSLPG WKPK+IGGIGGFIKVRQYD
Sbjct: 1   PQVTLWQRPLVTIKIGGQLKEALLDTGADDTVLEEMSLPGAWKPKMIGGIGGFIKVRQYD 60

Query: 77  QILIEICGHKAIGTVLVGPTPVNILGRNLLTQIGCTLNF 115
           QILIEICGHKAIGTVLVGPTPVNI+GRNLLTQIGCTLNF
Sbjct: 61  QILIEICGHKAIGTVLVGPTPVNIIGRNLLTQIGCTLNF 99


>gi|197724931|pdb|2R38|A Chain A, I84v Hiv-1 Protease Mutant In
           Complex With A Carbamoyl Decorated Pyrrolidine-Based
           Inhibitor
 Chain B, I84v Hiv-1 Protease Mutant In Complex With A Carbamoyl
           Decorated Pyrrolidine-Based Inhibitor
 Chain A, I84v Hiv-1 Protease In Complex With A Amino Decorated
           Pyrrolidine-Based Inhibitor
 Chain B, I84v Hiv-1 Protease In Complex With A Amino Decorated
           Pyrrolidine-Based Inhibitor
 Chain A, I84v Hiv-1 Protease In Complex With A Pyrrolidine Diester
          Length = 99

 Score =  191 bits (484), Expect = 7e-50,   Method: Compositional matrix adjust.
 Identities = 93/99 (93%), Positives = 97/99 (97%)

Query: 17  PQITLYQRPLVTIKIGGQLKEALLKTGADDTVLEEMSLPGEWKPKLIGGIGGFIKVRQYD 76
           PQITL+QRPLVTIKIGGQLKEALL TGADDTVLEEMSLPG WKPK+IGGIGGFIKVRQYD
Sbjct: 1   PQITLWQRPLVTIKIGGQLKEALLDTGADDTVLEEMSLPGRWKPKMIGGIGGFIKVRQYD 60

Query: 77  QILIEICGHKAIGTVLVGPTPVNILGRNLLTQIGCTLNF 115
           QILIEICGHKAIGTVLVGPTPVN++GRNLLTQIGCTLNF
Sbjct: 61  QILIEICGHKAIGTVLVGPTPVNVIGRNLLTQIGCTLNF 99


>gi|197724933|pdb|2R3T|A Chain A, I50v Hiv-1 Protease Mutant In
           Complex With A Carbamoyl Decorated Pyrrolidine-Based
           Inhibitor
 Chain B, I50v Hiv-1 Protease Mutant In Complex With A Carbamoyl
           Decorated Pyrrolidine-Based Inhibitor
 Chain A, I50v Hiv-1 Protease In Complex With An Amino Decorated
           Pyrrolidine-Based Inhibitor
 Chain B, I50v Hiv-1 Protease In Complex With An Amino Decorated
           Pyrrolidine-Based Inhibitor
          Length = 99

 Score =  191 bits (484), Expect = 7e-50,   Method: Compositional matrix adjust.
 Identities = 93/99 (93%), Positives = 97/99 (97%)

Query: 17  PQITLYQRPLVTIKIGGQLKEALLKTGADDTVLEEMSLPGEWKPKLIGGIGGFIKVRQYD 76
           PQITL+QRPLVTIKIGGQLKEALL TGADDTVLEEMSLPG WKPK+IGG+GGFIKVRQYD
Sbjct: 1   PQITLWQRPLVTIKIGGQLKEALLDTGADDTVLEEMSLPGRWKPKMIGGVGGFIKVRQYD 60

Query: 77  QILIEICGHKAIGTVLVGPTPVNILGRNLLTQIGCTLNF 115
           QILIEICGHKAIGTVLVGPTPVNI+GRNLLTQIGCTLNF
Sbjct: 61  QILIEICGHKAIGTVLVGPTPVNIIGRNLLTQIGCTLNF 99


>gi|443017|pdb|1HIV|A Chain A, Crystal Structure Of A Complex Of
           Hiv-1 Protease With A Dihydroethylene-Containing
           Inhibitor: Comparisons With Molecular Modeling
 Chain B, Crystal Structure Of A Complex Of Hiv-1 Protease With A
           Dihydroethylene-Containing Inhibitor: Comparisons With
           Molecular Modeling
 Chain A, Hiv-1 Proteinase Complexed With Ro 31-8959
 Chain B, Hiv-1 Proteinase Complexed With Ro 31-8959
 Chain A, Native Hiv-1 Proteinase
 Chain B, Native Hiv-1 Proteinase
          Length = 99

 Score =  191 bits (484), Expect = 7e-50,   Method: Compositional matrix adjust.
 Identities = 93/99 (93%), Positives = 97/99 (97%)

Query: 17  PQITLYQRPLVTIKIGGQLKEALLKTGADDTVLEEMSLPGEWKPKLIGGIGGFIKVRQYD 76
           PQ+TL+QRPLVTIKIGGQLKEALL TGADDTVLEEMSLPG WKPK+IGGIGGFIKVRQYD
Sbjct: 1   PQVTLWQRPLVTIKIGGQLKEALLDTGADDTVLEEMSLPGRWKPKMIGGIGGFIKVRQYD 60

Query: 77  QILIEICGHKAIGTVLVGPTPVNILGRNLLTQIGCTLNF 115
           QILIEICGHKAIGTVLVGPTPVNI+GRNLLTQIGCTLNF
Sbjct: 61  QILIEICGHKAIGTVLVGPTPVNIIGRNLLTQIGCTLNF 99


>gi|126030406|pdb|2FLE|A Chain A, Structural Analysis Of Asymmetric
           Inhibitor Bound To The Hiv-1 Protease V82a Mutant
 Chain B, Structural Analysis Of Asymmetric Inhibitor Bound To The
           Hiv-1 Protease V82a Mutant
          Length = 99

 Score =  190 bits (483), Expect = 1e-49,   Method: Compositional matrix adjust.
 Identities = 93/99 (93%), Positives = 97/99 (97%)

Query: 17  PQITLYQRPLVTIKIGGQLKEALLKTGADDTVLEEMSLPGEWKPKLIGGIGGFIKVRQYD 76
           PQITL+QRPLVTIKIGGQLKEALL TGADDTVLEEMSLPG+WKPK+IGGIGGFIKVRQYD
Sbjct: 1   PQITLWQRPLVTIKIGGQLKEALLDTGADDTVLEEMSLPGKWKPKMIGGIGGFIKVRQYD 60

Query: 77  QILIEICGHKAIGTVLVGPTPVNILGRNLLTQIGCTLNF 115
           QILIEICGHKAIGTVLVGPTP NI+GRNLLTQIGCTLNF
Sbjct: 61  QILIEICGHKAIGTVLVGPTPANIIGRNLLTQIGCTLNF 99


>gi|493788|pdb|1AAQ|A Chain A, Hydroxyethylene Isostere Inhibitors
           Of Human Immunodeficiency Virus-1 Protease:
           Structure-Activity Analysis Using Enzyme Kinetics, X-Ray
           Crystallography, And Infected T-Cell Assays
 Chain B, Hydroxyethylene Isostere Inhibitors Of Human
           Immunodeficiency Virus-1 Protease: Structure-Activity
           Analysis Using Enzyme Kinetics, X-Ray Crystallography,
           And Infected T-Cell Assays
          Length = 99

 Score =  190 bits (483), Expect = 1e-49,   Method: Compositional matrix adjust.
 Identities = 93/99 (93%), Positives = 97/99 (97%)

Query: 17  PQITLYQRPLVTIKIGGQLKEALLKTGADDTVLEEMSLPGEWKPKLIGGIGGFIKVRQYD 76
           PQITL+QRPLVTIKIGGQLKEALL TGADDTVLEEMSLPG WKPK+IGGIGGFIKVRQYD
Sbjct: 1   PQITLWQRPLVTIKIGGQLKEALLDTGADDTVLEEMSLPGRWKPKMIGGIGGFIKVRQYD 60

Query: 77  QILIEICGHKAIGTVLVGPTPVNILGRNLLTQIGCTLNF 115
           QI+IEICGHKAIGTVLVGPTPVNI+GRNLLTQIGCTLNF
Sbjct: 61  QIIIEICGHKAIGTVLVGPTPVNIIGRNLLTQIGCTLNF 99


>gi|6980896|pdb|1BV9|A Chain A, Hiv-1 Protease (I84v) Complexed With
           Xv638 Of Dupont Pharmaceuticals
 Chain B, Hiv-1 Protease (I84v) Complexed With Xv638 Of Dupont
           Pharmaceuticals
          Length = 99

 Score =  190 bits (482), Expect = 1e-49,   Method: Compositional matrix adjust.
 Identities = 92/99 (92%), Positives = 97/99 (97%)

Query: 17  PQITLYQRPLVTIKIGGQLKEALLKTGADDTVLEEMSLPGEWKPKLIGGIGGFIKVRQYD 76
           PQ+TL+QRPLVTIKIGGQLKEALL TGADDTVLEEMSLPG WKPK+IGGIGGFIKVRQYD
Sbjct: 1   PQVTLWQRPLVTIKIGGQLKEALLDTGADDTVLEEMSLPGRWKPKMIGGIGGFIKVRQYD 60

Query: 77  QILIEICGHKAIGTVLVGPTPVNILGRNLLTQIGCTLNF 115
           QILIEICGHKAIGTVLVGPTPVN++GRNLLTQIGCTLNF
Sbjct: 61  QILIEICGHKAIGTVLVGPTPVNVIGRNLLTQIGCTLNF 99


>gi|3114324|pdb|1AXA|A Chain A, Active-Site Mobility In Human
           Immunodeficiency Virus Type 1 Protease As Demonstrated
           By Crystal Structure Of A28s Mutant
 Chain B, Active-Site Mobility In Human Immunodeficiency Virus Type
           1 Protease As Demonstrated By Crystal Structure Of A28s
           Mutant
          Length = 99

 Score =  190 bits (482), Expect = 1e-49,   Method: Compositional matrix adjust.
 Identities = 93/99 (93%), Positives = 97/99 (97%)

Query: 17  PQITLYQRPLVTIKIGGQLKEALLKTGADDTVLEEMSLPGEWKPKLIGGIGGFIKVRQYD 76
           PQITL+QRPLVTIKIGGQLKEALL TG+DDTVLEEMSLPG WKPK+IGGIGGFIKVRQYD
Sbjct: 1   PQITLWQRPLVTIKIGGQLKEALLDTGSDDTVLEEMSLPGRWKPKMIGGIGGFIKVRQYD 60

Query: 77  QILIEICGHKAIGTVLVGPTPVNILGRNLLTQIGCTLNF 115
           QILIEICGHKAIGTVLVGPTPVNI+GRNLLTQIGCTLNF
Sbjct: 61  QILIEICGHKAIGTVLVGPTPVNIIGRNLLTQIGCTLNF 99


>gi|66360070|pdb|1RL8|A Chain A, Crystal Structure Of The Complex Of
           Resistant Strain Of Hiv- 1 Protease(V82a Mutant) With
           Ritonavir
 Chain B, Crystal Structure Of The Complex Of Resistant Strain Of
           Hiv- 1 Protease(V82a Mutant) With Ritonavir
          Length = 99

 Score =  189 bits (481), Expect = 1e-49,   Method: Compositional matrix adjust.
 Identities = 93/99 (93%), Positives = 96/99 (96%)

Query: 17  PQITLYQRPLVTIKIGGQLKEALLKTGADDTVLEEMSLPGEWKPKLIGGIGGFIKVRQYD 76
           PQITL+QRPLVTIKIGGQLKEALL TGADDTVLEEMSLPG WKPK+IGGIGGFIKVRQYD
Sbjct: 1   PQITLWQRPLVTIKIGGQLKEALLDTGADDTVLEEMSLPGAWKPKMIGGIGGFIKVRQYD 60

Query: 77  QILIEICGHKAIGTVLVGPTPVNILGRNLLTQIGCTLNF 115
           QILIEICGHKAIGTVLVGPTP NI+GRNLLTQIGCTLNF
Sbjct: 61  QILIEICGHKAIGTVLVGPTPANIIGRNLLTQIGCTLNF 99


>gi|6729844|pdb|3TLH|A Chain A, Structural Studies Of Hiv And Fiv
           Proteases Complexed Withan Efficient Inhibitor Of Fiv Pr
 Chain A, Hiv Protease With Scripps Ab-3 Inhibitor
 Chain A, Hiv Protease With Inhibitor Ab-2
 Chain A, Crystal Structure Of Hiv-1 Protease (Q7k) In Complex With
           Atazanavir
 Chain B, Crystal Structure Of Hiv-1 Protease (Q7k) In Complex With
           Atazanavir
 Chain A, Crystal Structure Of Hiv-1 Protease (Q7k) In Complex With
           Tipranavir
 Chain B, Crystal Structure Of Hiv-1 Protease (Q7k) In Complex With
           Tipranavir
 Chain A, Crystal Structure Of Hiv-1 Protease (Q7k) In Complex With
           Lopinavir
 Chain B, Crystal Structure Of Hiv-1 Protease (Q7k) In Complex With
           Lopinavir
 Chain A, Crystal Structure Of The Subtype B Wild Type Hiv Protease
           Complexed With Tl-3 Inhibitor
          Length = 99

 Score =  189 bits (481), Expect = 2e-49,   Method: Compositional matrix adjust.
 Identities = 93/99 (93%), Positives = 97/99 (97%)

Query: 17  PQITLYQRPLVTIKIGGQLKEALLKTGADDTVLEEMSLPGEWKPKLIGGIGGFIKVRQYD 76
           PQITL++RPLVTIKIGGQLKEALL TGADDTVLEEMSLPG WKPK+IGGIGGFIKVRQYD
Sbjct: 1   PQITLWKRPLVTIKIGGQLKEALLDTGADDTVLEEMSLPGRWKPKMIGGIGGFIKVRQYD 60

Query: 77  QILIEICGHKAIGTVLVGPTPVNILGRNLLTQIGCTLNF 115
           QILIEICGHKAIGTVLVGPTPVNI+GRNLLTQIGCTLNF
Sbjct: 61  QILIEICGHKAIGTVLVGPTPVNIIGRNLLTQIGCTLNF 99


>gi|194368486|pdb|2QHC|A Chain A, The Influence Of I47a Mutation On
           Reduced Susceptibility To The Protease Inhibitor
           Lopinavir
 Chain B, The Influence Of I47a Mutation On Reduced Susceptibility
           To The Protease Inhibitor Lopinavir
          Length = 99

 Score =  189 bits (481), Expect = 2e-49,   Method: Compositional matrix adjust.
 Identities = 93/99 (93%), Positives = 96/99 (96%)

Query: 17  PQITLYQRPLVTIKIGGQLKEALLKTGADDTVLEEMSLPGEWKPKLIGGIGGFIKVRQYD 76
           PQITL+QRPLVTIKIGGQLKEALL TGADDTVLEEMSLPG WKPK+ GGIGGFIKVRQYD
Sbjct: 1   PQITLWQRPLVTIKIGGQLKEALLDTGADDTVLEEMSLPGRWKPKMAGGIGGFIKVRQYD 60

Query: 77  QILIEICGHKAIGTVLVGPTPVNILGRNLLTQIGCTLNF 115
           QILIEICGHKAIGTVLVGPTPVNI+GRNLLTQIGCTLNF
Sbjct: 61  QILIEICGHKAIGTVLVGPTPVNIIGRNLLTQIGCTLNF 99


>gi|231149|pdb|5HVP|A Chain A, Crystallographic Analysis Of A
           Complex Between Human Immunodeficiency Virus Type 1
           Protease And Acetyl- Pepstatin At 2.0-Angstroms
           Resolution
 Chain B, Crystallographic Analysis Of A Complex Between Human
           Immunodeficiency Virus Type 1 Protease And Acetyl-
           Pepstatin At 2.0-Angstroms Resolution
 Chain A, Design, Activity And 2.8 Angstroms Crystal Structure Of A
           C2 Symmetric Inhibitor Complexed To Hiv-1 Protease
 Chain B, Design, Activity And 2.8 Angstroms Crystal Structure Of A
           C2 Symmetric Inhibitor Complexed To Hiv-1 Protease
 Chain A, X-Ray Crystal Structure Of The Hiv Protease Complex With
           L- 700,417, An Inhibitor With Pseudo C2 Symmetry
 Chain B, X-Ray Crystal Structure Of The Hiv Protease Complex With
           L- 700,417, An Inhibitor With Pseudo C2 Symmetry
 Chain A, An Orally-Bioavailable Hiv-1 Protease Inhibitor Containing
           An Imidazole-Derived Peptide Bond Replacement.
           Crystallographic And Pharmacokinetic Analysis
 Chain B, An Orally-Bioavailable Hiv-1 Protease Inhibitor Containing
           An Imidazole-Derived Peptide Bond Replacement.
           Crystallographic And Pharmacokinetic Analysis
 Chain A, Hiv-1 Protease Dimer Complexed With A-98881
 Chain B, Hiv-1 Protease Dimer Complexed With A-98881
 Chain A, Hiv-1 Protease In Complex With Sdz283-910
 Chain B, Hiv-1 Protease In Complex With Sdz283-910
 Chain A, Hiv-1 Protease Complexed With The Inhibitor HoeBAY 793
           Orthorhombic Form
 Chain B, Hiv-1 Protease Complexed With The Inhibitor HoeBAY 793
           Orthorhombic Form
 Chain A, Hiv-1 Protease Complexed With The Inhibitor HoeBAY 793
           Hexagonal Form
 Chain B, Hiv-1 Protease Complexed With The Inhibitor HoeBAY 793
           Hexagonal Form
 Chain A, Hiv-1 Protease In Complex With The Inhibitor Bea369
 Chain B, Hiv-1 Protease In Complex With The Inhibitor Bea369
 Chain A, Inhibitor Of Hiv Protease With Unusual Binding Mode
           Potently Inhibiting Multi-Resistant Protease Mutants
 Chain B, Inhibitor Of Hiv Protease With Unusual Binding Mode
           Potently Inhibiting Multi-Resistant Protease Mutants
 Chain A, Three-Dimensional Structure Of Aspartyl Protease From
           Human Immunodeficiency Virus Hiv-1
 Chain A, Crystal Structure Of Hiv-1 Protease Complexed With Pl-100
 Chain B, Crystal Structure Of Hiv-1 Protease Complexed With Pl-100
          Length = 99

 Score =  189 bits (481), Expect = 2e-49,   Method: Compositional matrix adjust.
 Identities = 93/99 (93%), Positives = 97/99 (97%)

Query: 17  PQITLYQRPLVTIKIGGQLKEALLKTGADDTVLEEMSLPGEWKPKLIGGIGGFIKVRQYD 76
           PQITL+QRPLVTIKIGGQLKEALL TGADDTVLEEM+LPG WKPK+IGGIGGFIKVRQYD
Sbjct: 1   PQITLWQRPLVTIKIGGQLKEALLDTGADDTVLEEMNLPGRWKPKMIGGIGGFIKVRQYD 60

Query: 77  QILIEICGHKAIGTVLVGPTPVNILGRNLLTQIGCTLNF 115
           QILIEICGHKAIGTVLVGPTPVNI+GRNLLTQIGCTLNF
Sbjct: 61  QILIEICGHKAIGTVLVGPTPVNIIGRNLLTQIGCTLNF 99


>gi|1942941|pdb|1TCX|A Chain A, Hiv Triple Mutant Protease Complexed
           With Inhibitor Sb203386
 Chain B, Hiv Triple Mutant Protease Complexed With Inhibitor
           Sb203386
          Length = 99

 Score =  189 bits (480), Expect = 2e-49,   Method: Compositional matrix adjust.
 Identities = 91/99 (91%), Positives = 97/99 (97%)

Query: 17  PQITLYQRPLVTIKIGGQLKEALLKTGADDTVLEEMSLPGEWKPKLIGGIGGFIKVRQYD 76
           PQITL+QRPLVTIKIGGQLKEALL TGADDT+LEEMSLPG WKPK++GGIGGFIKVRQYD
Sbjct: 1   PQITLWQRPLVTIKIGGQLKEALLDTGADDTILEEMSLPGRWKPKMVGGIGGFIKVRQYD 60

Query: 77  QILIEICGHKAIGTVLVGPTPVNILGRNLLTQIGCTLNF 115
           QILIEICGHKAIGTVLVGPTP+NI+GRNLLTQIGCTLNF
Sbjct: 61  QILIEICGHKAIGTVLVGPTPINIIGRNLLTQIGCTLNF 99


>gi|168988684|pdb|2Q64|A Chain A, Hiv-1 Pr Mutant In Complex With
           Nelfinavir
 Chain B, Hiv-1 Pr Mutant In Complex With Nelfinavir
          Length = 99

 Score =  189 bits (480), Expect = 2e-49,   Method: Compositional matrix adjust.
 Identities = 93/99 (93%), Positives = 97/99 (97%)

Query: 17  PQITLYQRPLVTIKIGGQLKEALLKTGADDTVLEEMSLPGEWKPKLIGGIGGFIKVRQYD 76
           PQITL+QRPLVTIKIGGQLKEALL TGAD+TVLEEMSLPG WKPK+IGGIGGFIKVRQYD
Sbjct: 1   PQITLWQRPLVTIKIGGQLKEALLDTGADNTVLEEMSLPGAWKPKMIGGIGGFIKVRQYD 60

Query: 77  QILIEICGHKAIGTVLVGPTPVNILGRNLLTQIGCTLNF 115
           QILIEICGHKAIGTVLVGPTPVNI+GRNLLTQIGCTLNF
Sbjct: 61  QILIEICGHKAIGTVLVGPTPVNIIGRNLLTQIGCTLNF 99


>gi|122921397|pdb|2O4L|A Chain A, Crystal Structure Of Hiv-1
           Protease (Q7k, I50v) In Complex With Tipranavir
 Chain B, Crystal Structure Of Hiv-1 Protease (Q7k, I50v) In Complex
           With Tipranavir
          Length = 99

 Score =  189 bits (480), Expect = 2e-49,   Method: Compositional matrix adjust.
 Identities = 92/99 (92%), Positives = 97/99 (97%)

Query: 17  PQITLYQRPLVTIKIGGQLKEALLKTGADDTVLEEMSLPGEWKPKLIGGIGGFIKVRQYD 76
           PQITL++RPLVTIKIGGQLKEALL TGADDTVLEEMSLPG WKPK+IGG+GGFIKVRQYD
Sbjct: 1   PQITLWKRPLVTIKIGGQLKEALLDTGADDTVLEEMSLPGRWKPKMIGGVGGFIKVRQYD 60

Query: 77  QILIEICGHKAIGTVLVGPTPVNILGRNLLTQIGCTLNF 115
           QILIEICGHKAIGTVLVGPTPVNI+GRNLLTQIGCTLNF
Sbjct: 61  QILIEICGHKAIGTVLVGPTPVNIIGRNLLTQIGCTLNF 99


>gi|193506629|pdb|2Z54|A Chain A, The Influence Of I47a Mutation On
           Reduced Susceptibility To The Protease Inhibitor
           Lopinavir
 Chain B, The Influence Of I47a Mutation On Reduced Susceptibility
           To The Protease Inhibitor Lopinavir
          Length = 99

 Score =  189 bits (480), Expect = 2e-49,   Method: Compositional matrix adjust.
 Identities = 92/99 (92%), Positives = 96/99 (96%)

Query: 17  PQITLYQRPLVTIKIGGQLKEALLKTGADDTVLEEMSLPGEWKPKLIGGIGGFIKVRQYD 76
           PQITL+QRPLVTIKIGGQLKEALL TGADDTVLEEMSLPG WKPK+ GGIGGF+KVRQYD
Sbjct: 1   PQITLWQRPLVTIKIGGQLKEALLDTGADDTVLEEMSLPGRWKPKMAGGIGGFVKVRQYD 60

Query: 77  QILIEICGHKAIGTVLVGPTPVNILGRNLLTQIGCTLNF 115
           QILIEICGHKAIGTVLVGPTPVNI+GRNLLTQIGCTLNF
Sbjct: 61  QILIEICGHKAIGTVLVGPTPVNIIGRNLLTQIGCTLNF 99


>gi|6435759|pdb|1D4S|A Chain A, Hiv-1 Protease V82fI84V DOUBLE
           MUTANTTIPRANAVIR COMPLEX
 Chain B, Hiv-1 Protease V82fI84V DOUBLE MUTANTTIPRANAVIR COMPLEX
          Length = 99

 Score =  189 bits (479), Expect = 3e-49,   Method: Compositional matrix adjust.
 Identities = 92/99 (92%), Positives = 96/99 (96%)

Query: 17  PQITLYQRPLVTIKIGGQLKEALLKTGADDTVLEEMSLPGEWKPKLIGGIGGFIKVRQYD 76
           PQITL+QRPLVTIKIGGQLKEALL TGADDTVLEEMSLPG WKPK+IGGIGGFIKVRQYD
Sbjct: 1   PQITLWQRPLVTIKIGGQLKEALLDTGADDTVLEEMSLPGRWKPKMIGGIGGFIKVRQYD 60

Query: 77  QILIEICGHKAIGTVLVGPTPVNILGRNLLTQIGCTLNF 115
           QILIEICGHKAIGTVLVGPTP N++GRNLLTQIGCTLNF
Sbjct: 61  QILIEICGHKAIGTVLVGPTPFNVIGRNLLTQIGCTLNF 99


>gi|6980882|pdb|1BV7|A Chain A, Counteracting Hiv-1 Protease Drug
           Resistance: Structural Analysis Of Mutant Proteases
           Complexed With Xv638 And Sd146, Cyclic Urea Amides With
           Broad Specificities
 Chain B, Counteracting Hiv-1 Protease Drug Resistance: Structural
           Analysis Of Mutant Proteases Complexed With Xv638 And
           Sd146, Cyclic Urea Amides With Broad Specificities
          Length = 99

 Score =  189 bits (479), Expect = 3e-49,   Method: Compositional matrix adjust.
 Identities = 92/99 (92%), Positives = 96/99 (96%)

Query: 17  PQITLYQRPLVTIKIGGQLKEALLKTGADDTVLEEMSLPGEWKPKLIGGIGGFIKVRQYD 76
           PQ+TL+QRPLVTIKIGGQLKEALL TGADDTVLEEMSLPG WKPK+IGGIGGFIKVRQYD
Sbjct: 1   PQVTLWQRPLVTIKIGGQLKEALLDTGADDTVLEEMSLPGRWKPKMIGGIGGFIKVRQYD 60

Query: 77  QILIEICGHKAIGTVLVGPTPVNILGRNLLTQIGCTLNF 115
           QILIEICGHKAIGTVLVGPTP NI+GRNLLTQIGCTLNF
Sbjct: 61  QILIEICGHKAIGTVLVGPTPFNIIGRNLLTQIGCTLNF 99


>gi|1421455|pdb|1DIF|A Chain A, Hiv-1 Protease In Complex With A
           Difluoroketone Containing Inhibitor A79285
 Chain B, Hiv-1 Protease In Complex With A Difluoroketone Containing
           Inhibitor A79285
 Chain A, Influence Of Stereochemistry On Activity And Binding Modes
           For C2 Symmetry-Based Diol Inhibitors Of Hiv-1 Protease
 Chain B, Influence Of Stereochemistry On Activity And Binding Modes
           For C2 Symmetry-Based Diol Inhibitors Of Hiv-1 Protease
 Chain A, Influence Of Stereochemistry On Activity And Binding Modes
           For C2 Symmetry-Based Diol Inhibitors Of Hiv-1 Protease
 Chain B, Influence Of Stereochemistry On Activity And Binding Modes
           For C2 Symmetry-Based Diol Inhibitors Of Hiv-1 Protease
 Chain A, Influence Of Stereochemistry On Activity And Binding Modes
           For C2 Symmetry-Based Diol Inhibitors Of Hiv-1 Protease
 Chain B, Influence Of Stereochemistry On Activity And Binding Modes
           For C2 Symmetry-Based Diol Inhibitors Of Hiv-1 Protease
 Chain A, Influence Of Stereochemistry On Activity And Binding Modes
           For C2 Symmetry-Based Diol Inhibitors Of Hiv-1 Protease
 Chain B, Influence Of Stereochemistry On Activity And Binding Modes
           For C2 Symmetry-Based Diol Inhibitors Of Hiv-1 Protease
 Chain A, Viracept (R) (Nelfinavir Mesylate, Ag1343): A Potent
           Orally Bioavailable Inhibitor Of Hiv-1 Protease
 Chain B, Viracept (R) (Nelfinavir Mesylate, Ag1343): A Potent
           Orally Bioavailable Inhibitor Of Hiv-1 Protease
          Length = 99

 Score =  189 bits (479), Expect = 3e-49,   Method: Compositional matrix adjust.
 Identities = 93/98 (94%), Positives = 96/98 (97%)

Query: 18  QITLYQRPLVTIKIGGQLKEALLKTGADDTVLEEMSLPGEWKPKLIGGIGGFIKVRQYDQ 77
           QITL+QRPLVTIKIGGQLKEALL TGADDTVLEEMSLPG WKPK+IGGIGGFIKVRQYDQ
Sbjct: 2   QITLWQRPLVTIKIGGQLKEALLDTGADDTVLEEMSLPGRWKPKMIGGIGGFIKVRQYDQ 61

Query: 78  ILIEICGHKAIGTVLVGPTPVNILGRNLLTQIGCTLNF 115
           ILIEICGHKAIGTVLVGPTPVNI+GRNLLTQIGCTLNF
Sbjct: 62  ILIEICGHKAIGTVLVGPTPVNIIGRNLLTQIGCTLNF 99


>gi|1943546|pdb|1GNN|A Chain A, Hiv-1 Protease Mutant With Val 82
           Replaced By Asn (V82n) Complexed With U89360e
           (Inhibitor)
 Chain B, Hiv-1 Protease Mutant With Val 82 Replaced By Asn (V82n)
           Complexed With U89360e (Inhibitor)
          Length = 99

 Score =  188 bits (478), Expect = 3e-49,   Method: Compositional matrix adjust.
 Identities = 93/99 (93%), Positives = 96/99 (96%)

Query: 17  PQITLYQRPLVTIKIGGQLKEALLKTGADDTVLEEMSLPGEWKPKLIGGIGGFIKVRQYD 76
           PQITL+QRPLVTIKIGGQLKEALL TGADDTVLEEMSLPG WKPK+IGGIGGFIKVRQYD
Sbjct: 1   PQITLWQRPLVTIKIGGQLKEALLDTGADDTVLEEMSLPGRWKPKMIGGIGGFIKVRQYD 60

Query: 77  QILIEICGHKAIGTVLVGPTPVNILGRNLLTQIGCTLNF 115
           QILIEICGHKAIGTVLVGPTP NI+GRNLLTQIGCTLNF
Sbjct: 61  QILIEICGHKAIGTVLVGPTPNNIIGRNLLTQIGCTLNF 99


>gi|6980900|pdb|1BWA|A Chain A, Hiv-1 Protease (V82fI84V) DOUBLE
           MUTANT COMPLEXED WITH Xv638 Of Dupont Pharmaceuticals
 Chain B, Hiv-1 Protease (V82fI84V) DOUBLE MUTANT COMPLEXED WITH
           Xv638 Of Dupont Pharmaceuticals
          Length = 99

 Score =  188 bits (478), Expect = 3e-49,   Method: Compositional matrix adjust.
 Identities = 91/99 (91%), Positives = 96/99 (96%)

Query: 17  PQITLYQRPLVTIKIGGQLKEALLKTGADDTVLEEMSLPGEWKPKLIGGIGGFIKVRQYD 76
           PQ+TL+QRPLVTIKIGGQLKEALL TGADDTVLEEMSLPG WKPK+IGGIGGFIKVRQYD
Sbjct: 1   PQVTLWQRPLVTIKIGGQLKEALLDTGADDTVLEEMSLPGRWKPKMIGGIGGFIKVRQYD 60

Query: 77  QILIEICGHKAIGTVLVGPTPVNILGRNLLTQIGCTLNF 115
           QILIEICGHKAIGTVLVGPTP N++GRNLLTQIGCTLNF
Sbjct: 61  QILIEICGHKAIGTVLVGPTPFNVIGRNLLTQIGCTLNF 99


>gi|1943544|pdb|1GNM|A Chain A, Hiv-1 Protease Mutant With Val 82
           Replaced By Asp (V82d) Complexed With U89360e
           (Inhibitor)
 Chain B, Hiv-1 Protease Mutant With Val 82 Replaced By Asp (V82d)
           Complexed With U89360e (Inhibitor)
          Length = 99

 Score =  188 bits (478), Expect = 4e-49,   Method: Compositional matrix adjust.
 Identities = 93/99 (93%), Positives = 96/99 (96%)

Query: 17  PQITLYQRPLVTIKIGGQLKEALLKTGADDTVLEEMSLPGEWKPKLIGGIGGFIKVRQYD 76
           PQITL+QRPLVTIKIGGQLKEALL TGADDTVLEEMSLPG WKPK+IGGIGGFIKVRQYD
Sbjct: 1   PQITLWQRPLVTIKIGGQLKEALLDTGADDTVLEEMSLPGRWKPKMIGGIGGFIKVRQYD 60

Query: 77  QILIEICGHKAIGTVLVGPTPVNILGRNLLTQIGCTLNF 115
           QILIEICGHKAIGTVLVGPTP NI+GRNLLTQIGCTLNF
Sbjct: 61  QILIEICGHKAIGTVLVGPTPDNIIGRNLLTQIGCTLNF 99


>gi|21730861|pdb|1LV1|A Chain A, Crystal Structure Analysis Of The
           Non-Active Site Mutant Of Tethered Hiv-1 Protease To
           2.1a Resolution
 Chain A, X-Ray Structure Of Hiv-1 Protease In Situ Product Complex
          Length = 203

 Score =  188 bits (478), Expect = 4e-49,   Method: Compositional matrix adjust.
 Identities = 92/102 (90%), Positives = 97/102 (95%)

Query: 14  NCEPQITLYQRPLVTIKIGGQLKEALLKTGADDTVLEEMSLPGEWKPKLIGGIGGFIKVR 73
           +  PQ+TL+QRPLVTIKIGGQLKEALL TGADDTVLEEMSLPG WKPK+IGGIGGFIKVR
Sbjct: 102 SSGPQVTLWQRPLVTIKIGGQLKEALLDTGADDTVLEEMSLPGRWKPKMIGGIGGFIKVR 161

Query: 74  QYDQILIEICGHKAIGTVLVGPTPVNILGRNLLTQIGCTLNF 115
           QYDQILIEICGHKAIGTVLVGPTPVNI+GRNLLTQIG TLNF
Sbjct: 162 QYDQILIEICGHKAIGTVLVGPTPVNIIGRNLLTQIGATLNF 203



 Score =  187 bits (476), Expect = 6e-49,   Method: Compositional matrix adjust.
 Identities = 92/99 (92%), Positives = 96/99 (96%)

Query: 17  PQITLYQRPLVTIKIGGQLKEALLKTGADDTVLEEMSLPGEWKPKLIGGIGGFIKVRQYD 76
           PQ+TL+QRPLVTIKIGGQLKEALL TGADDTVLEEMSLPG WKPK+IGGIGGFIKVRQYD
Sbjct: 1   PQVTLWQRPLVTIKIGGQLKEALLDTGADDTVLEEMSLPGRWKPKMIGGIGGFIKVRQYD 60

Query: 77  QILIEICGHKAIGTVLVGPTPVNILGRNLLTQIGCTLNF 115
           QILIEICGHKAIGTVLVGPTPVNI+GRNLLTQIG TLNF
Sbjct: 61  QILIEICGHKAIGTVLVGPTPVNIIGRNLLTQIGMTLNF 99


>gi|3318945|pdb|1A9M|A Chain A, G48h Mutant Of Hiv-1 Protease In
           Complex With A Peptidic Inhibitor U-89360e
 Chain B, G48h Mutant Of Hiv-1 Protease In Complex With A Peptidic
           Inhibitor U-89360e
          Length = 99

 Score =  188 bits (478), Expect = 4e-49,   Method: Compositional matrix adjust.
 Identities = 93/99 (93%), Positives = 96/99 (96%)

Query: 17  PQITLYQRPLVTIKIGGQLKEALLKTGADDTVLEEMSLPGEWKPKLIGGIGGFIKVRQYD 76
           PQITL+QRPLVTIKIGGQLKEALL TGADDTVLEEMSLPG WKPK+I GIGGFIKVRQYD
Sbjct: 1   PQITLWQRPLVTIKIGGQLKEALLDTGADDTVLEEMSLPGRWKPKMIHGIGGFIKVRQYD 60

Query: 77  QILIEICGHKAIGTVLVGPTPVNILGRNLLTQIGCTLNF 115
           QILIEICGHKAIGTVLVGPTPVNI+GRNLLTQIGCTLNF
Sbjct: 61  QILIEICGHKAIGTVLVGPTPVNIIGRNLLTQIGCTLNF 99


>gi|4139495|pdb|1HVH|A Chain A, Nonpeptide Cyclic Cyanoguanidines As
           Hiv Protease Inhibitors
 Chain B, Nonpeptide Cyclic Cyanoguanidines As Hiv Protease
           Inhibitors
          Length = 99

 Score =  188 bits (477), Expect = 4e-49,   Method: Compositional matrix adjust.
 Identities = 92/99 (92%), Positives = 96/99 (96%)

Query: 17  PQITLYQRPLVTIKIGGQLKEALLKTGADDTVLEEMSLPGEWKPKLIGGIGGFIKVRQYD 76
           PQ+TL+QRPLVTIKIGGQLKEALL TGADDTVLEEMSLPG WKPK+IGGIGGFIKVRQYD
Sbjct: 1   PQVTLWQRPLVTIKIGGQLKEALLDTGADDTVLEEMSLPGRWKPKMIGGIGGFIKVRQYD 60

Query: 77  QILIEICGHKAIGTVLVGPTPVNILGRNLLTQIGCTLNF 115
           QILIEICGHKAIGTVLVGPTPVNI+GRNLLTQIG TLNF
Sbjct: 61  QILIEICGHKAIGTVLVGPTPVNIIGRNLLTQIGATLNF 99


>gi|90108773|pdb|2AZ8|A Chain A, Hiv-1 Protease Nl4-3 In Complex
           With Inhibitor, Tl-3
 Chain A, Structure Of Hiv Protease Nl4-3 In An Unliganded State
 Chain A, Apo Wild-Type Hiv Protease In The Open Conformation
          Length = 99

 Score =  188 bits (477), Expect = 5e-49,   Method: Compositional matrix adjust.
 Identities = 92/99 (92%), Positives = 97/99 (97%)

Query: 17  PQITLYQRPLVTIKIGGQLKEALLKTGADDTVLEEMSLPGEWKPKLIGGIGGFIKVRQYD 76
           PQITL++RPLVTIKIGGQLKEALL TGADDTVLEEM+LPG WKPK+IGGIGGFIKVRQYD
Sbjct: 1   PQITLWKRPLVTIKIGGQLKEALLDTGADDTVLEEMNLPGRWKPKMIGGIGGFIKVRQYD 60

Query: 77  QILIEICGHKAIGTVLVGPTPVNILGRNLLTQIGCTLNF 115
           QILIEICGHKAIGTVLVGPTPVNI+GRNLLTQIGCTLNF
Sbjct: 61  QILIEICGHKAIGTVLVGPTPVNIIGRNLLTQIGCTLNF 99


>gi|158428675|pdb|2I4U|A Chain A, Hiv-1 Protease With Tmc-126
 Chain B, Hiv-1 Protease With Tmc-126
 Chain A, Hiv-1 Protease Wt With Gs-8374
 Chain B, Hiv-1 Protease Wt With Gs-8374
 Chain A, Crystal Structure Of Wt Hiv-1 Protease With Gs-8373
 Chain B, Crystal Structure Of Wt Hiv-1 Protease With Gs-8373
          Length = 99

 Score =  188 bits (477), Expect = 5e-49,   Method: Compositional matrix adjust.
 Identities = 93/99 (93%), Positives = 96/99 (96%)

Query: 17  PQITLYQRPLVTIKIGGQLKEALLKTGADDTVLEEMSLPGEWKPKLIGGIGGFIKVRQYD 76
           PQITL+QRPLVTIKIGGQLKEALL TGADDTVLEEMSLPG WKPK+IGGIGGFIKVRQYD
Sbjct: 1   PQITLWQRPLVTIKIGGQLKEALLDTGADDTVLEEMSLPGRWKPKMIGGIGGFIKVRQYD 60

Query: 77  QILIEICGHKAIGTVLVGPTPVNILGRNLLTQIGCTLNF 115
           QILIEICGHKAIGTVLVGPTPVNI+GRNLLTQIG TLNF
Sbjct: 61  QILIEICGHKAIGTVLVGPTPVNIIGRNLLTQIGMTLNF 99


>gi|3114315|pdb|1MER|A Chain A, Hiv-1 Mutant (I84v) Protease
           Complexed With Dmp450
 Chain B, Hiv-1 Mutant (I84v) Protease Complexed With Dmp450
 Chain A, Hiv-1 Mutant (I84v) Protease Complexed With Dmp323
 Chain B, Hiv-1 Mutant (I84v) Protease Complexed With Dmp323
          Length = 99

 Score =  188 bits (477), Expect = 5e-49,   Method: Compositional matrix adjust.
 Identities = 91/98 (92%), Positives = 96/98 (97%)

Query: 18  QITLYQRPLVTIKIGGQLKEALLKTGADDTVLEEMSLPGEWKPKLIGGIGGFIKVRQYDQ 77
           Q+TL+QRPLVTIKIGGQLKEALL TGADDTVLEEMSLPG WKPK+IGGIGGFIKVRQYDQ
Sbjct: 2   QVTLWQRPLVTIKIGGQLKEALLDTGADDTVLEEMSLPGRWKPKMIGGIGGFIKVRQYDQ 61

Query: 78  ILIEICGHKAIGTVLVGPTPVNILGRNLLTQIGCTLNF 115
           ILIEICGHKAIGTVLVGPTPVN++GRNLLTQIGCTLNF
Sbjct: 62  ILIEICGHKAIGTVLVGPTPVNVIGRNLLTQIGCTLNF 99


>gi|122920942|pdb|2NPH|A Chain A, Crystal Structure Of Hiv1 Protease
           In Situ Product Complex
 Chain B, Crystal Structure Of Hiv1 Protease In Situ Product Complex
          Length = 99

 Score =  187 bits (476), Expect = 6e-49,   Method: Compositional matrix adjust.
 Identities = 92/99 (92%), Positives = 96/99 (96%)

Query: 17  PQITLYQRPLVTIKIGGQLKEALLKTGADDTVLEEMSLPGEWKPKLIGGIGGFIKVRQYD 76
           PQ+TL+QRPLVTIKIGGQLKEALL TGADDTVLEEMSLPG WKPK+IGGIGGFIKVRQYD
Sbjct: 1   PQVTLWQRPLVTIKIGGQLKEALLDTGADDTVLEEMSLPGRWKPKMIGGIGGFIKVRQYD 60

Query: 77  QILIEICGHKAIGTVLVGPTPVNILGRNLLTQIGCTLNF 115
           QILIEICGHKAIGTVLVGPTPVNI+GRNLLTQIG TLNF
Sbjct: 61  QILIEICGHKAIGTVLVGPTPVNIIGRNLLTQIGMTLNF 99


>gi|576147|pdb|1HEF|E Chain E, The Crystal Structures At 2.2
           Angstroms Resolution Of Hydroxyethylene-Based Inhibitors
           Bound To Human Immunodeficiency Virus Type 1 Protease
           Show That The Inhibitors Are Present In Two Distinct
           Orientations
 Chain E, The Crystal Structures At 2.2 Angstroms Resolution Of
           Hydroxyethylene-Based Inhibitors Bound To Human
           Immunodeficiency Virus Type 1 Protease Show That The
           Inhibitors Are Present In Two Distinct Orientations
          Length = 99

 Score =  187 bits (476), Expect = 6e-49,   Method: Compositional matrix adjust.
 Identities = 93/99 (93%), Positives = 96/99 (96%)

Query: 17  PQITLYQRPLVTIKIGGQLKEALLKTGADDTVLEEMSLPGEWKPKLIGGIGGFIKVRQYD 76
           PQITL+QRPLVTIKIGGQLKEALL TGADDTVLEE SLPG WKPK+IGGIGGFIKVRQYD
Sbjct: 1   PQITLWQRPLVTIKIGGQLKEALLDTGADDTVLEENSLPGRWKPKMIGGIGGFIKVRQYD 60

Query: 77  QILIEICGHKAIGTVLVGPTPVNILGRNLLTQIGCTLNF 115
           QILIEICGHKAIGTVLVGPTPVNI+GRNLLTQIGCTLNF
Sbjct: 61  QILIEICGHKAIGTVLVGPTPVNIIGRNLLTQIGCTLNF 99


>gi|2098471|pdb|1ODX|A Chain A, Hiv-1 Proteinase Mutant A71t, V82a
 Chain B, Hiv-1 Proteinase Mutant A71t, V82a
          Length = 99

 Score =  187 bits (476), Expect = 6e-49,   Method: Compositional matrix adjust.
 Identities = 92/99 (92%), Positives = 95/99 (95%)

Query: 17  PQITLYQRPLVTIKIGGQLKEALLKTGADDTVLEEMSLPGEWKPKLIGGIGGFIKVRQYD 76
           PQITL+QRPLVTIKIGGQLKEALL TGADDTVLEEMSLPG WKPK+IGGIGGFIKVRQYD
Sbjct: 1   PQITLWQRPLVTIKIGGQLKEALLDTGADDTVLEEMSLPGRWKPKMIGGIGGFIKVRQYD 60

Query: 77  QILIEICGHKAIGTVLVGPTPVNILGRNLLTQIGCTLNF 115
           QILIEICGHK IGTVLVGPTP NI+GRNLLTQIGCTLNF
Sbjct: 61  QILIEICGHKTIGTVLVGPTPANIIGRNLLTQIGCTLNF 99


>gi|168988674|pdb|2PYM|A Chain A, Hiv-1 Pr Mutant In Complex With
           Nelfinavir
 Chain B, Hiv-1 Pr Mutant In Complex With Nelfinavir
          Length = 99

 Score =  187 bits (476), Expect = 6e-49,   Method: Compositional matrix adjust.
 Identities = 92/99 (92%), Positives = 97/99 (97%)

Query: 17  PQITLYQRPLVTIKIGGQLKEALLKTGADDTVLEEMSLPGEWKPKLIGGIGGFIKVRQYD 76
           PQITL+QRPLVTIKIGGQLKEALL TGAD+TVLEEMSLPG WKPK+IGGIGGFIKVRQYD
Sbjct: 1   PQITLWQRPLVTIKIGGQLKEALLDTGADNTVLEEMSLPGAWKPKMIGGIGGFIKVRQYD 60

Query: 77  QILIEICGHKAIGTVLVGPTPVNILGRNLLTQIGCTLNF 115
           QILIEICGHKAIGTVLVGPTPVNI+GR+LLTQIGCTLNF
Sbjct: 61  QILIEICGHKAIGTVLVGPTPVNIIGRDLLTQIGCTLNF 99


>gi|2098357|pdb|1HPO|A Chain A, Hiv-1 Protease Triple MutantU103265
           COMPLEX
 Chain B, Hiv-1 Protease Triple MutantU103265 COMPLEX
 Chain A, Hiv-1 Protease Complexed With A Tripeptide Inhibitor
 Chain B, Hiv-1 Protease Complexed With A Tripeptide Inhibitor
 Chain A, Crystallographic Analysis Of Human Immunodeficiency Virus
           1 Protease With An Analog Of The Conserved Ca-P2
           Substrate: Interactions With Frequently Occurring
           Glutamic Acid Residue At P2' Position Of Substrates
 Chain B, Crystallographic Analysis Of Human Immunodeficiency Virus
           1 Protease With An Analog Of The Conserved Ca-P2
           Substrate: Interactions With Frequently Occurring
           Glutamic Acid Residue At P2' Position Of Substrates
 Chain D, Crystallographic Analysis Of Human Immunodeficiency Virus
           1 Protease With An Analog Of The Conserved Ca-P2
           Substrate: Interactions With Frequently Occurring
           Glutamic Acid Residue At P2' Position Of Substrates
 Chain E, Crystallographic Analysis Of Human Immunodeficiency Virus
           1 Protease With An Analog Of The Conserved Ca-P2
           Substrate: Interactions With Frequently Occurring
           Glutamic Acid Residue At P2' Position Of Substrates
 Chain A, Hiv-1 Protease Triple MutantTIPRANAVIR COMPLEX
 Chain B, Hiv-1 Protease Triple MutantTIPRANAVIR COMPLEX
 Chain A, Structure Of Hiv Protease (Mutant Q7k L33i L63i) Complexed
           With Kni-577
 Chain B, Structure Of Hiv Protease (Mutant Q7k L33i L63i) Complexed
           With Kni-577
 Chain A, The Hiv Protease (Mutant Q7k L33i L63i) Complexed With
           Kni- 764 (An Inhibitor)
 Chain B, The Hiv Protease (Mutant Q7k L33i L63i) Complexed With
           Kni- 764 (An Inhibitor)
 Chain A, Crystal Structure Of Hiv Protease- Metallacarborane
           Complex
 Chain B, Crystal Structure Of Hiv Protease- Metallacarborane
           Complex
 Chain A, Crystal Structure Of Hiv-1 Protease (Q7k, L33i, L63i ) In
           Complex With Kni-10075
 Chain B, Crystal Structure Of Hiv-1 Protease (Q7k, L33i, L63i ) In
           Complex With Kni-10075
 Chain A, Crystal Structure Of Hiv-1 Protease (Q7k, L33i, L63i) In
           Complex With Kni-10033
 Chain B, Crystal Structure Of Hiv-1 Protease (Q7k, L33i, L63i) In
           Complex With Kni-10033
          Length = 99

 Score =  187 bits (476), Expect = 7e-49,   Method: Compositional matrix adjust.
 Identities = 91/99 (91%), Positives = 97/99 (97%)

Query: 17  PQITLYQRPLVTIKIGGQLKEALLKTGADDTVLEEMSLPGEWKPKLIGGIGGFIKVRQYD 76
           PQITL++RPLVTIKIGGQLKEALL TGADDTV+EEMSLPG WKPK+IGGIGGFIKVRQYD
Sbjct: 1   PQITLWKRPLVTIKIGGQLKEALLDTGADDTVIEEMSLPGRWKPKMIGGIGGFIKVRQYD 60

Query: 77  QILIEICGHKAIGTVLVGPTPVNILGRNLLTQIGCTLNF 115
           QI+IEICGHKAIGTVLVGPTPVNI+GRNLLTQIGCTLNF
Sbjct: 61  QIIIEICGHKAIGTVLVGPTPVNIIGRNLLTQIGCTLNF 99


>gi|99031740|pdb|1ZSF|A Chain A, Crystal Structure Of Complex Of A
           Hydroxyethylamine Inhibitor With Hiv-1 Protease At 2.0a
           Resolution
 Chain B, Crystal Structure Of Complex Of A Hydroxyethylamine
           Inhibitor With Hiv-1 Protease At 2.0a Resolution
 Chain A, Crystal Structure Of Wild Type Hiv-1 Protease (Bru
           Isolate) With A Hydroxyethylamine Peptidomimetic
           Inhibitor Boc-Phe- Psi[s-Ch(Oh)ch2nh]-Phe-Glu-Phe-Nh2
 Chain B, Crystal Structure Of Wild Type Hiv-1 Protease (Bru
           Isolate) With A Hydroxyethylamine Peptidomimetic
           Inhibitor Boc-Phe- Psi[s-Ch(Oh)ch2nh]-Phe-Glu-Phe-Nh2
          Length = 99

 Score =  187 bits (476), Expect = 7e-49,   Method: Compositional matrix adjust.
 Identities = 93/99 (93%), Positives = 96/99 (96%)

Query: 17  PQITLYQRPLVTIKIGGQLKEALLKTGADDTVLEEMSLPGEWKPKLIGGIGGFIKVRQYD 76
           PQITL+QRPLVTIKIGGQLKEALL TGADDTVLEEMSLPG WKPK+IGGIGGFIKVRQYD
Sbjct: 1   PQITLWQRPLVTIKIGGQLKEALLDTGADDTVLEEMSLPGRWKPKMIGGIGGFIKVRQYD 60

Query: 77  QILIEICGHKAIGTVLVGPTPVNILGRNLLTQIGCTLNF 115
           QILIEI GHKAIGTVLVGPTPVNI+GRNLLTQIGCTLNF
Sbjct: 61  QILIEIXGHKAIGTVLVGPTPVNIIGRNLLTQIGCTLNF 99


>gi|1421550|pdb|1HVS|A Chain A, Structural Basis Of Drug Resistance
           For The V82a Mutant Of Hiv-1 Protease: Backbone
           Flexibility And Subsite Repacking
 Chain B, Structural Basis Of Drug Resistance For The V82a Mutant Of
           Hiv-1 Protease: Backbone Flexibility And Subsite
           Repacking
          Length = 99

 Score =  187 bits (475), Expect = 8e-49,   Method: Compositional matrix adjust.
 Identities = 92/98 (93%), Positives = 95/98 (96%)

Query: 18  QITLYQRPLVTIKIGGQLKEALLKTGADDTVLEEMSLPGEWKPKLIGGIGGFIKVRQYDQ 77
           QITL+QRPLVTIKIGGQLKEALL TGADDTVLEEMSLPG WKPK+IGGIGGFIKVRQYDQ
Sbjct: 2   QITLWQRPLVTIKIGGQLKEALLDTGADDTVLEEMSLPGRWKPKMIGGIGGFIKVRQYDQ 61

Query: 78  ILIEICGHKAIGTVLVGPTPVNILGRNLLTQIGCTLNF 115
           ILIEICGHKAIGTVLVGPTP NI+GRNLLTQIGCTLNF
Sbjct: 62  ILIEICGHKAIGTVLVGPTPANIIGRNLLTQIGCTLNF 99


>gi|158428677|pdb|2I4V|A Chain A, Hiv-1 Protease I84v, L90m With
           Tmc126
 Chain B, Hiv-1 Protease I84v, L90m With Tmc126
 Chain A, Hiv-1 Protease I84v, L90m With Gs-8374
 Chain B, Hiv-1 Protease I84v, L90m With Gs-8374
          Length = 99

 Score =  187 bits (475), Expect = 8e-49,   Method: Compositional matrix adjust.
 Identities = 91/99 (91%), Positives = 96/99 (96%)

Query: 17  PQITLYQRPLVTIKIGGQLKEALLKTGADDTVLEEMSLPGEWKPKLIGGIGGFIKVRQYD 76
           PQITL+QRPLVTIKIGGQLKEALL TGADDTVLEEMSLPG WKPK+IGGIGGFIKVRQYD
Sbjct: 1   PQITLWQRPLVTIKIGGQLKEALLDTGADDTVLEEMSLPGRWKPKMIGGIGGFIKVRQYD 60

Query: 77  QILIEICGHKAIGTVLVGPTPVNILGRNLLTQIGCTLNF 115
           QILIEICGHKAIGTVLVGPTPVN++GRNL+TQIG TLNF
Sbjct: 61  QILIEICGHKAIGTVLVGPTPVNVIGRNLMTQIGMTLNF 99


>gi|168988682|pdb|2Q63|A Chain A, Hiv-1 Pr Mutant In Complex With
           Nelfinavir
 Chain B, Hiv-1 Pr Mutant In Complex With Nelfinavir
 Chain A, Hiv-1 Pr Mutant In Complex With Nelfinavir
 Chain B, Hiv-1 Pr Mutant In Complex With Nelfinavir
          Length = 99

 Score =  187 bits (475), Expect = 8e-49,   Method: Compositional matrix adjust.
 Identities = 91/99 (91%), Positives = 96/99 (96%)

Query: 17  PQITLYQRPLVTIKIGGQLKEALLKTGADDTVLEEMSLPGEWKPKLIGGIGGFIKVRQYD 76
           PQITL+QRPLVTIKIGGQLKEALL TGAD+TVLEEMSLPG WKPK+IGGIGGFI VRQYD
Sbjct: 1   PQITLWQRPLVTIKIGGQLKEALLDTGADNTVLEEMSLPGRWKPKMIGGIGGFIAVRQYD 60

Query: 77  QILIEICGHKAIGTVLVGPTPVNILGRNLLTQIGCTLNF 115
           QILIEICGHKAIGTVLVGPTPVNI+GRNL+TQIGCTLNF
Sbjct: 61  QILIEICGHKAIGTVLVGPTPVNIIGRNLMTQIGCTLNF 99


>gi|12084485|pdb|1FB7|A Chain A, Crystal Structure Of An In Vivo
           Hiv-1 Protease Mutant In Complex With Saquinavir:
           Insights Into The Mechanisms Of Drug Resistance
          Length = 99

 Score =  187 bits (475), Expect = 8e-49,   Method: Compositional matrix adjust.
 Identities = 91/99 (91%), Positives = 96/99 (96%)

Query: 17  PQITLYQRPLVTIKIGGQLKEALLKTGADDTVLEEMSLPGEWKPKLIGGIGGFIKVRQYD 76
           PQ+TL+QRPLVTIKIGGQLKEALL TGADDTVLEEMSLPG WKPK+I GIGGFIKVRQYD
Sbjct: 1   PQVTLWQRPLVTIKIGGQLKEALLDTGADDTVLEEMSLPGRWKPKMIVGIGGFIKVRQYD 60

Query: 77  QILIEICGHKAIGTVLVGPTPVNILGRNLLTQIGCTLNF 115
           QILIEICGHKAIGTVLVGPTPVNI+GRNL+TQIGCTLNF
Sbjct: 61  QILIEICGHKAIGTVLVGPTPVNIIGRNLMTQIGCTLNF 99


>gi|168988676|pdb|2PYN|A Chain A, Hiv-1 Pr Mutant In Complex With
           Nelfinavir
 Chain B, Hiv-1 Pr Mutant In Complex With Nelfinavir
          Length = 99

 Score =  187 bits (475), Expect = 9e-49,   Method: Compositional matrix adjust.
 Identities = 92/99 (92%), Positives = 96/99 (96%)

Query: 17  PQITLYQRPLVTIKIGGQLKEALLKTGADDTVLEEMSLPGEWKPKLIGGIGGFIKVRQYD 76
           PQITL+QRPLVTIKIGGQLKEALL TGAD+TVLEEMSLPG WKPK+IGGIGGFIKVRQYD
Sbjct: 1   PQITLWQRPLVTIKIGGQLKEALLDTGADNTVLEEMSLPGAWKPKMIGGIGGFIKVRQYD 60

Query: 77  QILIEICGHKAIGTVLVGPTPVNILGRNLLTQIGCTLNF 115
           QILIEICGHK IGTVLVGPTPVNI+GRNLLTQIGCTLNF
Sbjct: 61  QILIEICGHKVIGTVLVGPTPVNIIGRNLLTQIGCTLNF 99


>gi|30749426|pdb|1LZQ|A Chain A, Crystal Structure Of The Complex Of
           Mutant Hiv-1 Protease (A71v, V82t, I84v) With An
           Ethylenamine Peptidomimetic Inhibitor
           Boc-Phe-Psi[ch2ch2nh]-Phe-Glu-Phe-Nh2
 Chain B, Crystal Structure Of The Complex Of Mutant Hiv-1 Protease
           (A71v, V82t, I84v) With An Ethylenamine Peptidomimetic
           Inhibitor Boc-Phe-Psi[ch2ch2nh]-Phe-Glu-Phe-Nh2
 Chain A, Crystal Structure Of A Complex Of Mutant Hiv-1 Protease
           (A71v, V82t, I84v) With A Hydroxyethylamine
           Peptidomimetic Inhibitor
 Chain B, Crystal Structure Of A Complex Of Mutant Hiv-1 Protease
           (A71v, V82t, I84v) With A Hydroxyethylamine
           Peptidomimetic Inhibitor
 Chain A, Crystal Structure Of A Complex Of Mutant Hiv-1 Protease
           (A71v, V82t, I84v) With A Hydroxyethylamine
           Peptidomimetic Inhibitor
           Boc-Phe-Psi[s-Ch(Oh)ch2nh]-Phe-Glu-Phe-Nh2
          Length = 99

 Score =  187 bits (474), Expect = 9e-49,   Method: Compositional matrix adjust.
 Identities = 91/99 (91%), Positives = 95/99 (95%)

Query: 17  PQITLYQRPLVTIKIGGQLKEALLKTGADDTVLEEMSLPGEWKPKLIGGIGGFIKVRQYD 76
           PQITL+QRPLVTIKIGGQLKEALL TGADDTVLEEMSLPG WKPK+IGGIGGFIKVRQYD
Sbjct: 1   PQITLWQRPLVTIKIGGQLKEALLDTGADDTVLEEMSLPGRWKPKMIGGIGGFIKVRQYD 60

Query: 77  QILIEICGHKAIGTVLVGPTPVNILGRNLLTQIGCTLNF 115
           QILIEICGHK IGTVLVGPTP N++GRNLLTQIGCTLNF
Sbjct: 61  QILIEICGHKVIGTVLVGPTPTNVIGRNLLTQIGCTLNF 99


>gi|2914186|pdb|1HXW|A Chain A, Hiv-1 Protease Dimer Complexed With
           A-84538
 Chain B, Hiv-1 Protease Dimer Complexed With A-84538
          Length = 99

 Score =  187 bits (474), Expect = 1e-48,   Method: Compositional matrix adjust.
 Identities = 92/98 (93%), Positives = 96/98 (97%)

Query: 18  QITLYQRPLVTIKIGGQLKEALLKTGADDTVLEEMSLPGEWKPKLIGGIGGFIKVRQYDQ 77
           QITL+QRPLVTIKIGGQLKEALL TGADDTVLEEM+LPG WKPK+IGGIGGFIKVRQYDQ
Sbjct: 2   QITLWQRPLVTIKIGGQLKEALLDTGADDTVLEEMNLPGRWKPKMIGGIGGFIKVRQYDQ 61

Query: 78  ILIEICGHKAIGTVLVGPTPVNILGRNLLTQIGCTLNF 115
           ILIEICGHKAIGTVLVGPTPVNI+GRNLLTQIGCTLNF
Sbjct: 62  ILIEICGHKAIGTVLVGPTPVNIIGRNLLTQIGCTLNF 99


>gi|90108775|pdb|2AZ9|A Chain A, Hiv-1 Protease Nl4-3 1x Mutant
          Length = 99

 Score =  186 bits (473), Expect = 1e-48,   Method: Compositional matrix adjust.
 Identities = 91/99 (91%), Positives = 96/99 (96%)

Query: 17  PQITLYQRPLVTIKIGGQLKEALLKTGADDTVLEEMSLPGEWKPKLIGGIGGFIKVRQYD 76
           PQITL++RPLVTIKIGGQLKEALL TGADDTVLEEM+LPG WKPK+IGGIGGFIKVRQYD
Sbjct: 1   PQITLWKRPLVTIKIGGQLKEALLDTGADDTVLEEMNLPGRWKPKMIGGIGGFIKVRQYD 60

Query: 77  QILIEICGHKAIGTVLVGPTPVNILGRNLLTQIGCTLNF 115
           QILIEICGHKAIGTVLVGPTP NI+GRNLLTQIGCTLNF
Sbjct: 61  QILIEICGHKAIGTVLVGPTPANIIGRNLLTQIGCTLNF 99


>gi|3114319|pdb|1MET|A Chain A, Hiv-1 Mutant (V82f) Protease
           Complexed With Dmp323
 Chain B, Hiv-1 Mutant (V82f) Protease Complexed With Dmp323
          Length = 99

 Score =  186 bits (473), Expect = 1e-48,   Method: Compositional matrix adjust.
 Identities = 91/98 (92%), Positives = 95/98 (96%)

Query: 18  QITLYQRPLVTIKIGGQLKEALLKTGADDTVLEEMSLPGEWKPKLIGGIGGFIKVRQYDQ 77
           Q+TL+QRPLVTIKIGGQLKEALL TGADDTVLEEMSLPG WKPK+IGGIGGFIKVRQYDQ
Sbjct: 2   QVTLWQRPLVTIKIGGQLKEALLDTGADDTVLEEMSLPGRWKPKMIGGIGGFIKVRQYDQ 61

Query: 78  ILIEICGHKAIGTVLVGPTPVNILGRNLLTQIGCTLNF 115
           ILIEICGHKAIGTVLVGPTP NI+GRNLLTQIGCTLNF
Sbjct: 62  ILIEICGHKAIGTVLVGPTPFNIIGRNLLTQIGCTLNF 99


>gi|3114321|pdb|1MEU|A Chain A, Hiv-1 Mutant (V82f, I84v) Protease
           Complexed With Dmp323
 Chain B, Hiv-1 Mutant (V82f, I84v) Protease Complexed With Dmp323
 Chain A, Hiv-1 Protease (V82fI84V) DOUBLE MUTANT COMPLEXED WITH
           Sd146 Of Dupont Pharmaceuticals
 Chain B, Hiv-1 Protease (V82fI84V) DOUBLE MUTANT COMPLEXED WITH
           Sd146 Of Dupont Pharmaceuticals
          Length = 99

 Score =  186 bits (473), Expect = 1e-48,   Method: Compositional matrix adjust.
 Identities = 90/98 (91%), Positives = 95/98 (96%)

Query: 18  QITLYQRPLVTIKIGGQLKEALLKTGADDTVLEEMSLPGEWKPKLIGGIGGFIKVRQYDQ 77
           Q+TL+QRPLVTIKIGGQLKEALL TGADDTVLEEMSLPG WKPK+IGGIGGFIKVRQYDQ
Sbjct: 2   QVTLWQRPLVTIKIGGQLKEALLDTGADDTVLEEMSLPGRWKPKMIGGIGGFIKVRQYDQ 61

Query: 78  ILIEICGHKAIGTVLVGPTPVNILGRNLLTQIGCTLNF 115
           ILIEICGHKAIGTVLVGPTP N++GRNLLTQIGCTLNF
Sbjct: 62  ILIEICGHKAIGTVLVGPTPFNVIGRNLLTQIGCTLNF 99


>gi|146387074|pdb|2P3B|B Chain B, Crystal Structure Of The Subtype B
           Wild Type Hiv Protease Complexed With Tl-3 Inhibitor
          Length = 99

 Score =  186 bits (472), Expect = 2e-48,   Method: Compositional matrix adjust.
 Identities = 92/99 (92%), Positives = 96/99 (96%)

Query: 17  PQITLYQRPLVTIKIGGQLKEALLKTGADDTVLEEMSLPGEWKPKLIGGIGGFIKVRQYD 76
           PQITL++RPLVTIKIGGQLKEALL TGADDTVLEEMSLPG WKPK+IGGIGGFIKVRQYD
Sbjct: 1   PQITLWKRPLVTIKIGGQLKEALLDTGADDTVLEEMSLPGRWKPKMIGGIGGFIKVRQYD 60

Query: 77  QILIEICGHKAIGTVLVGPTPVNILGRNLLTQIGCTLNF 115
           QILIEI GHKAIGTVLVGPTPVNI+GRNLLTQIGCTLNF
Sbjct: 61  QILIEIXGHKAIGTVLVGPTPVNIIGRNLLTQIGCTLNF 99


>gi|28373793|pdb|1MTB|A Chain A, Viability Of A Drug-Resistant Hiv-1
           Protease Mutant: Structural Insights For Better
           Antiviral Therapy
 Chain B, Viability Of A Drug-Resistant Hiv-1 Protease Mutant:
           Structural Insights For Better Antiviral Therapy
          Length = 99

 Score =  186 bits (471), Expect = 2e-48,   Method: Compositional matrix adjust.
 Identities = 90/99 (90%), Positives = 97/99 (97%)

Query: 17  PQITLYQRPLVTIKIGGQLKEALLKTGADDTVLEEMSLPGEWKPKLIGGIGGFIKVRQYD 76
           PQITL+QRPLVTI+IGGQLKEALL TGADDTVLEEM+LPG+WKPK+IGGIGGFIKVRQYD
Sbjct: 1   PQITLWQRPLVTIRIGGQLKEALLNTGADDTVLEEMNLPGKWKPKMIGGIGGFIKVRQYD 60

Query: 77  QILIEICGHKAIGTVLVGPTPVNILGRNLLTQIGCTLNF 115
           QI +EICGHKAIGTVLVGPTPVNI+GRNLLTQIGCTLNF
Sbjct: 61  QIPVEICGHKAIGTVLVGPTPVNIIGRNLLTQIGCTLNF 99


>gi|2624873|pdb|1AID|A Chain A, Structure Of A Non-Peptide Inhibitor
           Complexed With Hiv-1 Protease: Developing A Cycle Of
           Structure-Based Drug Design
 Chain B, Structure Of A Non-Peptide Inhibitor Complexed With Hiv-1
           Protease: Developing A Cycle Of Structure-Based Drug
           Design
          Length = 99

 Score =  186 bits (471), Expect = 2e-48,   Method: Compositional matrix adjust.
 Identities = 90/99 (90%), Positives = 97/99 (97%)

Query: 17  PQITLYQRPLVTIKIGGQLKEALLKTGADDTVLEEMSLPGEWKPKLIGGIGGFIKVRQYD 76
           PQITL+QRPLVTI+IGGQLKEALL TGADDTVLEEM+LPG+WKPK+IGGIGGFIKVRQYD
Sbjct: 1   PQITLWQRPLVTIRIGGQLKEALLDTGADDTVLEEMNLPGKWKPKMIGGIGGFIKVRQYD 60

Query: 77  QILIEICGHKAIGTVLVGPTPVNILGRNLLTQIGCTLNF 115
           QI +EICGHKAIGTVLVGPTPVNI+GRNLLTQIGCTLNF
Sbjct: 61  QIPVEICGHKAIGTVLVGPTPVNIIGRNLLTQIGCTLNF 99


>gi|1421543|pdb|1HVR|A Chain A, Rational Design Of Potent,
           Bioavailable, Nonpeptide Cyclic Ureas As Hiv Protease
           Inhibitors
 Chain B, Rational Design Of Potent, Bioavailable, Nonpeptide Cyclic
           Ureas As Hiv Protease Inhibitors
 Chain A, Hiv-1 Protease-Dmp323 Complex In Solution, Nmr Minimized
           Average Structure
 Chain B, Hiv-1 Protease-Dmp323 Complex In Solution, Nmr Minimized
           Average Structure
 Chain A, Hiv-1 Protease-Dmp323 Complex In Solution, Nmr, 28
           Structures
 Chain B, Hiv-1 Protease-Dmp323 Complex In Solution, Nmr, 28
           Structures
 Chain A, Hiv-1 Protease Inhibitors Wiih Low Nanomolar Potency
 Chain B, Hiv-1 Protease Inhibitors Wiih Low Nanomolar Potency
 Chain A, Hiv-1 Protease Inhibitors Wiih Low Nanomolar Potency
 Chain B, Hiv-1 Protease Inhibitors Wiih Low Nanomolar Potency
 Chain A, Hiv-1 Protease Inhibitors Wiih Low Nanomolar Potency
 Chain B, Hiv-1 Protease Inhibitors Wiih Low Nanomolar Potency
 Chain A, Molecular Recognition Of Cyclic Urea Hiv Protease
           Inhibitors
 Chain B, Molecular Recognition Of Cyclic Urea Hiv Protease
           Inhibitors
          Length = 99

 Score =  186 bits (471), Expect = 3e-48,   Method: Compositional matrix adjust.
 Identities = 91/98 (92%), Positives = 95/98 (96%)

Query: 18  QITLYQRPLVTIKIGGQLKEALLKTGADDTVLEEMSLPGEWKPKLIGGIGGFIKVRQYDQ 77
           Q+TL+QRPLVTIKIGGQLKEALL TGADDTVLEEMSLPG WKPK+IGGIGGFIKVRQYDQ
Sbjct: 2   QVTLWQRPLVTIKIGGQLKEALLDTGADDTVLEEMSLPGRWKPKMIGGIGGFIKVRQYDQ 61

Query: 78  ILIEICGHKAIGTVLVGPTPVNILGRNLLTQIGCTLNF 115
           ILIEICGHKAIGTVLVGPTPVNI+GRNLLTQIG TLNF
Sbjct: 62  ILIEICGHKAIGTVLVGPTPVNIIGRNLLTQIGATLNF 99


>gi|38492434|pdb|1MRX|A Chain A, Structure Of Hiv Protease (Mutant
           Q7k L33i L63i V82f I84v ) Complexed With Kni-577
 Chain B, Structure Of Hiv Protease (Mutant Q7k L33i L63i V82f I84v
           ) Complexed With Kni-577
 Chain A, The Hiv Protease (Mutant Q7k L33i L63i V82f I84v)
           Complexed With Kni-764 (An Inhibitor)
 Chain B, The Hiv Protease (Mutant Q7k L33i L63i V82f I84v)
           Complexed With Kni-764 (An Inhibitor)
          Length = 99

 Score =  185 bits (470), Expect = 3e-48,   Method: Compositional matrix adjust.
 Identities = 89/99 (89%), Positives = 96/99 (96%)

Query: 17  PQITLYQRPLVTIKIGGQLKEALLKTGADDTVLEEMSLPGEWKPKLIGGIGGFIKVRQYD 76
           PQITL++RPLVTIKIGGQLKEALL TGADDTV+EEMSLPG WKPK+IGGIGGFIKVRQYD
Sbjct: 1   PQITLWKRPLVTIKIGGQLKEALLDTGADDTVIEEMSLPGRWKPKMIGGIGGFIKVRQYD 60

Query: 77  QILIEICGHKAIGTVLVGPTPVNILGRNLLTQIGCTLNF 115
           QI+IEICGHKAIGTVLVGPTP N++GRNLLTQIGCTLNF
Sbjct: 61  QIIIEICGHKAIGTVLVGPTPFNVIGRNLLTQIGCTLNF 99


>gi|27573665|pdb|1IZI|A Chain A, Inhibitor Of Hiv Protease With
           Unusual Binding Mode Potently Inhibiting Multi-Resistant
           Protease Mutants
 Chain B, Inhibitor Of Hiv Protease With Unusual Binding Mode
           Potently Inhibiting Multi-Resistant Protease Mutants
          Length = 99

 Score =  185 bits (470), Expect = 3e-48,   Method: Compositional matrix adjust.
 Identities = 90/99 (90%), Positives = 95/99 (95%)

Query: 17  PQITLYQRPLVTIKIGGQLKEALLKTGADDTVLEEMSLPGEWKPKLIGGIGGFIKVRQYD 76
           PQITL+QRPLVTIKIGGQLKEALL TGADDTVLEEM+LPG WKPK+IGGIGGFIKVRQYD
Sbjct: 1   PQITLWQRPLVTIKIGGQLKEALLDTGADDTVLEEMNLPGRWKPKMIGGIGGFIKVRQYD 60

Query: 77  QILIEICGHKAIGTVLVGPTPVNILGRNLLTQIGCTLNF 115
           QILIEICGHK IGTVLVGPTP N++GRNLLTQIGCTLNF
Sbjct: 61  QILIEICGHKVIGTVLVGPTPTNVIGRNLLTQIGCTLNF 99


>gi|158429165|pdb|2NXD|A Chain A, Structure Of Hiv-1 Protease D25n
           Complexed With Rt-Rh Analogue Peptide
           Gly-Ala-Asp-Ile-PheTyr-Leu-Asp-Gly-Ala
 Chain B, Structure Of Hiv-1 Protease D25n Complexed With Rt-Rh
           Analogue Peptide Gly-Ala-Asp-Ile-PheTyr-Leu-Asp-Gly-Ala
 Chain A, Structure Of Hiv-1 Protease D25n Complexed With The Rt-Rh
           Analogue Peptide Gly-Ala-Glu-Val-PheTyr-Val-Asp-Gly-Ala
 Chain B, Structure Of Hiv-1 Protease D25n Complexed With The Rt-Rh
           Analogue Peptide Gly-Ala-Glu-Val-PheTyr-Val-Asp-Gly-Ala
 Chain A, Structure Of Hiv-1 Protease D25n Complexed With The Rt-Rh
           Analogue Peptide Gly-Ala-Gln-Thr-PheTyr-Val-Asp-Gly-Ala
 Chain B, Structure Of Hiv-1 Protease D25n Complexed With The Rt-Rh
           Analogue Peptide Gly-Ala-Gln-Thr-PheTyr-Val-Asp-Gly-Ala
          Length = 99

 Score =  184 bits (468), Expect = 5e-48,   Method: Compositional matrix adjust.
 Identities = 90/99 (90%), Positives = 97/99 (97%)

Query: 17  PQITLYQRPLVTIKIGGQLKEALLKTGADDTVLEEMSLPGEWKPKLIGGIGGFIKVRQYD 76
           PQITL++RPLVTI+IGGQLKEALL TGADDTVLEEM+LPG+WKPK+IGGIGGFIKVRQYD
Sbjct: 1   PQITLWKRPLVTIRIGGQLKEALLNTGADDTVLEEMNLPGKWKPKMIGGIGGFIKVRQYD 60

Query: 77  QILIEICGHKAIGTVLVGPTPVNILGRNLLTQIGCTLNF 115
           QI IEICGHKAIGTVLVGPTPVNI+GRNLLTQIGCTLNF
Sbjct: 61  QIPIEICGHKAIGTVLVGPTPVNIIGRNLLTQIGCTLNF 99


>gi|119389416|pdb|2F3K|A Chain A, Substrate Envelope And Drug
           Resistance: Crystal Structure Of R01 In Complex With
           Wild-Type Hiv-1 Protease
 Chain B, Substrate Envelope And Drug Resistance: Crystal Structure
           Of R01 In Complex With Wild-Type Hiv-1 Protease
 Chain A, Crystal Structure Of Kb-19 Complexed With Wild Type Hiv-1
           Protease
 Chain B, Crystal Structure Of Kb-19 Complexed With Wild Type Hiv-1
           Protease
 Chain A, Crystal Structure Of Ad-81 Complexed With Wild Type Hiv-1
           Protease
 Chain B, Crystal Structure Of Ad-81 Complexed With Wild Type Hiv-1
           Protease
 Chain A, Crystal Structure Of Wild Type Hiv-1 Protease In Complex
           With Carb-Ad37
 Chain B, Crystal Structure Of Wild Type Hiv-1 Protease In Complex
           With Carb-Ad37
 Chain A, Crystal Structure Of Wild Type Hiv-1 Protease In Complex
           With Carb-Kb45
 Chain B, Crystal Structure Of Wild Type Hiv-1 Protease In Complex
           With Carb-Kb45
 Chain A, Crystal Structure Of Kb73 Bound To Hiv-1 Protease
 Chain B, Crystal Structure Of Kb73 Bound To Hiv-1 Protease
 Chain A, Crystal Structure Of Kk44 Bound To Hiv-1 Protease
 Chain B, Crystal Structure Of Kk44 Bound To Hiv-1 Protease
 Chain A, Crystal Structure Of Lopinavir Bound To Wild Type Hiv-1
           Protease
 Chain B, Crystal Structure Of Lopinavir Bound To Wild Type Hiv-1
           Protease
 Chain A, Crystal Structure Of Lysine Sulfonamide Inhibitor Reveals
           The Displacement Of The Conserved Flap Water Molecule In
           Hiv-1 Protease
 Chain B, Crystal Structure Of Lysine Sulfonamide Inhibitor Reveals
           The Displacement Of The Conserved Flap Water Molecule In
           Hiv-1 Protease
 Chain A, Crystal Structure Of Protease Inhibitor, Mit-1-Ac86 In
           Complex With Wild Type Hiv-1 Protease
 Chain B, Crystal Structure Of Protease Inhibitor, Mit-1-Ac86 In
           Complex With Wild Type Hiv-1 Protease
 Chain A, Crystal Structure Of Protease Inhibitor, Mit-1-Ac87 In
           Complex With Wild Type Hiv-1 Protease
 Chain B, Crystal Structure Of Protease Inhibitor, Mit-1-Ac87 In
           Complex With Wild Type Hiv-1 Protease
 Chain A, Crystal Structure Of Protease Inhibitor, Mit-1-Kk80 In
           Complex With Wild Type Hiv-1 Protease
 Chain B, Crystal Structure Of Protease Inhibitor, Mit-1-Kk80 In
           Complex With Wild Type Hiv-1 Protease
 Chain A, Crystal Structure Of Protease Inhibitor, Mit-1-Kk81 In
           Complex With Wild Type Hiv-1 Protease
 Chain B, Crystal Structure Of Protease Inhibitor, Mit-1-Kk81 In
           Complex With Wild Type Hiv-1 Protease
 Chain A, Crystal Structure Of Protease Inhibitor, Mit-2-Ad94 In
           Complex With Wild Type Hiv-1 Protease
 Chain B, Crystal Structure Of Protease Inhibitor, Mit-2-Ad94 In
           Complex With Wild Type Hiv-1 Protease
 Chain A, Crystal Structure Of Protease Inhibitor, Mit-2-Ad93 In
           Complex With Wild Type Hiv-1 Protease
 Chain B, Crystal Structure Of Protease Inhibitor, Mit-2-Ad93 In
           Complex With Wild Type Hiv-1 Protease
 Chain A, Crystal Structure Of Protease Inhibitor, Mit-2-Kc08 In
           Complex With Wild Type Hiv-1 Protease
 Chain B, Crystal Structure Of Protease Inhibitor, Mit-2-Kc08 In
           Complex With Wild Type Hiv-1 Protease
 Chain A, Crystal Structure Of Protease Inhibitor, Mit-2-Kb98 In
           Complex With Wild Type Hiv-1 Protease
 Chain B, Crystal Structure Of Protease Inhibitor, Mit-2-Kb98 In
           Complex With Wild Type Hiv-1 Protease
 Chain A, Crystal Structure Of Protease Inhibitor, Mit-2-Ad86 In
           Complex With Wild Type Hiv-1 Protease
 Chain B, Crystal Structure Of Protease Inhibitor, Mit-2-Ad86 In
           Complex With Wild Type Hiv-1 Protease
          Length = 99

 Score =  184 bits (468), Expect = 5e-48,   Method: Compositional matrix adjust.
 Identities = 90/99 (90%), Positives = 97/99 (97%)

Query: 17  PQITLYQRPLVTIKIGGQLKEALLKTGADDTVLEEMSLPGEWKPKLIGGIGGFIKVRQYD 76
           PQITL++RPLVTI+IGGQLKEALL TGADDTVLEEM+LPG+WKPK+IGGIGGFIKVRQYD
Sbjct: 1   PQITLWKRPLVTIRIGGQLKEALLDTGADDTVLEEMNLPGKWKPKMIGGIGGFIKVRQYD 60

Query: 77  QILIEICGHKAIGTVLVGPTPVNILGRNLLTQIGCTLNF 115
           QI IEICGHKAIGTVLVGPTPVNI+GRNLLTQIGCTLNF
Sbjct: 61  QIPIEICGHKAIGTVLVGPTPVNIIGRNLLTQIGCTLNF 99


>gi|1942083|pdb|1YTG|A Chain A, Siv Protease Crystallized With
           Peptide Product
 Chain B, Siv Protease Crystallized With Peptide Product
 Chain A, Siv Protease Crystallized With Peptide Product
 Chain B, Siv Protease Crystallized With Peptide Product
 Chain A, Structure Of A Non-Peptide Inhibitor Complexed With Hiv-1
           Protease: Developing A Cycle Of Structure-Based Drug
           Design
 Chain B, Structure Of A Non-Peptide Inhibitor Complexed With Hiv-1
           Protease: Developing A Cycle Of Structure-Based Drug
           Design
 Chain A, Hiv Protease Wild-Type In Complex With Tmc114 Inhibitor
 Chain B, Hiv Protease Wild-Type In Complex With Tmc114 Inhibitor
 Chain A, Je-2147-Hiv Protease Complex
 Chain B, Je-2147-Hiv Protease Complex
          Length = 99

 Score =  184 bits (467), Expect = 6e-48,   Method: Compositional matrix adjust.
 Identities = 89/99 (89%), Positives = 97/99 (97%)

Query: 17  PQITLYQRPLVTIKIGGQLKEALLKTGADDTVLEEMSLPGEWKPKLIGGIGGFIKVRQYD 76
           PQITL++RPLVTI+IGGQLKEALL TGADDTVLEEM+LPG+WKPK+IGGIGGFIKVRQYD
Sbjct: 1   PQITLWKRPLVTIRIGGQLKEALLDTGADDTVLEEMNLPGKWKPKMIGGIGGFIKVRQYD 60

Query: 77  QILIEICGHKAIGTVLVGPTPVNILGRNLLTQIGCTLNF 115
           QI +EICGHKAIGTVLVGPTPVNI+GRNLLTQIGCTLNF
Sbjct: 61  QIPVEICGHKAIGTVLVGPTPVNIIGRNLLTQIGCTLNF 99


>gi|14719532|pdb|1F7A|A Chain A, How Does A Symmetric Dimer
           Recognize An Asymmetric Substrate? A Substrate Complex
           Of Hiv-1 Protease.
 Chain B, How Does A Symmetric Dimer Recognize An Asymmetric
           Substrate? A Substrate Complex Of Hiv-1 Protease.
 Chain A, Substrate Shape Determines Specificity Of Recognition
           Recognition For Hiv-1 Protease: Analysis Of Crystal
           Structures Of Six Substrate Complexes
 Chain B, Substrate Shape Determines Specificity Of Recognition
           Recognition For Hiv-1 Protease: Analysis Of Crystal
           Structures Of Six Substrate Complexes
 Chain C, Substrate Shape Determines Specificity Of Recognition
           Recognition For Hiv-1 Protease: Analysis Of Crystal
           Structures Of Six Substrate Complexes
 Chain D, Substrate Shape Determines Specificity Of Recognition
           Recognition For Hiv-1 Protease: Analysis Of Crystal
           Structures Of Six Substrate Complexes
 Chain A, Substrate Shape Determines Specificity Of Recognition
           Recognition For Hiv-1 Protease: Analysis Of Crystal
           Structures Of Six Substrate Complexes
 Chain B, Substrate Shape Determines Specificity Of Recognition
           Recognition For Hiv-1 Protease: Analysis Of Crystal
           Structures Of Six Substrate Complexes
 Chain A, Substrate Shape Determines Specificity Of Recognition
           Recognition For Hiv-1 Protease: Analysis Of Crystal
           Structures Of Six Substrate Complexes
 Chain B, Substrate Shape Determines Specificity Of Recognition
           Recognition For Hiv-1 Protease: Analysis Of Crystal
           Structures Of Six Substrate Complexes
 Chain A, Substrate Shape Determines Specificity Of Recognition
           Recognition For Hiv-1 Protease: Analysis Of Crystal
           Structures Of Six Substrate Complexes
 Chain B, Substrate Shape Determines Specificity Of Recognition
           Recognition For Hiv-1 Protease: Analysis Of Crystal
           Structures Of Six Substrate Complexes
 Chain A, Substrate Shape Determines Specificity Of Recognition
           Recognition For Hiv-1 Protease: Analysis Of Crystal
           Structures Of Six Substrate Complexes
 Chain B, Substrate Shape Determines Specificity Of Recognition
           Recognition For Hiv-1 Protease: Analysis Of Crystal
           Structures Of Six Substrate Complexes
 Chain A, Crystal Structure Of Decamer Ncp1 Substrate Peptide In
           Complex With Wild-Type D25n Hiv-1 Protease Variant
 Chain B, Crystal Structure Of Decamer Ncp1 Substrate Peptide In
           Complex With Wild-Type D25n Hiv-1 Protease Variant
 Chain A, Crystal Structure Of Wild-Type Inactive (D25n) Hiv-1
           Protease Complexed With Wild-Type Hiv-1 Nc-P1 Substrate.
 Chain B, Crystal Structure Of Wild-Type Inactive (D25n) Hiv-1
           Protease Complexed With Wild-Type Hiv-1 Nc-P1 Substrate
          Length = 99

 Score =  184 bits (467), Expect = 7e-48,   Method: Compositional matrix adjust.
 Identities = 89/99 (89%), Positives = 97/99 (97%)

Query: 17  PQITLYQRPLVTIKIGGQLKEALLKTGADDTVLEEMSLPGEWKPKLIGGIGGFIKVRQYD 76
           PQITL++RPLVTI+IGGQLKEALL TGADDTVLEEM+LPG+WKPK+IGGIGGFIKVRQYD
Sbjct: 1   PQITLWKRPLVTIRIGGQLKEALLNTGADDTVLEEMNLPGKWKPKMIGGIGGFIKVRQYD 60

Query: 77  QILIEICGHKAIGTVLVGPTPVNILGRNLLTQIGCTLNF 115
           QI +EICGHKAIGTVLVGPTPVNI+GRNLLTQIGCTLNF
Sbjct: 61  QIPVEICGHKAIGTVLVGPTPVNIIGRNLLTQIGCTLNF 99


>gi|116667812|pdb|2HS2|A Chain A, Crystal Structure Of M46l Mutant
           Of Hiv-1 Protease Complexed With Tmc114 (Darunavir)
 Chain B, Crystal Structure Of M46l Mutant Of Hiv-1 Protease
           Complexed With Tmc114 (Darunavir)
          Length = 99

 Score =  184 bits (466), Expect = 9e-48,   Method: Compositional matrix adjust.
 Identities = 90/99 (90%), Positives = 95/99 (95%)

Query: 17  PQITLYQRPLVTIKIGGQLKEALLKTGADDTVLEEMSLPGEWKPKLIGGIGGFIKVRQYD 76
           PQITL++RPLVTIKIGGQLKEALL TGADDTV+EEMSLPG WKPKLIGGIGGFIKVRQYD
Sbjct: 1   PQITLWKRPLVTIKIGGQLKEALLDTGADDTVIEEMSLPGRWKPKLIGGIGGFIKVRQYD 60

Query: 77  QILIEICGHKAIGTVLVGPTPVNILGRNLLTQIGCTLNF 115
           QI+IEI GHKAIGTVLVGPTPVNI+GRNLLTQIG TLNF
Sbjct: 61  QIIIEIAGHKAIGTVLVGPTPVNIIGRNLLTQIGATLNF 99


>gi|99031669|pdb|1ZBG|A Chain A, Crystal Structure Of A Complex Of
           Mutant Hiv-1 Protease (A71v, V82t, I84v) With A
           Hydroxyethylamine Peptidomimetic Inhibitor
           Boc-Phe-Psi[r-Ch(Oh)ch2nh]-Phe-Glu-Phe-Nh2
 Chain B, Crystal Structure Of A Complex Of Mutant Hiv-1 Protease
           (A71v, V82t, I84v) With A Hydroxyethylamine
           Peptidomimetic Inhibitor
           Boc-Phe-Psi[r-Ch(Oh)ch2nh]-Phe-Glu-Phe-Nh2
 Chain A, Crystal Structure Of The Complex Of Mutant Hiv-1 Protease
           (A71v, V82t, I84v) With A Hydroxyethylamine
           Peptidomimetic Inhibitor
           Boc-Phe-Psi[r-Ch(Oh)ch2nh]-Phe-Glu-Phe-Nh2
 Chain B, Crystal Structure Of The Complex Of Mutant Hiv-1 Protease
           (A71v, V82t, I84v) With A Hydroxyethylamine
           Peptidomimetic Inhibitor
           Boc-Phe-Psi[r-Ch(Oh)ch2nh]-Phe-Glu-Phe-Nh2
          Length = 99

 Score =  184 bits (466), Expect = 9e-48,   Method: Compositional matrix adjust.
 Identities = 90/99 (90%), Positives = 94/99 (94%)

Query: 17  PQITLYQRPLVTIKIGGQLKEALLKTGADDTVLEEMSLPGEWKPKLIGGIGGFIKVRQYD 76
           PQITL+QRPLVTIKIGGQLKEALL TGADDTVLEEMSLPG WKPK+IGGIGGFIKVRQYD
Sbjct: 1   PQITLWQRPLVTIKIGGQLKEALLDTGADDTVLEEMSLPGRWKPKMIGGIGGFIKVRQYD 60

Query: 77  QILIEICGHKAIGTVLVGPTPVNILGRNLLTQIGCTLNF 115
           QILIEI GHK IGTVLVGPTP N++GRNLLTQIGCTLNF
Sbjct: 61  QILIEIXGHKVIGTVLVGPTPTNVIGRNLLTQIGCTLNF 99


>gi|171849052|pdb|3BVA|A Chain A, Cystal Structure Of Hiv-1 Active
           Site Mutant D25n And P2-Nc Analog Inhibitor
 Chain B, Cystal Structure Of Hiv-1 Active Site Mutant D25n And
           P2-Nc Analog Inhibitor
 Chain A, Cystal Structure Of Hiv-1 Active Site Mutant D25n And
           Inhibitor Darunavir
 Chain B, Cystal Structure Of Hiv-1 Active Site Mutant D25n And
           Inhibitor Darunavir
          Length = 99

 Score =  184 bits (466), Expect = 1e-47,   Method: Compositional matrix adjust.
 Identities = 89/99 (89%), Positives = 95/99 (95%)

Query: 17  PQITLYQRPLVTIKIGGQLKEALLKTGADDTVLEEMSLPGEWKPKLIGGIGGFIKVRQYD 76
           PQITL++RPLVTIKIGGQLKEALL TGADDTV+EEMSLPG WKPK+IGGIGGFIKVRQYD
Sbjct: 1   PQITLWKRPLVTIKIGGQLKEALLNTGADDTVIEEMSLPGRWKPKMIGGIGGFIKVRQYD 60

Query: 77  QILIEICGHKAIGTVLVGPTPVNILGRNLLTQIGCTLNF 115
           QI+IEI GHKAIGTVLVGPTPVNI+GRNLLTQIG TLNF
Sbjct: 61  QIIIEIAGHKAIGTVLVGPTPVNIIGRNLLTQIGATLNF 99


>gi|14488620|pdb|1FGC|C Chain C, Structural Implications Of Drug
           Resistant Mutants Of Hiv-1 Protease: High Resolution
           Crystal Structures Of The Mutant ProteaseSUBSTRATE
           ANALOG COMPLEXES
 Chain D, Structural Implications Of Drug Resistant Mutants Of Hiv-1
           Protease: High Resolution Crystal Structures Of The
           Mutant ProteaseSUBSTRATE ANALOG COMPLEXES
 Chain A, Crystal Structures Of Hiv Protease V82a And L90m Mutants
           Reveal Changes In Indinavir Binding Site.
 Chain B, Crystal Structures Of Hiv Protease V82a And L90m Mutants
           Reveal Changes In Indinavir Binding Site.
 Chain A, Crystal Structure Analysis Of Hiv-1 Protease With A
           Substrate Analog P2-Nc
 Chain B, Crystal Structure Analysis Of Hiv-1 Protease With A
           Substrate Analog P2-Nc
 Chain A, Crystal Structure Analysis Of Hiv-1 Protease With A
           Substrate Analog P1-P6
 Chain B, Crystal Structure Analysis Of Hiv-1 Protease With A
           Substrate Analog P1-P6
 Chain A, Crystal Structure Analysis Of Hiv-1 Protease With A
           Substrate Analog P6-Pr
 Chain B, Crystal Structure Analysis Of Hiv-1 Protease With A
           Substrate Analog P6-Pr
 Chain A, Wild-Type Hiv-1 Protease In Complex With Potent Inhibitor
           Grl06579
 Chain B, Wild-Type Hiv-1 Protease In Complex With Potent Inhibitor
           Grl06579
 Chain A, Crystal Structure Analysis Of Hiv-1 Protease With A Potent
           Non-Peptide Inhibitor (Uic-94017)
 Chain B, Crystal Structure Analysis Of Hiv-1 Protease With A Potent
           Non-Peptide Inhibitor (Uic-94017)
 Chain A, Crystal Structure Analysis Of Hiv-1 Protease With A
           Inhibitor Saquinavir
 Chain B, Crystal Structure Analysis Of Hiv-1 Protease With A
           Inhibitor Saquinavir
 Chain A, Hiv-1 Protease Complexed With Gem-Diol-Amine Tetrahedral
           Intermediate Nlltqi
 Chain B, Hiv-1 Protease Complexed With Gem-Diol-Amine Tetrahedral
           Intermediate Nlltqi
 Chain A, Wild Type Hiv-1 Protease With Potent Antiviral Inhibitor
           Grl-98065
 Chain B, Wild Type Hiv-1 Protease With Potent Antiviral Inhibitor
           Grl-98065
 Chain A, Wild Type Hiv-1 Protease With Potent Antiviral Inhibitor
           Grl-0255a
 Chain B, Wild Type Hiv-1 Protease With Potent Antiviral Inhibitor
           Grl-0255a
 Chain A, Structure Of Hiv-1 Protease In Complex With Potent
           Inhibitor Kni-272 Determined By High Resolution X-Ray
           Crystallography
 Chain B, Structure Of Hiv-1 Protease In Complex With Potent
           Inhibitor Kni-272 Determined By High Resolution X-Ray
           Crystallography
 Chain A, Wild Type Hiv-1 Protease With Potent Antiviral Inhibitor
           Grl-0105a
 Chain B, Wild Type Hiv-1 Protease With Potent Antiviral Inhibitor
           Grl-0105a
 Chain A, Crystal Structure Of Wild Type Hiv-1 Protease With Novel
           P1'-Ligand Grl-02031
 Chain B, Crystal Structure Of Wild Type Hiv-1 Protease With Novel
           P1'-Ligand Grl-02031
          Length = 99

 Score =  183 bits (465), Expect = 1e-47,   Method: Compositional matrix adjust.
 Identities = 89/99 (89%), Positives = 95/99 (95%)

Query: 17  PQITLYQRPLVTIKIGGQLKEALLKTGADDTVLEEMSLPGEWKPKLIGGIGGFIKVRQYD 76
           PQITL++RPLVTIKIGGQLKEALL TGADDTV+EEMSLPG WKPK+IGGIGGFIKVRQYD
Sbjct: 1   PQITLWKRPLVTIKIGGQLKEALLDTGADDTVIEEMSLPGRWKPKMIGGIGGFIKVRQYD 60

Query: 77  QILIEICGHKAIGTVLVGPTPVNILGRNLLTQIGCTLNF 115
           QI+IEI GHKAIGTVLVGPTPVNI+GRNLLTQIG TLNF
Sbjct: 61  QIIIEIAGHKAIGTVLVGPTPVNIIGRNLLTQIGATLNF 99


>gi|28373784|pdb|1MT7|A Chain A, Viability Of A Drug-Resistant Hiv-1
           Protease Mutant: Structural Insights For Better
           Antiviral Therapy
 Chain B, Viability Of A Drug-Resistant Hiv-1 Protease Mutant:
           Structural Insights For Better Antiviral Therapy
 Chain A, Viability Of A Drug-Resistant Hiv-1 Protease Mutant:
           Structural Insights For Better Antiviral Therapy
 Chain B, Viability Of A Drug-Resistant Hiv-1 Protease Mutant:
           Structural Insights For Better Antiviral Therapy
 Chain A, Viability Of A Drug-Resistant Hiv-1 Protease Mutant:
           Structural Insights For Better Antiviral Therapy
 Chain B, Viability Of A Drug-Resistant Hiv-1 Protease Mutant:
           Structural Insights For Better Antiviral Therapy
 Chain A, Viability Of A Drug-Resistant Hiv-1 Protease Variant:
           Structural Insights For Better Anti-Viral Therapy
 Chain B, Viability Of A Drug-Resistant Hiv-1 Protease Variant:
           Structural Insights For Better Anti-Viral Therapy
 Chain C, Viability Of A Drug-Resistant Hiv-1 Protease Variant:
           Structural Insights For Better Anti-Viral Therapy
 Chain D, Viability Of A Drug-Resistant Hiv-1 Protease Variant:
           Structural Insights For Better Anti-Viral Therapy
 Chain A, Crystal Structure Of Ap2v Substrate Variant Of Nc-P1
           Decamer Peptide In Complex With V82aD25N HIV-1 Protease
           Mutant
 Chain B, Crystal Structure Of Ap2v Substrate Variant Of Nc-P1
           Decamer Peptide In Complex With V82aD25N HIV-1 Protease
           Mutant
 Chain A, Crystal Structure Of A Drug-Resistant (V82a) Inactive
           (D25n) Hiv-1 Protease Complexed With Ap2v Variant Of
           Hiv-1 Nc-P1 Substrate.
 Chain B, Crystal Structure Of A Drug-Resistant (V82a) Inactive
           (D25n) Hiv-1 Protease Complexed With Ap2v Variant Of
           Hiv-1 Nc-P1 Substrate
          Length = 99

 Score =  183 bits (464), Expect = 1e-47,   Method: Compositional matrix adjust.
 Identities = 88/99 (88%), Positives = 96/99 (96%)

Query: 17  PQITLYQRPLVTIKIGGQLKEALLKTGADDTVLEEMSLPGEWKPKLIGGIGGFIKVRQYD 76
           PQITL++RPLVTI+IGGQLKEALL TGADDTVLEEM+LPG+WKPK+IGGIGGFIKVRQYD
Sbjct: 1   PQITLWKRPLVTIRIGGQLKEALLNTGADDTVLEEMNLPGKWKPKMIGGIGGFIKVRQYD 60

Query: 77  QILIEICGHKAIGTVLVGPTPVNILGRNLLTQIGCTLNF 115
           QI +EICGHKAIGTVLVGPTP NI+GRNLLTQIGCTLNF
Sbjct: 61  QIPVEICGHKAIGTVLVGPTPANIIGRNLLTQIGCTLNF 99


>gi|119389478|pdb|2FGU|A Chain A, X-Ray Crystal Structure Of Hiv-1
           Protease T80s Variant In Complex With The Inhibitor
           Saquinavir Used To Explore The Role Of Invariant Thr80
           In Hiv-1 Protease Structure, Function, And Viral
           Infectivity.
 Chain B, X-Ray Crystal Structure Of Hiv-1 Protease T80s Variant In
           Complex With The Inhibitor Saquinavir Used To Explore
           The Role Of Invariant Thr80 In Hiv-1 Protease Structure,
           Function, And Viral Infectivity
          Length = 99

 Score =  183 bits (464), Expect = 1e-47,   Method: Compositional matrix adjust.
 Identities = 88/99 (88%), Positives = 97/99 (97%)

Query: 17  PQITLYQRPLVTIKIGGQLKEALLKTGADDTVLEEMSLPGEWKPKLIGGIGGFIKVRQYD 76
           PQITL++RPLVTI+IGGQLKEALL TGADDTVLEEM+LPG+WKPK+IGGIGGFIKVRQYD
Sbjct: 1   PQITLWKRPLVTIRIGGQLKEALLDTGADDTVLEEMNLPGKWKPKMIGGIGGFIKVRQYD 60

Query: 77  QILIEICGHKAIGTVLVGPTPVNILGRNLLTQIGCTLNF 115
           QI +EICGHKAIGTVLVGP+PVNI+GRNLLTQIGCTLNF
Sbjct: 61  QIPVEICGHKAIGTVLVGPSPVNIIGRNLLTQIGCTLNF 99


>gi|9955095|pdb|1DW6|C Chain C, Structural And Kinetic Analysis Of
           Drug Resistant Mutants Of Hiv-1 Protease
 Chain D, Structural And Kinetic Analysis Of Drug Resistant Mutants
           Of Hiv-1 Protease
 Chain C, Structural Implications Of Drug Resistant Mutants Of Hiv-1
           Protease: High Resolution Crystal Structures Of The
           Mutant ProteaseSUBSTRATE ANALOG COMPLEXES
 Chain D, Structural Implications Of Drug Resistant Mutants Of Hiv-1
           Protease: High Resolution Crystal Structures Of The
           Mutant ProteaseSUBSTRATE ANALOG COMPLEXES
 Chain A, Crystal Structures Of Hiv Protease V82a And L90m Mutants
           Reveal Changes In Indinavir Binding Site.
 Chain B, Crystal Structures Of Hiv Protease V82a And L90m Mutants
           Reveal Changes In Indinavir Binding Site.
 Chain A, Hiv-1 Protease Mutant L90m Complexed With Inhibitor Tmc114
 Chain B, Hiv-1 Protease Mutant L90m Complexed With Inhibitor Tmc114
          Length = 99

 Score =  183 bits (464), Expect = 2e-47,   Method: Compositional matrix adjust.
 Identities = 88/99 (88%), Positives = 95/99 (95%)

Query: 17  PQITLYQRPLVTIKIGGQLKEALLKTGADDTVLEEMSLPGEWKPKLIGGIGGFIKVRQYD 76
           PQITL++RPLVTIKIGGQLKEALL TGADDTV+EEMSLPG WKPK+IGGIGGFIKVRQYD
Sbjct: 1   PQITLWKRPLVTIKIGGQLKEALLDTGADDTVIEEMSLPGRWKPKMIGGIGGFIKVRQYD 60

Query: 77  QILIEICGHKAIGTVLVGPTPVNILGRNLLTQIGCTLNF 115
           QI+IEI GHKAIGTVLVGPTPVNI+GRNL+TQIG TLNF
Sbjct: 61  QIIIEIAGHKAIGTVLVGPTPVNIIGRNLMTQIGATLNF 99


>gi|163311028|pdb|3B80|A Chain A, Hiv-1 Protease Mutant I54v
           Complexed With Gem-Diol-Amine Intermediate Nlltqi
 Chain B, Hiv-1 Protease Mutant I54v Complexed With Gem-Diol-Amine
           Intermediate Nlltqi
 Chain A, Crystal Structure Of Hiv-1 Mutant I54v And Inhibitor
           Saquina
 Chain B, Crystal Structure Of Hiv-1 Mutant I54v And Inhibitor
           Saquina
 Chain A, Crystal Structure Of Hiv-1 Mutant I54v And Inhibitor
           Darunavia
 Chain B, Crystal Structure Of Hiv-1 Mutant I54v And Inhibitor
           Darunavia
          Length = 99

 Score =  183 bits (464), Expect = 2e-47,   Method: Compositional matrix adjust.
 Identities = 88/99 (88%), Positives = 95/99 (95%)

Query: 17  PQITLYQRPLVTIKIGGQLKEALLKTGADDTVLEEMSLPGEWKPKLIGGIGGFIKVRQYD 76
           PQITL++RPLVTIKIGGQLKEALL TGADDTV+EEMSLPG WKPK+IGGIGGF+KVRQYD
Sbjct: 1   PQITLWKRPLVTIKIGGQLKEALLDTGADDTVIEEMSLPGRWKPKMIGGIGGFVKVRQYD 60

Query: 77  QILIEICGHKAIGTVLVGPTPVNILGRNLLTQIGCTLNF 115
           QI+IEI GHKAIGTVLVGPTPVNI+GRNLLTQIG TLNF
Sbjct: 61  QIIIEIAGHKAIGTVLVGPTPVNIIGRNLLTQIGATLNF 99


>gi|88192086|pdb|2AOC|A Chain A, Crystal Structure Analysis Of Hiv-1
           Protease Mutant I84v With A Substrate Analog P2-Nc
 Chain B, Crystal Structure Analysis Of Hiv-1 Protease Mutant I84v
           With A Substrate Analog P2-Nc
 Chain A, Crystal Structure Analysis Of Hiv-1 Protease Mutant I84v
           With A Potent Non-Peptide Inhibitor (Uic-94017)
 Chain B, Crystal Structure Analysis Of Hiv-1 Protease Mutant I84v
           With A Potent Non-Peptide Inhibitor (Uic-94017)
 Chain A, Crystal Structure Analysis Of Hiv-1 Protease Mutant I84v
           With A Inhibitor Saquinavir
 Chain B, Crystal Structure Analysis Of Hiv-1 Protease Mutant I84v
           With A Inhibitor Saquinavir
 Chain A, Crystal Structure Analysis Of Hiv-1 Protease Mutant I84v
           With A Inhibitor Saquinavir
 Chain B, Crystal Structure Analysis Of Hiv-1 Protease Mutant I84v
           With A Inhibitor Saquinavir
 Chain A, Hiv-1 Protease Mutant I84v With Potent Antiviral Inhibitor
           Grl-98065
 Chain B, Hiv-1 Protease Mutant I84v With Potent Antiviral Inhibitor
           Grl-98065
          Length = 99

 Score =  183 bits (464), Expect = 2e-47,   Method: Compositional matrix adjust.
 Identities = 88/99 (88%), Positives = 95/99 (95%)

Query: 17  PQITLYQRPLVTIKIGGQLKEALLKTGADDTVLEEMSLPGEWKPKLIGGIGGFIKVRQYD 76
           PQITL++RPLVTIKIGGQLKEALL TGADDTV+EEMSLPG WKPK+IGGIGGFIKVRQYD
Sbjct: 1   PQITLWKRPLVTIKIGGQLKEALLDTGADDTVIEEMSLPGRWKPKMIGGIGGFIKVRQYD 60

Query: 77  QILIEICGHKAIGTVLVGPTPVNILGRNLLTQIGCTLNF 115
           QI+IEI GHKAIGTVLVGPTPVN++GRNLLTQIG TLNF
Sbjct: 61  QIIIEIAGHKAIGTVLVGPTPVNVIGRNLLTQIGATLNF 99


>gi|88192162|pdb|2AVQ|A Chain A, Kinetics, Stability, And Structural
           Changes In High Resolution Crystal Structures Of Hiv-1
           Protease With Drug Resistant Mutations L24i, I50v, And
           G73s
 Chain B, Kinetics, Stability, And Structural Changes In High
           Resolution Crystal Structures Of Hiv-1 Protease With
           Drug Resistant Mutations L24i, I50v, And G73s
 Chain A, Kinetics, Stability, And Structural Changes In High
           Resolution Crystal Structures Of Hiv-1 Protease With
           Drug Resistant Mutations L24i, I50v, And G73s
 Chain B, Kinetics, Stability, And Structural Changes In High
           Resolution Crystal Structures Of Hiv-1 Protease With
           Drug Resistant Mutations L24i, I50v, And G73s
 Chain A, Hiv-1 Protease Mutant I50v Complexed With Inhibitor Tmc114
 Chain B, Hiv-1 Protease Mutant I50v Complexed With Inhibitor Tmc114
 Chain A, Hiv-1 Protease Mutant I50v With Potent Antiviral Inhibitor
           Grl-98065
 Chain B, Hiv-1 Protease Mutant I50v With Potent Antiviral Inhibitor
           Grl-98065
 Chain A, Crystal Structure Of Hiv-1 Mutant I50v And Inhibitor
           Saquinavira
 Chain B, Crystal Structure Of Hiv-1 Mutant I50v And Inhibitor
           Saquinavira
          Length = 99

 Score =  183 bits (464), Expect = 2e-47,   Method: Compositional matrix adjust.
 Identities = 88/99 (88%), Positives = 95/99 (95%)

Query: 17  PQITLYQRPLVTIKIGGQLKEALLKTGADDTVLEEMSLPGEWKPKLIGGIGGFIKVRQYD 76
           PQITL++RPLVTIKIGGQLKEALL TGADDTV+EEMSLPG WKPK+IGG+GGFIKVRQYD
Sbjct: 1   PQITLWKRPLVTIKIGGQLKEALLDTGADDTVIEEMSLPGRWKPKMIGGVGGFIKVRQYD 60

Query: 77  QILIEICGHKAIGTVLVGPTPVNILGRNLLTQIGCTLNF 115
           QI+IEI GHKAIGTVLVGPTPVNI+GRNLLTQIG TLNF
Sbjct: 61  QIIIEIAGHKAIGTVLVGPTPVNIIGRNLLTQIGATLNF 99


>gi|2624506|pdb|1DMP|A Chain A, Structure Of Hiv-1 Protease Complex
 Chain B, Structure Of Hiv-1 Protease Complex
 Chain A, Hiv-1 Protease Inhibitors Wiih Low Nanomolar Potency
 Chain B, Hiv-1 Protease Inhibitors Wiih Low Nanomolar Potency
          Length = 99

 Score =  182 bits (463), Expect = 2e-47,   Method: Compositional matrix adjust.
 Identities = 90/98 (91%), Positives = 94/98 (95%)

Query: 18  QITLYQRPLVTIKIGGQLKEALLKTGADDTVLEEMSLPGEWKPKLIGGIGGFIKVRQYDQ 77
           Q+TL+QRPLVTIKIGGQLKEALL TGADDTVLEEMSLPG WKPK+IGGIGGFIKVRQYDQ
Sbjct: 2   QVTLWQRPLVTIKIGGQLKEALLDTGADDTVLEEMSLPGRWKPKMIGGIGGFIKVRQYDQ 61

Query: 78  ILIEICGHKAIGTVLVGPTPVNILGRNLLTQIGCTLNF 115
           ILIEI GHKAIGTVLVGPTPVNI+GRNLLTQIG TLNF
Sbjct: 62  ILIEIXGHKAIGTVLVGPTPVNIIGRNLLTQIGATLNF 99


>gi|116667810|pdb|2HS1|A Chain A, Ultra-High Resolution X-Ray
           Crystal Structure Of Hiv-1 Protease V32i Mutant With
           Tmc114 (Darunavir) Inhibitor
 Chain B, Ultra-High Resolution X-Ray Crystal Structure Of Hiv-1
           Protease V32i Mutant With Tmc114 (Darunavir) Inhibitor
          Length = 99

 Score =  182 bits (463), Expect = 2e-47,   Method: Compositional matrix adjust.
 Identities = 88/99 (88%), Positives = 95/99 (95%)

Query: 17  PQITLYQRPLVTIKIGGQLKEALLKTGADDTVLEEMSLPGEWKPKLIGGIGGFIKVRQYD 76
           PQITL++RPLVTIKIGGQLKEALL TGADDT++EEMSLPG WKPK+IGGIGGFIKVRQYD
Sbjct: 1   PQITLWKRPLVTIKIGGQLKEALLDTGADDTIIEEMSLPGRWKPKMIGGIGGFIKVRQYD 60

Query: 77  QILIEICGHKAIGTVLVGPTPVNILGRNLLTQIGCTLNF 115
           QI+IEI GHKAIGTVLVGPTPVNI+GRNLLTQIG TLNF
Sbjct: 61  QIIIEIAGHKAIGTVLVGPTPVNIIGRNLLTQIGATLNF 99


>gi|189096255|pdb|3D1Z|A Chain A, Crystal Structure Of Hiv-1 Mutant
           I54m And Inhibitor Darunavir
 Chain B, Crystal Structure Of Hiv-1 Mutant I54m And Inhibitor
           Darunavir
 Chain A, Crystal Structure Of Hiv-1 Mutant I54m And Inhibitor
           Saquinavir
 Chain B, Crystal Structure Of Hiv-1 Mutant I54m And Inhibitor
           Saquinavir
          Length = 99

 Score =  182 bits (463), Expect = 2e-47,   Method: Compositional matrix adjust.
 Identities = 88/99 (88%), Positives = 95/99 (95%)

Query: 17  PQITLYQRPLVTIKIGGQLKEALLKTGADDTVLEEMSLPGEWKPKLIGGIGGFIKVRQYD 76
           PQITL++RPLVTIKIGGQLKEALL TGADDTV+EEMSLPG WKPK+IGGIGGF+KVRQYD
Sbjct: 1   PQITLWKRPLVTIKIGGQLKEALLDTGADDTVIEEMSLPGRWKPKMIGGIGGFMKVRQYD 60

Query: 77  QILIEICGHKAIGTVLVGPTPVNILGRNLLTQIGCTLNF 115
           QI+IEI GHKAIGTVLVGPTPVNI+GRNLLTQIG TLNF
Sbjct: 61  QIIIEIAGHKAIGTVLVGPTPVNIIGRNLLTQIGATLNF 99


>gi|88192157|pdb|2AVM|A Chain A, Kinetics, Stability, And Structural
           Changes In High Resolution Crystal Structures Of Hiv-1
           Protease With Drug Resistant Mutations L24i, I50v, And
           G73s
 Chain B, Kinetics, Stability, And Structural Changes In High
           Resolution Crystal Structures Of Hiv-1 Protease With
           Drug Resistant Mutations L24i, I50v, And G73s
 Chain A, Kinetics, Stability, And Structural Changes In High
           Resolution Crystal Structures Of Hiv-1 Protease With
           Drug Resistant Mutations L24i, I50v, And G73s
 Chain B, Kinetics, Stability, And Structural Changes In High
           Resolution Crystal Structures Of Hiv-1 Protease With
           Drug Resistant Mutations L24i, I50v, And G73s
          Length = 99

 Score =  182 bits (462), Expect = 2e-47,   Method: Compositional matrix adjust.
 Identities = 88/99 (88%), Positives = 95/99 (95%)

Query: 17  PQITLYQRPLVTIKIGGQLKEALLKTGADDTVLEEMSLPGEWKPKLIGGIGGFIKVRQYD 76
           PQITL++RPLVTIKIGGQLKEAL+ TGADDTV+EEMSLPG WKPK+IGGIGGFIKVRQYD
Sbjct: 1   PQITLWKRPLVTIKIGGQLKEALIDTGADDTVIEEMSLPGRWKPKMIGGIGGFIKVRQYD 60

Query: 77  QILIEICGHKAIGTVLVGPTPVNILGRNLLTQIGCTLNF 115
           QI+IEI GHKAIGTVLVGPTPVNI+GRNLLTQIG TLNF
Sbjct: 61  QIIIEIAGHKAIGTVLVGPTPVNIIGRNLLTQIGATLNF 99


>gi|119389480|pdb|2FGV|A Chain A, X-Ray Crystal Structure Of Hiv-1
           Protease T80n Variant In Complex With The Inhibitor
           Saquinavir Used To Explore The Role Of Invariant Thr80
           In Hiv-1 Protease Structure, Function, And Viral
           Infectivity.
 Chain B, X-Ray Crystal Structure Of Hiv-1 Protease T80n Variant In
           Complex With The Inhibitor Saquinavir Used To Explore
           The Role Of Invariant Thr80 In Hiv-1 Protease Structure,
           Function, And Viral Infectivity
          Length = 99

 Score =  182 bits (462), Expect = 2e-47,   Method: Compositional matrix adjust.
 Identities = 88/99 (88%), Positives = 96/99 (96%)

Query: 17  PQITLYQRPLVTIKIGGQLKEALLKTGADDTVLEEMSLPGEWKPKLIGGIGGFIKVRQYD 76
           PQITL++RPLVTI+IGGQLKEALL TGADDTVLEEM+LPG+WKPK+IGGIGGFIKVRQYD
Sbjct: 1   PQITLWKRPLVTIRIGGQLKEALLDTGADDTVLEEMNLPGKWKPKMIGGIGGFIKVRQYD 60

Query: 77  QILIEICGHKAIGTVLVGPTPVNILGRNLLTQIGCTLNF 115
           QI +EICGHKAIGTVLVGP PVNI+GRNLLTQIGCTLNF
Sbjct: 61  QIPVEICGHKAIGTVLVGPNPVNIIGRNLLTQIGCTLNF 99


>gi|18655473|pdb|1K6C|A Chain A, Lack Of Synergy For Inhibitors
           Targeting A Multi-Drug Resistant Hiv-1 Protease
 Chain B, Lack Of Synergy For Inhibitors Targeting A Multi-Drug
           Resistant Hiv-1 Protease
 Chain A, Lack Of Synergy For Inhibitors Targeting A Multi-Drug
           Resistant Hiv-1 Protease
 Chain B, Lack Of Synergy For Inhibitors Targeting A Multi-Drug
           Resistant Hiv-1 Protease
 Chain A, Lack Of Synergy For Inhibitors Targeting A Multi-Drug
           Resistant Hiv-1 Protease
 Chain B, Lack Of Synergy For Inhibitors Targeting A Multi-Drug
           Resistant Hiv-1 Protease
 Chain A, Lack Of Synergy For Inhibitors Targeting A Multi-Drug
           Resistant Hiv-1 Protease
 Chain B, Lack Of Synergy For Inhibitors Targeting A Multi-Drug
           Resistant Hiv-1 Protease
 Chain A, The Structural And Thermodynamic Basis For The Binding Of
           Tmc114, A Next-Generation Hiv-1 Protease Inhibitor.
 Chain B, The Structural And Thermodynamic Basis For The Binding Of
           Tmc114, A Next-Generation Hiv-1 Protease Inhibitor.
 Chain A, Crystal Structure Of Inhibitor Amprenavir In Complex With
           A Multi-Drug Resistant Variant Of Hiv-1 Protease
           (L63pV82TI84V)
 Chain B, Crystal Structure Of Inhibitor Amprenavir In Complex With
           A Multi-Drug Resistant Variant Of Hiv-1 Protease
           (L63pV82TI84V)
          Length = 99

 Score =  182 bits (462), Expect = 3e-47,   Method: Compositional matrix adjust.
 Identities = 88/99 (88%), Positives = 95/99 (95%)

Query: 17  PQITLYQRPLVTIKIGGQLKEALLKTGADDTVLEEMSLPGEWKPKLIGGIGGFIKVRQYD 76
           PQITL++RPLVTI+IGGQLKEALL TGADDTVLEEM+LPG WKPK+IGGIGGFIKVRQYD
Sbjct: 1   PQITLWKRPLVTIRIGGQLKEALLDTGADDTVLEEMNLPGRWKPKMIGGIGGFIKVRQYD 60

Query: 77  QILIEICGHKAIGTVLVGPTPVNILGRNLLTQIGCTLNF 115
           QI IEICGHKAIGTVLVGPTP N++GRNLLTQIGCTLNF
Sbjct: 61  QIPIEICGHKAIGTVLVGPTPTNVIGRNLLTQIGCTLNF 99


>gi|49258965|pdb|1SDV|A Chain A, Crystal Structures Of Hiv Protease
           V82a And L90m Mutants Reveal Changes In Indinavir
           Binding Site.
 Chain B, Crystal Structures Of Hiv Protease V82a And L90m Mutants
           Reveal Changes In Indinavir Binding Site.
 Chain A, Crystal Structure Analysis Of Hiv-1 Protease Mutant V82a
           With A Substrate Analog Ca-P2
 Chain B, Crystal Structure Analysis Of Hiv-1 Protease Mutant V82a
           With A Substrate Analog Ca-P2
 Chain A, Crystal Structure Analysis Of Hiv-1 Protease Mutant V82a
           With A Substrate Analog P1-P6
 Chain B, Crystal Structure Analysis Of Hiv-1 Protease Mutant V82a
           With A Substrate Analog P1-P6
 Chain A, Crystal Structure Analysis Of Hiv-1 Protease Mutant V82a
           With A Substrate Analog P2-Nc
 Chain B, Crystal Structure Analysis Of Hiv-1 Protease Mutant V82a
           With A Substrate Analog P2-Nc
 Chain A, Crystal Structure Analysis Of Hiv-1 Protease Mutant V82a
           With A Substrate Analog P6-Pr
 Chain B, Crystal Structure Analysis Of Hiv-1 Protease Mutant V82a
           With A Substrate Analog P6-Pr
 Chain A, Crystal Structure Analysis Of Hiv-1 Protease Mutant V82a
           With A Potent Non-Peptide Inhibitor (Uic-94017)
 Chain B, Crystal Structure Analysis Of Hiv-1 Protease Mutant V82a
           With A Potent Non-Peptide Inhibitor (Uic-94017)
 Chain A, Crystal Structure Analysis Of Hiv-1 Protease Mutant V82a
           With A Inhibitor Saquinavir
 Chain B, Crystal Structure Analysis Of Hiv-1 Protease Mutant V82a
           With A Inhibitor Saquinavir
 Chain A, Crystal Structure Analysis Of Hiv-1 Protease Mutant V82a
           With A Inhibitor Saquinavir
 Chain B, Crystal Structure Analysis Of Hiv-1 Protease Mutant V82a
           With A Inhibitor Saquinavir
 Chain A, Hiv-1 Protease Mutant V82a With Potent Antiviral Inhibitor
           Grl-98065
 Chain B, Hiv-1 Protease Mutant V82a With Potent Antiviral Inhibitor
           Grl-98065
          Length = 99

 Score =  182 bits (462), Expect = 3e-47,   Method: Compositional matrix adjust.
 Identities = 88/99 (88%), Positives = 94/99 (94%)

Query: 17  PQITLYQRPLVTIKIGGQLKEALLKTGADDTVLEEMSLPGEWKPKLIGGIGGFIKVRQYD 76
           PQITL++RPLVTIKIGGQLKEALL TGADDTV+EEMSLPG WKPK+IGGIGGFIKVRQYD
Sbjct: 1   PQITLWKRPLVTIKIGGQLKEALLDTGADDTVIEEMSLPGRWKPKMIGGIGGFIKVRQYD 60

Query: 77  QILIEICGHKAIGTVLVGPTPVNILGRNLLTQIGCTLNF 115
           QI+IEI GHKAIGTVLVGPTP NI+GRNLLTQIG TLNF
Sbjct: 61  QIIIEIAGHKAIGTVLVGPTPANIIGRNLLTQIGATLNF 99


>gi|4389373|pdb|1A94|A Chain A, Structural Basis For Specificity Of
           Retroviral Proteases
 Chain B, Structural Basis For Specificity Of Retroviral Proteases
 Chain D, Structural Basis For Specificity Of Retroviral Proteases
 Chain E, Structural Basis For Specificity Of Retroviral Proteases
          Length = 99

 Score =  182 bits (461), Expect = 4e-47,   Method: Compositional matrix adjust.
 Identities = 88/99 (88%), Positives = 95/99 (95%)

Query: 17  PQITLYQRPLVTIKIGGQLKEALLKTGADDTVLEEMSLPGEWKPKLIGGIGGFIKVRQYD 76
           PQITL++RPLVTIKIGGQLKEALL TGADDTV+EEMSLPG W+PK+IGGIGGFIKVRQYD
Sbjct: 1   PQITLWKRPLVTIKIGGQLKEALLDTGADDTVIEEMSLPGRWEPKMIGGIGGFIKVRQYD 60

Query: 77  QILIEICGHKAIGTVLVGPTPVNILGRNLLTQIGCTLNF 115
           QI+IEI GHKAIGTVLVGPTPVNI+GRNLLTQIG TLNF
Sbjct: 61  QIIIEIAGHKAIGTVLVGPTPVNIIGRNLLTQIGATLNF 99


>gi|14488614|pdb|1FG6|C Chain C, Structural Implications Of Drug
           Resistant Mutants Of Hiv-1 Protease: High Resolution
           Crystal Structures Of The Mutant ProteaseSUBSTRATE
           ANALOG COMPLEXES
 Chain D, Structural Implications Of Drug Resistant Mutants Of Hiv-1
           Protease: High Resolution Crystal Structures Of The
           Mutant ProteaseSUBSTRATE ANALOG COMPLEXES
 Chain C, Structural Implications Of Drug Resistant Mutants Of Hiv-1
           Protease: High Resolution Crystal Structures Of The
           Mutant ProteaseSUBSTRATE ANALOG COMPLEXES
 Chain D, Structural Implications Of Drug Resistant Mutants Of Hiv-1
           Protease: High Resolution Crystal Structures Of The
           Mutant ProteaseSUBSTRATE ANALOG COMPLEXES
          Length = 99

 Score =  182 bits (461), Expect = 4e-47,   Method: Compositional matrix adjust.
 Identities = 88/99 (88%), Positives = 95/99 (95%)

Query: 17  PQITLYQRPLVTIKIGGQLKEALLKTGADDTVLEEMSLPGEWKPKLIGGIGGFIKVRQYD 76
           PQITL++RPLVTIKIGGQLKEALL TGADDTV+EEMSLPG WKPK+IGGIGGFIKVRQYD
Sbjct: 1   PQITLWKRPLVTIKIGGQLKEALLDTGADDTVIEEMSLPGRWKPKMIGGIGGFIKVRQYD 60

Query: 77  QILIEICGHKAIGTVLVGPTPVNILGRNLLTQIGCTLNF 115
           QI+IEI GHKAIGTVLVGPTPVNI+GR+LLTQIG TLNF
Sbjct: 61  QIIIEIAGHKAIGTVLVGPTPVNIIGRDLLTQIGATLNF 99


>gi|88192169|pdb|2AVV|A Chain A, Kinetics, Stability, And Structural
           Changes In High Resolution Crystal Structures Of Hiv-1
           Protease With Drug Resistant Mutations L24i, I50v, And
           G73s
 Chain B, Kinetics, Stability, And Structural Changes In High
           Resolution Crystal Structures Of Hiv-1 Protease With
           Drug Resistant Mutations L24i, I50v, And G73s
 Chain D, Kinetics, Stability, And Structural Changes In High
           Resolution Crystal Structures Of Hiv-1 Protease With
           Drug Resistant Mutations L24i, I50v, And G73s
 Chain E, Kinetics, Stability, And Structural Changes In High
           Resolution Crystal Structures Of Hiv-1 Protease With
           Drug Resistant Mutations L24i, I50v, And G73s
          Length = 99

 Score =  182 bits (461), Expect = 4e-47,   Method: Compositional matrix adjust.
 Identities = 88/99 (88%), Positives = 94/99 (94%)

Query: 17  PQITLYQRPLVTIKIGGQLKEALLKTGADDTVLEEMSLPGEWKPKLIGGIGGFIKVRQYD 76
           PQITL++RPLVTIKIGGQLKEALL TGADDTV+EEMSLPG WKPK+IGGIGGFIKVRQYD
Sbjct: 1   PQITLWKRPLVTIKIGGQLKEALLDTGADDTVIEEMSLPGRWKPKMIGGIGGFIKVRQYD 60

Query: 77  QILIEICGHKAIGTVLVGPTPVNILGRNLLTQIGCTLNF 115
           QI+IEI GHKAI TVLVGPTPVNI+GRNLLTQIG TLNF
Sbjct: 61  QIIIEIAGHKAISTVLVGPTPVNIIGRNLLTQIGATLNF 99


>gi|2554747|pdb|3AID|A Chain A, A New Class Of Hiv-1 Protease
           Inhibitor: The Crystallographic Structure, Inhibition
           And Chemical Synthesis Of An Aminimide Peptide Isostere
          Length = 99

 Score =  182 bits (461), Expect = 4e-47,   Method: Compositional matrix adjust.
 Identities = 88/98 (89%), Positives = 96/98 (97%)

Query: 18  QITLYQRPLVTIKIGGQLKEALLKTGADDTVLEEMSLPGEWKPKLIGGIGGFIKVRQYDQ 77
           QITL++RPLVTI+IGGQLKEALL TGADDTVLEEM+LPG+WKPK+IGGIGGFIKVRQYDQ
Sbjct: 2   QITLWKRPLVTIRIGGQLKEALLDTGADDTVLEEMNLPGKWKPKMIGGIGGFIKVRQYDQ 61

Query: 78  ILIEICGHKAIGTVLVGPTPVNILGRNLLTQIGCTLNF 115
           I +EICGHKAIGTVLVGPTPVNI+GRNLLTQIGCTLNF
Sbjct: 62  IPVEICGHKAIGTVLVGPTPVNIIGRNLLTQIGCTLNF 99


>gi|14488608|pdb|1FFF|C Chain C, Structural Implications Of Drug
           Resistant Mutants Of Hiv-1 Protease : High Resolution
           Crystal Structures Of The Mutant ProteaseSUBSTRATE
           ANALOG COMPLEXES.
 Chain D, Structural Implications Of Drug Resistant Mutants Of Hiv-1
           Protease : High Resolution Crystal Structures Of The
           Mutant ProteaseSUBSTRATE ANALOG COMPLEXES.
 Chain C, Structural Implications Of Drug Resistant Mutants Of Hiv-1
           Protease: High Resolution Crystal Structures Of The
           Mutant ProteaseSUBSTRATE ANALOG COMPLEXES
 Chain D, Structural Implications Of Drug Resistant Mutants Of Hiv-1
           Protease: High Resolution Crystal Structures Of The
           Mutant ProteaseSUBSTRATE ANALOG COMPLEXES
 Chain A, Hiv-1 Protease Mutant D30n Complexed With Inhibitor Tmc114
 Chain B, Hiv-1 Protease Mutant D30n Complexed With Inhibitor Tmc114
 Chain A, Hiv-1 Protease Mutant D30n With Potent Antiviral Inhibitor
           Grl-98065
 Chain B, Hiv-1 Protease Mutant D30n With Potent Antiviral Inhibitor
           Grl-98065
          Length = 99

 Score =  181 bits (460), Expect = 4e-47,   Method: Compositional matrix adjust.
 Identities = 88/99 (88%), Positives = 95/99 (95%)

Query: 17  PQITLYQRPLVTIKIGGQLKEALLKTGADDTVLEEMSLPGEWKPKLIGGIGGFIKVRQYD 76
           PQITL++RPLVTIKIGGQLKEALL TGAD+TV+EEMSLPG WKPK+IGGIGGFIKVRQYD
Sbjct: 1   PQITLWKRPLVTIKIGGQLKEALLDTGADNTVIEEMSLPGRWKPKMIGGIGGFIKVRQYD 60

Query: 77  QILIEICGHKAIGTVLVGPTPVNILGRNLLTQIGCTLNF 115
           QI+IEI GHKAIGTVLVGPTPVNI+GRNLLTQIG TLNF
Sbjct: 61  QIIIEIAGHKAIGTVLVGPTPVNIIGRNLLTQIGATLNF 99


>gi|9955098|pdb|1EBK|C Chain C, Structural And Kinetic Analysis Of
           Drug Resistant Mutants Of Hiv-1 Protease
 Chain D, Structural And Kinetic Analysis Of Drug Resistant Mutants
           Of Hiv-1 Protease
 Chain E, Structural And Kinetic Analysis Of Drug Resistant Mutants
           Of Hiv-1 Protease
 Chain F, Structural And Kinetic Analysis Of Drug Resistant Mutants
           Of Hiv-1 Protease
          Length = 99

 Score =  181 bits (460), Expect = 4e-47,   Method: Compositional matrix adjust.
 Identities = 88/99 (88%), Positives = 95/99 (95%)

Query: 17  PQITLYQRPLVTIKIGGQLKEALLKTGADDTVLEEMSLPGEWKPKLIGGIGGFIKVRQYD 76
           PQITL+++PLVTIKIGGQLKEALL TGADDTV+EEMSLPG WKPK+IGGIGGFIKVRQYD
Sbjct: 1   PQITLWKQPLVTIKIGGQLKEALLDTGADDTVIEEMSLPGRWKPKMIGGIGGFIKVRQYD 60

Query: 77  QILIEICGHKAIGTVLVGPTPVNILGRNLLTQIGCTLNF 115
           QI+IEI GHKAIGTVLVGPTPVNI+GRNLLTQIG TLNF
Sbjct: 61  QIIIEIAGHKAIGTVLVGPTPVNIIGRNLLTQIGATLNF 99


>gi|193885421|pdb|3D3T|A Chain A, Crystal Structure Of Hiv-1
           Crf01_ae In Complex With The Substrate P1-P6
 Chain B, Crystal Structure Of Hiv-1 Crf01_ae In Complex With The
           Substrate P1-P6
          Length = 99

 Score =  181 bits (460), Expect = 4e-47,   Method: Compositional matrix adjust.
 Identities = 87/99 (87%), Positives = 97/99 (97%)

Query: 17  PQITLYQRPLVTIKIGGQLKEALLKTGADDTVLEEMSLPGEWKPKLIGGIGGFIKVRQYD 76
           PQITL+QRPLVTIKIGGQL+EALL TGADDTVLE+++LPG+WKPK+IGGIGGFIKVRQYD
Sbjct: 1   PQITLWQRPLVTIKIGGQLREALLNTGADDTVLEDINLPGKWKPKMIGGIGGFIKVRQYD 60

Query: 77  QILIEICGHKAIGTVLVGPTPVNILGRNLLTQIGCTLNF 115
           QILIEICG KAIGTVLVGPTPVNI+GRN+LTQ+GCTLNF
Sbjct: 61  QILIEICGKKAIGTVLVGPTPVNIIGRNMLTQLGCTLNF 99


>gi|22218898|pdb|1K2B|A Chain A, Combining Mutations In Hiv-1
           Protease To Understand Mechanisms Of Resistance
 Chain B, Combining Mutations In Hiv-1 Protease To Understand
           Mechanisms Of Resistance
          Length = 99

 Score =  181 bits (460), Expect = 5e-47,   Method: Compositional matrix adjust.
 Identities = 87/99 (87%), Positives = 95/99 (95%)

Query: 17  PQITLYQRPLVTIKIGGQLKEALLKTGADDTVLEEMSLPGEWKPKLIGGIGGFIKVRQYD 76
           PQITL++RPLVTIKIGGQLKEALL TGADDTV+EEMSLPG WKPK+IGGIGGFIKVRQYD
Sbjct: 1   PQITLWKRPLVTIKIGGQLKEALLDTGADDTVIEEMSLPGRWKPKMIGGIGGFIKVRQYD 60

Query: 77  QILIEICGHKAIGTVLVGPTPVNILGRNLLTQIGCTLNF 115
           QI+IEI GHKAIGTVLVGPTPVNI+GR+L+TQIG TLNF
Sbjct: 61  QIIIEIAGHKAIGTVLVGPTPVNIIGRDLMTQIGATLNF 99


>gi|93278539|pdb|1Z8C|A Chain A, Crystal Structure Of The Complex Of
           Mutant Hiv-1 Protease (L63p, A71v, V82t, I84v) With A
           Hydroxyethylamine Peptidomimetic Inhibitor
           Boc-Phe-Psi[r-Ch(Oh)ch2nh]-Phe- Glu-Phe-Nh2
 Chain B, Crystal Structure Of The Complex Of Mutant Hiv-1 Protease
           (L63p, A71v, V82t, I84v) With A Hydroxyethylamine
           Peptidomimetic Inhibitor Boc-Phe-Psi[r-Ch(Oh)ch2nh]-Phe-
           Glu-Phe-Nh2
          Length = 99

 Score =  181 bits (459), Expect = 6e-47,   Method: Compositional matrix adjust.
 Identities = 89/99 (89%), Positives = 93/99 (93%)

Query: 17  PQITLYQRPLVTIKIGGQLKEALLKTGADDTVLEEMSLPGEWKPKLIGGIGGFIKVRQYD 76
           PQITL+QRPLVTIKIGGQLKEALL TGADDTVLEEMSLPG WKPK+IGGIGGFIKVRQYD
Sbjct: 1   PQITLWQRPLVTIKIGGQLKEALLDTGADDTVLEEMSLPGRWKPKMIGGIGGFIKVRQYD 60

Query: 77  QILIEICGHKAIGTVLVGPTPVNILGRNLLTQIGCTLNF 115
           QI IEI GHK IGTVLVGPTP N++GRNLLTQIGCTLNF
Sbjct: 61  QIPIEIXGHKVIGTVLVGPTPTNVIGRNLLTQIGCTLNF 99


>gi|134104295|pdb|2FXE|A Chain A, X-Ray Crystal Structure Of Hiv-1
           Protease Crm Mutant Complexed With Atazanavir
           (Bms-232632)
 Chain B, X-Ray Crystal Structure Of Hiv-1 Protease Crm Mutant
           Complexed With Atazanavir (Bms-232632)
          Length = 99

 Score =  181 bits (458), Expect = 7e-47,   Method: Compositional matrix adjust.
 Identities = 86/99 (86%), Positives = 96/99 (96%)

Query: 17  PQITLYQRPLVTIKIGGQLKEALLKTGADDTVLEEMSLPGEWKPKLIGGIGGFIKVRQYD 76
           PQITL++RP+VT+KIGGQLKEALL TGADDTV+EEM+LPG+WKPK+IGGIGGFIKVRQYD
Sbjct: 1   PQITLWKRPIVTVKIGGQLKEALLDTGADDTVIEEMNLPGKWKPKMIGGIGGFIKVRQYD 60

Query: 77  QILIEICGHKAIGTVLVGPTPVNILGRNLLTQIGCTLNF 115
           QI+IEI GHKAIGTVLVGPTPVNI+GRNLLTQIG TLNF
Sbjct: 61  QIIIEIAGHKAIGTVLVGPTPVNIIGRNLLTQIGATLNF 99


>gi|90108667|pdb|2A1E|A Chain A, High Resolution Structure Of Hiv-1
           Pr With Ts-126
 Chain B, High Resolution Structure Of Hiv-1 Pr With Ts-126
 Chain A, Structure Of Hiv-1 Protease In Complex With Potent
           Inhibitor Kni-272 Determined By Neutron Crystallography
 Chain B, Structure Of Hiv-1 Protease In Complex With Potent
           Inhibitor Kni-272 Determined By Neutron Crystallography
          Length = 99

 Score =  181 bits (458), Expect = 7e-47,   Method: Compositional matrix adjust.
 Identities = 88/98 (89%), Positives = 94/98 (95%)

Query: 18  QITLYQRPLVTIKIGGQLKEALLKTGADDTVLEEMSLPGEWKPKLIGGIGGFIKVRQYDQ 77
           QITL++RPLVTIKIGGQLKEALL TGADDTV+EEMSLPG WKPK+IGGIGGFIKVRQYDQ
Sbjct: 2   QITLWKRPLVTIKIGGQLKEALLDTGADDTVIEEMSLPGRWKPKMIGGIGGFIKVRQYDQ 61

Query: 78  ILIEICGHKAIGTVLVGPTPVNILGRNLLTQIGCTLNF 115
           I+IEI GHKAIGTVLVGPTPVNI+GRNLLTQIG TLNF
Sbjct: 62  IIIEIAGHKAIGTVLVGPTPVNIIGRNLLTQIGATLNF 99


>gi|109157787|pdb|2G69|A Chain A, Structure Of Unliganded Hiv-1
           Protease F53l Mutant
          Length = 99

 Score =  181 bits (458), Expect = 7e-47,   Method: Compositional matrix adjust.
 Identities = 88/99 (88%), Positives = 94/99 (94%)

Query: 17  PQITLYQRPLVTIKIGGQLKEALLKTGADDTVLEEMSLPGEWKPKLIGGIGGFIKVRQYD 76
           PQITL++RPLVTIKIGGQLKEALL TGADDTV+EEMSLPG WKPK+IGGIGG IKVRQYD
Sbjct: 1   PQITLWKRPLVTIKIGGQLKEALLDTGADDTVIEEMSLPGRWKPKMIGGIGGLIKVRQYD 60

Query: 77  QILIEICGHKAIGTVLVGPTPVNILGRNLLTQIGCTLNF 115
           QI+IEI GHKAIGTVLVGPTPVNI+GRNLLTQIG TLNF
Sbjct: 61  QIIIEIAGHKAIGTVLVGPTPVNIIGRNLLTQIGATLNF 99


>gi|189096246|pdb|3CYW|A Chain A, Effect Of Flap Mutations On
           Structure Of Hiv-1 Protease And Inhibition By Saquinavir
           And Darunavir
 Chain B, Effect Of Flap Mutations On Structure Of Hiv-1 Protease
           And Inhibition By Saquinavir And Darunavir
          Length = 99

 Score =  180 bits (457), Expect = 1e-46,   Method: Compositional matrix adjust.
 Identities = 88/99 (88%), Positives = 94/99 (94%)

Query: 17  PQITLYQRPLVTIKIGGQLKEALLKTGADDTVLEEMSLPGEWKPKLIGGIGGFIKVRQYD 76
           PQITL++RPLVTIKIGGQLKEALL TGADDTV+EEMSLPG WKPK+I GIGGFIKVRQYD
Sbjct: 1   PQITLWKRPLVTIKIGGQLKEALLDTGADDTVIEEMSLPGRWKPKMIVGIGGFIKVRQYD 60

Query: 77  QILIEICGHKAIGTVLVGPTPVNILGRNLLTQIGCTLNF 115
           QI+IEI GHKAIGTVLVGPTPVNI+GRNLLTQIG TLNF
Sbjct: 61  QIIIEIAGHKAIGTVLVGPTPVNIIGRNLLTQIGATLNF 99


>gi|3891944|pdb|1BDR|A Chain A, Hiv-1 (2: 31, 33-37) Protease
           Complexed With Inhibitor Sb203386
 Chain B, Hiv-1 (2: 31, 33-37) Protease Complexed With Inhibitor
           Sb203386
          Length = 99

 Score =  180 bits (457), Expect = 1e-46,   Method: Compositional matrix adjust.
 Identities = 88/99 (88%), Positives = 94/99 (94%)

Query: 17  PQITLYQRPLVTIKIGGQLKEALLKTGADDTVLEEMSLPGEWKPKLIGGIGGFIKVRQYD 76
           PQITL+QRPLVTIKIGGQLKEALL TGADD+V+  + LPG WKPK+IGGIGGFIKVRQYD
Sbjct: 1   PQITLWQRPLVTIKIGGQLKEALLDTGADDSVVAGIELPGRWKPKMIGGIGGFIKVRQYD 60

Query: 77  QILIEICGHKAIGTVLVGPTPVNILGRNLLTQIGCTLNF 115
           QILIEICGHKAIGTVLVGPTPVNI+GRNLLTQIGCTLNF
Sbjct: 61  QILIEICGHKAIGTVLVGPTPVNIIGRNLLTQIGCTLNF 99


>gi|22218901|pdb|1K2C|A Chain A, Combining Mutations In Hiv-1
           Protease To Understand Mechanisms Of Resistance
 Chain B, Combining Mutations In Hiv-1 Protease To Understand
           Mechanisms Of Resistance
          Length = 99

 Score =  180 bits (456), Expect = 1e-46,   Method: Compositional matrix adjust.
 Identities = 87/99 (87%), Positives = 94/99 (94%)

Query: 17  PQITLYQRPLVTIKIGGQLKEALLKTGADDTVLEEMSLPGEWKPKLIGGIGGFIKVRQYD 76
           PQITL++RPLVTIKIGGQLKEALL TGAD+TV+EEMSLPG WKPK+IGGIGGFIKVRQYD
Sbjct: 1   PQITLWKRPLVTIKIGGQLKEALLDTGADNTVIEEMSLPGRWKPKMIGGIGGFIKVRQYD 60

Query: 77  QILIEICGHKAIGTVLVGPTPVNILGRNLLTQIGCTLNF 115
           QI+IEI GHKAIGTVLVGPTP NI+GRNLLTQIG TLNF
Sbjct: 61  QIIIEIAGHKAIGTVLVGPTPSNIIGRNLLTQIGATLNF 99


>gi|119389008|pdb|2B60|A Chain A, Structure Of Hiv-1 Protease Mutant
           Bound To Ritonavir
 Chain B, Structure Of Hiv-1 Protease Mutant Bound To Ritonavir
          Length = 99

 Score =  180 bits (456), Expect = 1e-46,   Method: Compositional matrix adjust.
 Identities = 86/99 (86%), Positives = 93/99 (93%)

Query: 17  PQITLYQRPLVTIKIGGQLKEALLKTGADDTVLEEMSLPGEWKPKLIGGIGGFIKVRQYD 76
           PQITL+QRPLVTIKIGGQL+EALL TGADDT+ EE+SLPG WKPK+IGGIGGFIKVRQYD
Sbjct: 1   PQITLWQRPLVTIKIGGQLREALLDTGADDTIFEEISLPGRWKPKMIGGIGGFIKVRQYD 60

Query: 77  QILIEICGHKAIGTVLVGPTPVNILGRNLLTQIGCTLNF 115
           QI IEICGHK IGTVLVGPTP NI+GRNL+TQIGCTLNF
Sbjct: 61  QIPIEICGHKVIGTVLVGPTPANIIGRNLMTQIGCTLNF 99


>gi|3659988|pdb|1BDL|A Chain A, Hiv-1 (2:31-37) Protease Complexed
           With Inhibitor Sb203386
 Chain B, Hiv-1 (2:31-37) Protease Complexed With Inhibitor Sb203386
          Length = 99

 Score =  179 bits (455), Expect = 2e-46,   Method: Compositional matrix adjust.
 Identities = 87/99 (87%), Positives = 94/99 (94%)

Query: 17  PQITLYQRPLVTIKIGGQLKEALLKTGADDTVLEEMSLPGEWKPKLIGGIGGFIKVRQYD 76
           PQITL+QRPLVTIKIGGQLKEALL TGADD+++  + LPG WKPK+IGGIGGFIKVRQYD
Sbjct: 1   PQITLWQRPLVTIKIGGQLKEALLDTGADDSIVAGIELPGRWKPKMIGGIGGFIKVRQYD 60

Query: 77  QILIEICGHKAIGTVLVGPTPVNILGRNLLTQIGCTLNF 115
           QILIEICGHKAIGTVLVGPTPVNI+GRNLLTQIGCTLNF
Sbjct: 61  QILIEICGHKAIGTVLVGPTPVNIIGRNLLTQIGCTLNF 99


>gi|58176641|pdb|1RPI|A Chain A, Crystal Structures Of A
           Multidrug-Resistant Hiv-1 Protease Reveal An Expanded
           Active Site Cavity
 Chain B, Crystal Structures Of A Multidrug-Resistant Hiv-1 Protease
           Reveal An Expanded Active Site Cavity
 Chain A, Crystal Structures Of A Multidrug-Resistant Hiv-1 Protease
           Reveal An Expanded Active Site Cavity
 Chain B, Crystal Structures Of A Multidrug-Resistant Hiv-1 Protease
           Reveal An Expanded Active Site Cavity
 Chain A, Crystal Structures Of A Multidrug-Resistant Hiv-1 Protease
           Reveal An Expanded Active Site Cavity
 Chain B, Crystal Structures Of A Multidrug-Resistant Hiv-1 Protease
           Reveal An Expanded Active Site Cavity
 Chain A, Wide Open 1.3a Structure Of A Multi-Drug Resistant Hiv-1
           Protease Represents A Novel Drug Target
 Chain B, Wide Open 1.3a Structure Of A Multi-Drug Resistant Hiv-1
           Protease Represents A Novel Drug Target
          Length = 99

 Score =  179 bits (455), Expect = 2e-46,   Method: Compositional matrix adjust.
 Identities = 85/99 (85%), Positives = 94/99 (94%)

Query: 17  PQITLYQRPLVTIKIGGQLKEALLKTGADDTVLEEMSLPGEWKPKLIGGIGGFIKVRQYD 76
           PQITL+QRP+VTIKIGGQLKEALL TGADDTVLEE++LPG WKPKLIGGIGGF+KVRQYD
Sbjct: 1   PQITLWQRPIVTIKIGGQLKEALLNTGADDTVLEEVNLPGRWKPKLIGGIGGFVKVRQYD 60

Query: 77  QILIEICGHKAIGTVLVGPTPVNILGRNLLTQIGCTLNF 115
           Q+ IEICGHK IGTVLVGPTP N++GRNL+TQIGCTLNF
Sbjct: 61  QVPIEICGHKVIGTVLVGPTPANVIGRNLMTQIGCTLNF 99


>gi|55669731|pdb|1SGU|A Chain A, Comparing The Accumulation Of
           Active Site And Non-Active Site Mutations In The Hiv-1
           Protease
 Chain B, Comparing The Accumulation Of Active Site And Non-Active
           Site Mutations In The Hiv-1 Protease
 Chain A, Comparing The Accumulation Of Active Site And Non-Active
           Site Mutations In The Hiv-1 Protease
 Chain B, Comparing The Accumulation Of Active Site And Non-Active
           Site Mutations In The Hiv-1 Protease
          Length = 99

 Score =  179 bits (454), Expect = 2e-46,   Method: Compositional matrix adjust.
 Identities = 84/99 (84%), Positives = 93/99 (93%)

Query: 17  PQITLYQRPLVTIKIGGQLKEALLKTGADDTVLEEMSLPGEWKPKLIGGIGGFIKVRQYD 76
           PQITL+QRPLVTIKIGGQL+EALL TGADDT+ EE+SLPG WKPK+IGGIGGF+KVRQYD
Sbjct: 1   PQITLWQRPLVTIKIGGQLREALLDTGADDTIFEEISLPGRWKPKMIGGIGGFVKVRQYD 60

Query: 77  QILIEICGHKAIGTVLVGPTPVNILGRNLLTQIGCTLNF 115
           QI IEICGHK IGTVLVGPTP N++GRNL+TQIGCTLNF
Sbjct: 61  QIPIEICGHKVIGTVLVGPTPANVIGRNLMTQIGCTLNF 99


>gi|231033|pdb|4HVP|A Chain A, Structure Of Complex Of Synthetic
           Hiv-1 Protease With A Stubtrate-Based Inhibitor At 2.3
           Angstroms Resolution
 Chain B, Structure Of Complex Of Synthetic Hiv-1 Protease With A
           Stubtrate-Based Inhibitor At 2.3 Angstroms Resolution
 Chain A, X-Ray Crystallographic Structure Of A Complex Between A
           Synthetic Protease Of Human Immunodeficiency Virus 1 And
           A Substrate-Based Hydroxyethylamine Inhibitor
 Chain B, X-Ray Crystallographic Structure Of A Complex Between A
           Synthetic Protease Of Human Immunodeficiency Virus 1 And
           A Substrate-Based Hydroxyethylamine Inhibitor
 Chain A, Structure At 2.5-Angstroms Resolution Of Chemically
           Synthesized Human Immunodeficiency Virus Type 1 Protease
           Complexed With A Hydroxyethylene-Based Inhibitor
 Chain B, Structure At 2.5-Angstroms Resolution Of Chemically
           Synthesized Human Immunodeficiency Virus Type 1 Protease
           Complexed With A Hydroxyethylene-Based Inhibitor
 Chain A, Regioselective Structural And Functional Mimicry Of
           Peptides. Design Of Hydrolytically Stable Cyclic
           Peptidomimetic Inhibitors Of Hiv-1 Protease
 Chain B, Regioselective Structural And Functional Mimicry Of
           Peptides. Design Of Hydrolytically Stable Cyclic
           Peptidomimetic Inhibitors Of Hiv-1 Protease
 Chain A, Hiv-1 Protease Complexed With Macrocyclic Peptidomimetic
           Inhibitor 1
 Chain B, Hiv-1 Protease Complexed With Macrocyclic Peptidomimetic
           Inhibitor 1
 Chain A, Conserved Folding In Retroviral Proteases. Crystal
           Structure Of A Synthetic Hiv-1 Protease
          Length = 99

 Score =  179 bits (454), Expect = 2e-46,   Method: Compositional matrix adjust.
 Identities = 88/99 (88%), Positives = 95/99 (95%)

Query: 17  PQITLYQRPLVTIKIGGQLKEALLKTGADDTVLEEMSLPGEWKPKLIGGIGGFIKVRQYD 76
           PQITL+QRPLVTI+IGGQLKEALL TGADDTVLEEM+LPG+WKPK+IGGIGGFIKVRQYD
Sbjct: 1   PQITLWQRPLVTIRIGGQLKEALLDTGADDTVLEEMNLPGKWKPKMIGGIGGFIKVRQYD 60

Query: 77  QILIEICGHKAIGTVLVGPTPVNILGRNLLTQIGCTLNF 115
           QI +EI GHKAIGTVLVGPTPVNI+GRNLLTQIG TLNF
Sbjct: 61  QIPVEIXGHKAIGTVLVGPTPVNIIGRNLLTQIGXTLNF 99


>gi|2554748|pdb|3AID|B Chain B, A New Class Of Hiv-1 Protease
           Inhibitor: The Crystallographic Structure, Inhibition
           And Chemical Synthesis Of An Aminimide Peptide Isostere
          Length = 99

 Score =  179 bits (453), Expect = 3e-46,   Method: Compositional matrix adjust.
 Identities = 87/97 (89%), Positives = 95/97 (97%)

Query: 18  QITLYQRPLVTIKIGGQLKEALLKTGADDTVLEEMSLPGEWKPKLIGGIGGFIKVRQYDQ 77
           QITL++RPLVTI+IGGQLKEALL TGADDTVLEEM+LPG+WKPK+IGGIGGFIKVRQYDQ
Sbjct: 2   QITLWKRPLVTIRIGGQLKEALLDTGADDTVLEEMNLPGKWKPKMIGGIGGFIKVRQYDQ 61

Query: 78  ILIEICGHKAIGTVLVGPTPVNILGRNLLTQIGCTLN 114
           I +EICGHKAIGTVLVGPTPVNI+GRNLLTQIGCTLN
Sbjct: 62  IPVEICGHKAIGTVLVGPTPVNIIGRNLLTQIGCTLN 98


>gi|3659990|pdb|1BDQ|A Chain A, Hiv-1 (2:31-37, 47, 82) Protease
           Complexed With Inhibitor Sb203386
 Chain B, Hiv-1 (2:31-37, 47, 82) Protease Complexed With Inhibitor
           Sb203386
          Length = 99

 Score =  178 bits (452), Expect = 3e-46,   Method: Compositional matrix adjust.
 Identities = 85/99 (85%), Positives = 94/99 (94%)

Query: 17  PQITLYQRPLVTIKIGGQLKEALLKTGADDTVLEEMSLPGEWKPKLIGGIGGFIKVRQYD 76
           PQITL+QRPLVTIKIGGQLKEALL TGADD+++  + LPG WKPK++GGIGGFIKVRQYD
Sbjct: 1   PQITLWQRPLVTIKIGGQLKEALLDTGADDSIVAGIELPGRWKPKMVGGIGGFIKVRQYD 60

Query: 77  QILIEICGHKAIGTVLVGPTPVNILGRNLLTQIGCTLNF 115
           QILIEICGHKAIGTVLVGPTP+NI+GRNLLTQIGCTLNF
Sbjct: 61  QILIEICGHKAIGTVLVGPTPINIIGRNLLTQIGCTLNF 99


>gi|195927280|pdb|2RKF|A Chain A, Hiv-1 Pr Resistant Mutant + Lpv
 Chain B, Hiv-1 Pr Resistant Mutant + Lpv
          Length = 99

 Score =  178 bits (451), Expect = 5e-46,   Method: Compositional matrix adjust.
 Identities = 83/99 (83%), Positives = 91/99 (91%)

Query: 17  PQITLYQRPLVTIKIGGQLKEALLKTGADDTVLEEMSLPGEWKPKLIGGIGGFIKVRQYD 76
           PQITL+QRP VT+KI GQL EALL TGADDT+LEEMSLPG W PK++GGIGGF+KVRQYD
Sbjct: 1   PQITLWQRPFVTVKIAGQLMEALLDTGADDTILEEMSLPGRWTPKVVGGIGGFMKVRQYD 60

Query: 77  QILIEICGHKAIGTVLVGPTPVNILGRNLLTQIGCTLNF 115
           QIL+EICGHK IGTVLVGPTP NI+GRNLLTQIGCTLNF
Sbjct: 61  QILVEICGHKVIGTVLVGPTPANIIGRNLLTQIGCTLNF 99


>gi|160877756|pdb|2R5P|A Chain A, Crystal Structure Analysis Of
           Hiv-1 Subtype C Protease Complexed With Indinavir
 Chain B, Crystal Structure Analysis Of Hiv-1 Subtype C Protease
           Complexed With Indinavir
 Chain C, Crystal Structure Analysis Of Hiv-1 Subtype C Protease
           Complexed With Indinavir
 Chain D, Crystal Structure Analysis Of Hiv-1 Subtype C Protease
           Complexed With Indinavir
 Chain A, Crystal Structure Analysis Of Hiv-1 Subtype C Protease
           Complexed With Nelfinavir
 Chain B, Crystal Structure Analysis Of Hiv-1 Subtype C Protease
           Complexed With Nelfinavir
 Chain C, Crystal Structure Analysis Of Hiv-1 Subtype C Protease
           Complexed With Nelfinavir
 Chain D, Crystal Structure Analysis Of Hiv-1 Subtype C Protease
           Complexed With Nelfinavir
 Chain A, Structural Analysis Of The Unbound Form Of Hiv-1 Subtype C
           Protease
          Length = 99

 Score =  178 bits (451), Expect = 5e-46,   Method: Compositional matrix adjust.
 Identities = 83/99 (83%), Positives = 96/99 (96%)

Query: 17  PQITLYQRPLVTIKIGGQLKEALLKTGADDTVLEEMSLPGEWKPKLIGGIGGFIKVRQYD 76
           PQITL++RPLV+IK+GGQ+KEALL TGADDTV+EE++LPG WKPK+IGGIGGFIKVRQYD
Sbjct: 1   PQITLWKRPLVSIKVGGQIKEALLDTGADDTVIEEIALPGRWKPKMIGGIGGFIKVRQYD 60

Query: 77  QILIEICGHKAIGTVLVGPTPVNILGRNLLTQIGCTLNF 115
           QI+IEICG KAIGTVLVGPTPVNI+GRN+LTQ+GCTLNF
Sbjct: 61  QIIIEICGKKAIGTVLVGPTPVNIIGRNMLTQLGCTLNF 99


>gi|12084156|pdb|1C6X|A Chain A, Alternate Binding Site For The
           P1-P3 Group Of A Class Of Potent Hiv-1 Protease
           Inhibitors As A Result Of Concerted Structural Change In
           80's Loop.
 Chain B, Alternate Binding Site For The P1-P3 Group Of A Class Of
           Potent Hiv-1 Protease Inhibitors As A Result Of
           Concerted Structural Change In 80's Loop.
 Chain A, Alternate Binding Site For The P1-P3 Group Of A Class Of
           Potent Hiv-1 Protease Inhibitors As A Result Of
           Concerted Structural Change In 80's Loop.
 Chain B, Alternate Binding Site For The P1-P3 Group Of A Class Of
           Potent Hiv-1 Protease Inhibitors As A Result Of
           Concerted Structural Change In 80's Loop.
 Chain A, Alternate Binding Site For The P1-P3 Group Of A Class Of
           Potent Hiv-1 Protease Inhibitors As A Result Of
           Concerted Structural Change In 80's Loop.
 Chain B, Alternate Binding Site For The P1-P3 Group Of A Class Of
           Potent Hiv-1 Protease Inhibitors As A Result Of
           Concerted Structural Change In 80's Loop
          Length = 99

 Score =  178 bits (451), Expect = 6e-46,   Method: Compositional matrix adjust.
 Identities = 86/99 (86%), Positives = 92/99 (92%)

Query: 17  PQITLYQRPLVTIKIGGQLKEALLKTGADDTVLEEMSLPGEWKPKLIGGIGGFIKVRQYD 76
           PQITL+QRP+VTIKIGGQL EAL+ TGADDTVLEEM LPG WKPK+IGGIGGF+KVRQYD
Sbjct: 1   PQITLWQRPVVTIKIGGQLMEALIDTGADDTVLEEMDLPGRWKPKIIGGIGGFVKVRQYD 60

Query: 77  QILIEICGHKAIGTVLVGPTPVNILGRNLLTQIGCTLNF 115
           QI IEICGHK IGTVLVGPTP NI+GRNLLTQIGCTLNF
Sbjct: 61  QIPIEICGHKVIGTVLVGPTPTNIIGRNLLTQIGCTLNF 99


>gi|146387071|pdb|2P3A|A Chain A, Crystal Structure Of The
           Multi-Drug Resistant Mutant Subtype B Hiv Protease
           Complexed With Tl-3 Inhibitor
 Chain B, Crystal Structure Of The Multi-Drug Resistant Mutant
           Subtype B Hiv Protease Complexed With Tl-3 Inhibitor
          Length = 99

 Score =  177 bits (450), Expect = 6e-46,   Method: Compositional matrix adjust.
 Identities = 85/99 (85%), Positives = 94/99 (94%)

Query: 17  PQITLYQRPLVTIKIGGQLKEALLKTGADDTVLEEMSLPGEWKPKLIGGIGGFIKVRQYD 76
           PQITL++RPLVTIKIGGQLKEALL TGADDTVLEEM+LPG+WKP++IGGIGGF+KVRQYD
Sbjct: 1   PQITLWKRPLVTIKIGGQLKEALLDTGADDTVLEEMALPGKWKPRMIGGIGGFVKVRQYD 60

Query: 77  QILIEICGHKAIGTVLVGPTPVNILGRNLLTQIGCTLNF 115
           QI IEI GHK IGTVLVGPTP NI+GRNL+TQIGCTLNF
Sbjct: 61  QIPIEIXGHKVIGTVLVGPTPANIIGRNLMTQIGCTLNF 99


>gi|170785196|pdb|3BXR|A Chain A, Crystal Structures Of Highly
           Constrained Substrate And Hydrolysis Products Bound To
           Hiv-1 Protease. Implications For Catalytic Mechanism
 Chain B, Crystal Structures Of Highly Constrained Substrate And
           Hydrolysis Products Bound To Hiv-1 Protease.
           Implications For Catalytic Mechanism
          Length = 99

 Score =  177 bits (448), Expect = 1e-45,   Method: Compositional matrix adjust.
 Identities = 86/99 (86%), Positives = 95/99 (95%)

Query: 17  PQITLYQRPLVTIKIGGQLKEALLKTGADDTVLEEMSLPGEWKPKLIGGIGGFIKVRQYD 76
           PQITL++RPLVTI+IGGQLKEALL TGADDTV+EEM+LPG+WKPK+IGGIGGFIKVRQYD
Sbjct: 1   PQITLWKRPLVTIRIGGQLKEALLNTGADDTVIEEMNLPGKWKPKMIGGIGGFIKVRQYD 60

Query: 77  QILIEICGHKAIGTVLVGPTPVNILGRNLLTQIGCTLNF 115
           QI +EI GHKAIGTVLVGPTPVNI+GRNLLTQIG TLNF
Sbjct: 61  QIPVEIXGHKAIGTVLVGPTPVNIIGRNLLTQIGXTLNF 99


>gi|1827895|pdb|1MTR|A Chain A, Hiv-1 Protease Complexed With A
           Cyclic Phe-Ile-Val Peptidomimetic Inhibitor
 Chain B, Hiv-1 Protease Complexed With A Cyclic Phe-Ile-Val
           Peptidomimetic Inhibitor
 Chain A, Hiv-1 Protease Complexed With Macrocyclic Peptidomimetic
           Inhibitor 5
 Chain B, Hiv-1 Protease Complexed With Macrocyclic Peptidomimetic
           Inhibitor 5
 Chain A, Hiv-1 Protease Complexed With Macrocyclic Peptidomimetic
           Inhibitor 4
 Chain B, Hiv-1 Protease Complexed With Macrocyclic Peptidomimetic
           Inhibitor 4
 Chain A, Hiv-1 Protease Complexed With Macrocyclic Peptidomimetic
           Inhibitor 6
 Chain B, Hiv-1 Protease Complexed With Macrocyclic Peptidomimetic
           Inhibitor 6
 Chain A, Hiv-1 Protease Complexed With Macrocyclic Peptidomimetic
           Inhibitor 7
 Chain B, Hiv-1 Protease Complexed With Macrocyclic Peptidomimetic
           Inhibitor 7
 Chain A, Hiv-1 Protease Complexed With A Macrocyclic Peptidomimetic
           Inhibitor
 Chain B, Hiv-1 Protease Complexed With A Macrocyclic Peptidomimetic
           Inhibitor
 Chain A, Hiv-1 Protease Complexed With A Macrocyclic Peptidomimetic
           Inhibitor
 Chain B, Hiv-1 Protease Complexed With A Macrocyclic Peptidomimetic
           Inhibitor
 Chain A, Hiv-1 Protease Complexed With Macrocyclic Peptidomimetic
           Inhibitor 3
 Chain B, Hiv-1 Protease Complexed With Macrocyclic Peptidomimetic
           Inhibitor 3
 Chain A, Hiv-1 Protease Complexed With Macrocyclic Peptidomimetic
           Inhibitor 2
 Chain B, Hiv-1 Protease Complexed With Macrocyclic Peptidomimetic
           Inhibitor 2
 Chain A, Crystal Structures Of Highly Constrained Substrate And
           Hydrolysis Products Bound To Hiv-1 Protease.
           Implications For Catalytic Mechanism
 Chain B, Crystal Structures Of Highly Constrained Substrate And
           Hydrolysis Products Bound To Hiv-1 Protease.
           Implications For Catalytic Mechanism
          Length = 99

 Score =  177 bits (448), Expect = 1e-45,   Method: Compositional matrix adjust.
 Identities = 86/99 (86%), Positives = 95/99 (95%)

Query: 17  PQITLYQRPLVTIKIGGQLKEALLKTGADDTVLEEMSLPGEWKPKLIGGIGGFIKVRQYD 76
           PQITL++RPLVTI+IGGQLKEALL TGADDTV+EEM+LPG+WKPK+IGGIGGFIKVRQYD
Sbjct: 1   PQITLWKRPLVTIRIGGQLKEALLDTGADDTVIEEMNLPGKWKPKMIGGIGGFIKVRQYD 60

Query: 77  QILIEICGHKAIGTVLVGPTPVNILGRNLLTQIGCTLNF 115
           QI +EI GHKAIGTVLVGPTPVNI+GRNLLTQIG TLNF
Sbjct: 61  QIPVEIXGHKAIGTVLVGPTPVNIIGRNLLTQIGXTLNF 99


>gi|169791925|pdb|1Q9P|A Chain A, Solution Structure Of The Mature
           Hiv-1 Protease Monomer
          Length = 95

 Score =  174 bits (442), Expect = 5e-45,   Method: Compositional matrix adjust.
 Identities = 85/95 (89%), Positives = 91/95 (95%)

Query: 17  PQITLYQRPLVTIKIGGQLKEALLKTGADDTVLEEMSLPGEWKPKLIGGIGGFIKVRQYD 76
           PQITL++RPLVTIKIGGQLKEALL TGADDTV+EEMSLPG WKPK+IGGIGGFIKVRQYD
Sbjct: 1   PQITLWKRPLVTIKIGGQLKEALLDTGADDTVIEEMSLPGRWKPKMIGGIGGFIKVRQYD 60

Query: 77  QILIEICGHKAIGTVLVGPTPVNILGRNLLTQIGC 111
           QI+IEI GHKAIGTVLVGPTPVNI+GRNLLTQIG 
Sbjct: 61  QIIIEIAGHKAIGTVLVGPTPVNIIGRNLLTQIGA 95


>gi|90109333|pdb|2FDD|A Chain A, Crystal Structure Of Hiv Protease
           D545701 Bound With Gw0385
 Chain B, Crystal Structure Of Hiv Protease D545701 Bound With
           Gw0385
          Length = 100

 Score =  174 bits (442), Expect = 6e-45,   Method: Compositional matrix adjust.
 Identities = 81/99 (81%), Positives = 93/99 (93%)

Query: 17  PQITLYQRPLVTIKIGGQLKEALLKTGADDTVLEEMSLPGEWKPKLIGGIGGFIKVRQYD 76
           PQITL+QRP+VTIKIGGQ +EALL TGADDTVLE+++LPG WKPK+IGG+GGF+KVRQYD
Sbjct: 2   PQITLWQRPIVTIKIGGQQREALLDTGADDTVLEDINLPGRWKPKIIGGVGGFVKVRQYD 61

Query: 77  QILIEICGHKAIGTVLVGPTPVNILGRNLLTQIGCTLNF 115
           Q+ IEICGHK IGTVLVGPTP NI+GRNL+TQIGCTLNF
Sbjct: 62  QVPIEICGHKVIGTVLVGPTPANIIGRNLMTQIGCTLNF 100


>gi|195927282|pdb|2RKG|A Chain A, Hiv-1 Pr Resistant Mutant + Lpv
 Chain B, Hiv-1 Pr Resistant Mutant + Lpv
          Length = 100

 Score =  173 bits (438), Expect = 1e-44,   Method: Compositional matrix adjust.
 Identities = 83/100 (83%), Positives = 91/100 (91%), Gaps = 1/100 (1%)

Query: 17  PQITLYQRPLVTIKIGGQLKEALLKTGADDTVLEE-MSLPGEWKPKLIGGIGGFIKVRQY 75
           PQITL+QRP VT+KI GQL EALL TGADDT+LEE MSLPG W PK++GGIGGF+KVRQY
Sbjct: 1   PQITLWQRPFVTVKIAGQLMEALLDTGADDTILEEEMSLPGRWTPKVVGGIGGFMKVRQY 60

Query: 76  DQILIEICGHKAIGTVLVGPTPVNILGRNLLTQIGCTLNF 115
           DQIL+EICGHK IGTVLVGPTP NI+GRNLLTQIGCTLNF
Sbjct: 61  DQILVEICGHKVIGTVLVGPTPANIIGRNLLTQIGCTLNF 100


>gi|146387075|pdb|2P3C|A Chain A, Crystal Structure Of The Subtype F
           Wild Type Hiv Protease Complexed With Tl-3 Inhibitor
 Chain B, Crystal Structure Of The Subtype F Wild Type Hiv Protease
           Complexed With Tl-3 Inhibitor
          Length = 99

 Score =  173 bits (438), Expect = 2e-44,   Method: Compositional matrix adjust.
 Identities = 81/99 (81%), Positives = 95/99 (95%)

Query: 17  PQITLYQRPLVTIKIGGQLKEALLKTGADDTVLEEMSLPGEWKPKLIGGIGGFIKVRQYD 76
           PQITL++RPLVTIK+GGQLKEALL TGADDTVLE+++LPG+WKPK+IGGIGGFIKV+QY+
Sbjct: 1   PQITLWKRPLVTIKVGGQLKEALLDTGADDTVLEDIALPGKWKPKMIGGIGGFIKVKQYE 60

Query: 77  QILIEICGHKAIGTVLVGPTPVNILGRNLLTQIGCTLNF 115
            + +EI GHKAIGTVLVGPTPVNI+GRN+LTQIGCTLNF
Sbjct: 61  NVSLEIXGHKAIGTVLVGPTPVNIIGRNMLTQIGCTLNF 99


>gi|90108777|pdb|2AZB|A Chain A, Hiv-1 Protease Nl4-3 3x Mutant In
           Complex With Inhibitor, Tl-3
          Length = 99

 Score =  167 bits (422), Expect = 1e-42,   Method: Compositional matrix adjust.
 Identities = 90/99 (90%), Positives = 95/99 (95%)

Query: 17  PQITLYQRPLVTIKIGGQLKEALLKTGADDTVLEEMSLPGEWKPKLIGGIGGFIKVRQYD 76
           PQITL++RPLVTIKIGGQLKEALL TGADDTVLEEM+LPG WKPK+IGGIGG IKVRQYD
Sbjct: 1   PQITLWKRPLVTIKIGGQLKEALLDTGADDTVLEEMNLPGRWKPKIIGGIGGLIKVRQYD 60

Query: 77  QILIEICGHKAIGTVLVGPTPVNILGRNLLTQIGCTLNF 115
           QILIEICGHKAIGTVLVGPTP NI+GRNLLTQIGCTLNF
Sbjct: 61  QILIEICGHKAIGTVLVGPTPANIIGRNLLTQIGCTLNF 99


>gi|146387077|pdb|2P3D|A Chain A, Crystal Structure Of The
           Multi-Drug Resistant Mutant Subtype F Hiv Protease
           Complexed With Tl-3 Inhibitor
 Chain B, Crystal Structure Of The Multi-Drug Resistant Mutant
           Subtype F Hiv Protease Complexed With Tl-3 Inhibitor
          Length = 99

 Score =  164 bits (416), Expect = 5e-42,   Method: Compositional matrix adjust.
 Identities = 75/99 (75%), Positives = 92/99 (92%)

Query: 17  PQITLYQRPLVTIKIGGQLKEALLKTGADDTVLEEMSLPGEWKPKLIGGIGGFIKVRQYD 76
           PQITL++RP+VTIK+ GQL+EALL TGADDTVLE+++L G+WKPK+IGGI GF+KV+QY+
Sbjct: 1   PQITLWKRPIVTIKVEGQLREALLDTGADDTVLEDINLSGKWKPKIIGGIRGFVKVKQYE 60

Query: 77  QILIEICGHKAIGTVLVGPTPVNILGRNLLTQIGCTLNF 115
            ILIEICGH+A+G VLVGPTP NI+GRN+LTQIGCTLNF
Sbjct: 61  DILIEICGHRAVGAVLVGPTPANIIGRNMLTQIGCTLNF 99


>gi|122921400|pdb|2O4N|A Chain A, Crystal Structure Of Hiv-1
           Protease (Trm Mutant) In Complex With Tipranavir
 Chain B, Crystal Structure Of Hiv-1 Protease (Trm Mutant) In
           Complex With Tipranavir
          Length = 99

 Score =  163 bits (413), Expect = 1e-41,   Method: Compositional matrix adjust.
 Identities = 87/99 (87%), Positives = 95/99 (95%)

Query: 17  PQITLYQRPLVTIKIGGQLKEALLKTGADDTVLEEMSLPGEWKPKLIGGIGGFIKVRQYD 76
           PQITL++RPLVT+KIGGQLKEALL TGADDT+ EEMSLPG WKP +IGGIGGFIKVRQYD
Sbjct: 1   PQITLWKRPLVTVKIGGQLKEALLDTGADDTIFEEMSLPGRWKPIMIGGIGGFIKVRQYD 60

Query: 77  QILIEICGHKAIGTVLVGPTPVNILGRNLLTQIGCTLNF 115
           QILIEICGHKAIGTVLVGPTP+N++GRNLLTQIGCTLNF
Sbjct: 61  QILIEICGHKAIGTVLVGPTPLNVIGRNLLTQIGCTLNF 99


>gi|90108779|pdb|2AZC|A Chain A, Hiv-1 Protease Nl4-3 6x Mutant
 Chain B, Hiv-1 Protease Nl4-3 6x Mutant
 Chain A, Structure Of Hiv Protease 6x Mutant In Apo Form
 Chain A, Structure Of Hiv Protease 6x Mutant In Complex With Ab-2.
 Chain B, Structure Of Hiv Protease 6x Mutant In Complex With Ab-2
          Length = 99

 Score =  162 bits (411), Expect = 2e-41,   Method: Compositional matrix adjust.
 Identities = 87/99 (87%), Positives = 94/99 (94%)

Query: 17  PQITLYQRPLVTIKIGGQLKEALLKTGADDTVLEEMSLPGEWKPKLIGGIGGFIKVRQYD 76
           PQITL++RPLVTIKIGGQLKEAL+ TGADDTVLEEM+LPG WKPK+IGGIGG IKVRQYD
Sbjct: 1   PQITLWKRPLVTIKIGGQLKEALIDTGADDTVLEEMNLPGRWKPKIIGGIGGLIKVRQYD 60

Query: 77  QILIEICGHKAIGTVLVGPTPVNILGRNLLTQIGCTLNF 115
           QI IEICGHKAIGTVL+GPTP NI+GRNLLTQIGCTLNF
Sbjct: 61  QIPIEICGHKAIGTVLIGPTPANIIGRNLLTQIGCTLNF 99


>gi|158428963|pdb|2JE4|A Chain A, Atomic-Resolution Crystal
           Structure Of Chemically- Synthesized Hiv-1 Protease In
           Complex With Jg-365
 Chain B, Atomic-Resolution Crystal Structure Of Chemically-
           Synthesized Hiv-1 Protease In Complex With Jg-365
          Length = 99

 Score =  162 bits (410), Expect = 3e-41,   Method: Compositional matrix adjust.
 Identities = 86/99 (86%), Positives = 94/99 (94%)

Query: 17  PQITLYQRPLVTIKIGGQLKEALLKTGADDTVLEEMSLPGEWKPKLIGGIGGFIKVRQYD 76
           PQITL++RPLVTI+IGGQLKEALL TGADDTV+EE +LPG+WKPK IGGIGGFIKVRQYD
Sbjct: 1   PQITLWKRPLVTIRIGGQLKEALLDTGADDTVIEEXNLPGKWKPKXIGGIGGFIKVRQYD 60

Query: 77  QILIEICGHKAIGTVLVGPTPVNILGRNLLTQIGCTLNF 115
           QI +EI GHKAIGTVLVGPTPVNI+GRNLLTQIGCTLNF
Sbjct: 61  QIPVEIXGHKAIGTVLVGPTPVNIIGRNLLTQIGCTLNF 99


>gi|7766825|pdb|1DAZ|C Chain C, Structural And Kinetic Analysis Of
           Drug Resistant Mutants Of Hiv-1 Protease
 Chain D, Structural And Kinetic Analysis Of Drug Resistant Mutants
           Of Hiv-1 Protease
 Chain C, Structural Implications Of Drug Resistant Mutants Of Hiv-1
           Protease: High Resolution Crystal Structures Of The
           Mutant ProteaseSUBSTRATE ANALOG COMPLEXES.
 Chain D, Structural Implications Of Drug Resistant Mutants Of Hiv-1
           Protease: High Resolution Crystal Structures Of The
           Mutant ProteaseSUBSTRATE ANALOG COMPLEXES
          Length = 99

 Score =  160 bits (406), Expect = 7e-41,   Method: Compositional matrix adjust.
 Identities = 88/99 (88%), Positives = 94/99 (94%)

Query: 17  PQITLYQRPLVTIKIGGQLKEALLKTGADDTVLEEMSLPGEWKPKLIGGIGGFIKVRQYD 76
           PQITL++RPLVTIKIGGQLKEALL TGADDTV+EEMSLPG WKP +IGGIGGFIKVRQYD
Sbjct: 1   PQITLWKRPLVTIKIGGQLKEALLDTGADDTVIEEMSLPGRWKPIMIGGIGGFIKVRQYD 60

Query: 77  QILIEICGHKAIGTVLVGPTPVNILGRNLLTQIGCTLNF 115
           QI+IEI GHKAIGTVLVGPTPVNI+GRNLLTQIG TLNF
Sbjct: 61  QIIIEIAGHKAIGTVLVGPTPVNIIGRNLLTQIGATLNF 99


>gi|22218895|pdb|1K1U|A Chain A, Combining Mutations In Hiv-1
           Protease To Understand Mechanisms Of Resistance
 Chain B, Combining Mutations In Hiv-1 Protease To Understand
           Mechanisms Of Resistance
          Length = 99

 Score =  160 bits (405), Expect = 1e-40,   Method: Compositional matrix adjust.
 Identities = 87/99 (87%), Positives = 94/99 (94%)

Query: 17  PQITLYQRPLVTIKIGGQLKEALLKTGADDTVLEEMSLPGEWKPKLIGGIGGFIKVRQYD 76
           PQITL++RPLVTIKIGGQLKEALL TGADDTV+EEMSLPG WKP +IGGIGGFIKVRQYD
Sbjct: 1   PQITLWKRPLVTIKIGGQLKEALLDTGADDTVIEEMSLPGRWKPIMIGGIGGFIKVRQYD 60

Query: 77  QILIEICGHKAIGTVLVGPTPVNILGRNLLTQIGCTLNF 115
           QI+IEI GHKAIGTVLVGPTPVNI+GRNL+TQIG TLNF
Sbjct: 61  QIIIEIAGHKAIGTVLVGPTPVNIIGRNLMTQIGATLNF 99


>gi|119389010|pdb|2B7Z|B Chain B, Structure Of Hiv-1 Protease Mutant
           Bound To Indinavir
 Chain A, Structure Of Hiv-1 Protease Mutant Bound To Indinavir
          Length = 99

 Score =  160 bits (404), Expect = 2e-40,   Method: Compositional matrix adjust.
 Identities = 85/99 (85%), Positives = 93/99 (93%)

Query: 17  PQITLYQRPLVTIKIGGQLKEALLKTGADDTVLEEMSLPGEWKPKLIGGIGGFIKVRQYD 76
           PQITL+QRPLVTIKIGGQL+EALL TGADDT+ EE+SLPG WKPK+IGGIGGFIKVRQYD
Sbjct: 1   PQITLWQRPLVTIKIGGQLREALLDTGADDTIFEEISLPGRWKPKIIGGIGGFIKVRQYD 60

Query: 77  QILIEICGHKAIGTVLVGPTPVNILGRNLLTQIGCTLNF 115
           QI IEICGHK IGTVLVGPTP N++GRNL+TQIGCTLNF
Sbjct: 61  QIPIEICGHKVIGTVLVGPTPANVIGRNLMTQIGCTLNF 99


>gi|22218892|pdb|1K1T|A Chain A, Combining Mutations In Hiv-1
           Protease To Understand Mechanisms Of Resistance
 Chain B, Combining Mutations In Hiv-1 Protease To Understand
           Mechanisms Of Resistance
          Length = 99

 Score =  159 bits (402), Expect = 2e-40,   Method: Compositional matrix adjust.
 Identities = 87/99 (87%), Positives = 93/99 (93%)

Query: 17  PQITLYQRPLVTIKIGGQLKEALLKTGADDTVLEEMSLPGEWKPKLIGGIGGFIKVRQYD 76
           PQITL++RPLVTIKIGGQLKEALL TGADDTV+EEMSLPG WKP +IGGIGGFIKVRQYD
Sbjct: 1   PQITLWKRPLVTIKIGGQLKEALLDTGADDTVIEEMSLPGRWKPIMIGGIGGFIKVRQYD 60

Query: 77  QILIEICGHKAIGTVLVGPTPVNILGRNLLTQIGCTLNF 115
           QI+IEI GHKAIGTVLVGPTP NI+GRNLLTQIG TLNF
Sbjct: 61  QIIIEIAGHKAIGTVLVGPTPSNIIGRNLLTQIGATLNF 99


>gi|197107260|pdb|3DCK|A Chain A, X-Ray Structure Of D25n Chemical
           Analogue Of Hiv-1 Protease Complexed With Ketomethylene
           Isostere Inhibitor
 Chain B, X-Ray Structure Of D25n Chemical Analogue Of Hiv-1
           Protease Complexed With Ketomethylene Isostere Inhibitor
          Length = 99

 Score =  159 bits (401), Expect = 3e-40,   Method: Compositional matrix adjust.
 Identities = 85/99 (85%), Positives = 92/99 (92%)

Query: 17  PQITLYQRPLVTIKIGGQLKEALLKTGADDTVLEEMSLPGEWKPKLIGGIGGFIKVRQYD 76
           PQITL++RPLVTI+IGGQLKEALL TGADDTV+EE +LPG WKPK IGGIGGFIKVRQYD
Sbjct: 1   PQITLWKRPLVTIRIGGQLKEALLNTGADDTVIEEXNLPGXWKPKXIGGIGGFIKVRQYD 60

Query: 77  QILIEICGHKAIGTVLVGPTPVNILGRNLLTQIGCTLNF 115
           QI +EI GHKAIGTVLVGPTPVNI+GRNLLTQIG TLNF
Sbjct: 61  QIPVEIXGHKAIGTVLVGPTPVNIIGRNLLTQIGXTLNF 99


>gi|158428936|pdb|2J9J|A Chain A, Atomic-Resolution Crystal
           Structure Of Chemically- Synthesized Hiv-1 Protease
           Complexed With Inhibitor Jg-365
 Chain A, Atomic-Resolution Crystal Structure Of Chemically-
           Synthesized Hiv-1 Protease Complexed With Inhibitor Mvt-
           101
 Chain B, Atomic-Resolution Crystal Structure Of Chemically-
           Synthesized Hiv-1 Protease Complexed With Inhibitor Mvt-
           101
 Chain A, X-Ray Structure Of Hiv-1 Protease And Hydrated Form Of
           Ketomethylene Isostere Inhibitor
 Chain B, X-Ray Structure Of Hiv-1 Protease And Hydrated Form Of
           Ketomethylene Isostere Inhibitor
          Length = 99

 Score =  158 bits (400), Expect = 4e-40,   Method: Compositional matrix adjust.
 Identities = 85/99 (85%), Positives = 92/99 (92%)

Query: 17  PQITLYQRPLVTIKIGGQLKEALLKTGADDTVLEEMSLPGEWKPKLIGGIGGFIKVRQYD 76
           PQITL++RPLVTI+IGGQLKEALL TGADDTV+EE +LPG WKPK IGGIGGFIKVRQYD
Sbjct: 1   PQITLWKRPLVTIRIGGQLKEALLDTGADDTVIEEXNLPGXWKPKXIGGIGGFIKVRQYD 60

Query: 77  QILIEICGHKAIGTVLVGPTPVNILGRNLLTQIGCTLNF 115
           QI +EI GHKAIGTVLVGPTPVNI+GRNLLTQIG TLNF
Sbjct: 61  QIPVEIXGHKAIGTVLVGPTPVNIIGRNLLTQIGXTLNF 99


>gi|134104293|pdb|2FXD|A Chain A, X-Ray Crystal Structure Of Hiv-1
           Protease Irm Mutant Complexed With Atazanavir
           (Bms-232632)
 Chain B, X-Ray Crystal Structure Of Hiv-1 Protease Irm Mutant
           Complexed With Atazanavir (Bms-232632)
          Length = 99

 Score =  158 bits (399), Expect = 5e-40,   Method: Compositional matrix adjust.
 Identities = 83/99 (83%), Positives = 95/99 (95%)

Query: 17  PQITLYQRPLVTIKIGGQLKEALLKTGADDTVLEEMSLPGEWKPKLIGGIGGFIKVRQYD 76
           PQITL++RP+VT+KIGGQLKEALL TGADDTV+EEM+LPG+WKPK+IGGIGGFIKVRQYD
Sbjct: 1   PQITLWKRPIVTVKIGGQLKEALLDTGADDTVIEEMNLPGKWKPKIIGGIGGFIKVRQYD 60

Query: 77  QILIEICGHKAIGTVLVGPTPVNILGRNLLTQIGCTLNF 115
           QI+IEI GHKAIGTVLVGPTP N++GRNL+TQIG TLNF
Sbjct: 61  QIIIEIAGHKAIGTVLVGPTPFNVIGRNLMTQIGATLNF 99


>gi|122921392|pdb|2O40|A Chain A, Crystal Structure Of A Chemically
           Synthesized 203 Amino Acid 'covalent Dimer' Hiv-1
           Protease Molecule
          Length = 203

 Score =  157 bits (398), Expect = 7e-40,   Method: Compositional matrix adjust.
 Identities = 85/99 (85%), Positives = 92/99 (92%)

Query: 17  PQITLYQRPLVTIKIGGQLKEALLKTGADDTVLEEMSLPGEWKPKLIGGIGGFIKVRQYD 76
           PQITL++RPLVTI+IGGQLKEALL TGADDTV+EE +LPG WKPK IGGIGGFIKVRQYD
Sbjct: 1   PQITLWKRPLVTIRIGGQLKEALLDTGADDTVIEEXNLPGXWKPKXIGGIGGFIKVRQYD 60

Query: 77  QILIEICGHKAIGTVLVGPTPVNILGRNLLTQIGCTLNF 115
           QI +EI GHKAIGTVLVGPTPVNI+GRNLLTQIG TLNF
Sbjct: 61  QIPVEIXGHKAIGTVLVGPTPVNIIGRNLLTQIGXTLNF 99



 Score =  157 bits (398), Expect = 7e-40,   Method: Compositional matrix adjust.
 Identities = 85/99 (85%), Positives = 92/99 (92%)

Query: 17  PQITLYQRPLVTIKIGGQLKEALLKTGADDTVLEEMSLPGEWKPKLIGGIGGFIKVRQYD 76
           PQITL++RPLVTI+IGGQLKEALL TGADDTV+EE +LPG WKPK IGGIGGFIKVRQYD
Sbjct: 105 PQITLWKRPLVTIRIGGQLKEALLDTGADDTVIEEXNLPGXWKPKXIGGIGGFIKVRQYD 164

Query: 77  QILIEICGHKAIGTVLVGPTPVNILGRNLLTQIGCTLNF 115
           QI +EI GHKAIGTVLVGPTPVNI+GRNLLTQIG TLNF
Sbjct: 165 QIPVEIXGHKAIGTVLVGPTPVNIIGRNLLTQIGXTLNF 203


>gi|158428937|pdb|2J9J|B Chain B, Atomic-Resolution Crystal
           Structure Of Chemically- Synthesized Hiv-1 Protease
           Complexed With Inhibitor Jg-365
          Length = 99

 Score =  156 bits (395), Expect = 1e-39,   Method: Compositional matrix adjust.
 Identities = 84/99 (84%), Positives = 91/99 (91%)

Query: 17  PQITLYQRPLVTIKIGGQLKEALLKTGADDTVLEEMSLPGEWKPKLIGGIGGFIKVRQYD 76
           PQITL++RPLVTI+IGG LKEALL TGADDTV+EE +LPG WKPK IGGIGGFIKVRQYD
Sbjct: 1   PQITLWKRPLVTIRIGGNLKEALLDTGADDTVIEEXNLPGXWKPKXIGGIGGFIKVRQYD 60

Query: 77  QILIEICGHKAIGTVLVGPTPVNILGRNLLTQIGCTLNF 115
           QI +EI GHKAIGTVLVGPTPVNI+GRNLLTQIG TLNF
Sbjct: 61  QIPVEIXGHKAIGTVLVGPTPVNIIGRNLLTQIGXTLNF 99


>gi|157833815|pdb|1SIP|A Chain A, Alternative Native Flap
           Conformation Revealed By 2.3 Angstroms Resolution
           Structure Of Siv Proteinase
          Length = 99

 Score =  107 bits (268), Expect = 9e-25,   Method: Compositional matrix adjust.
 Identities = 49/99 (49%), Positives = 70/99 (70%)

Query: 17  PQITLYQRPLVTIKIGGQLKEALLKTGADDTVLEEMSLPGEWKPKLIGGIGGFIKVRQYD 76
           PQ +L++RP+VT  I GQ  E LL TGADD+++  + L   + PK++GGIGGFI  ++Y 
Sbjct: 1   PQFSLWRRPVVTAHIEGQPVEVLLDTGADDSIVTGIELGPHYTPKIVGGIGGFINTKEYK 60

Query: 77  QILIEICGHKAIGTVLVGPTPVNILGRNLLTQIGCTLNF 115
            + IE+ G +  GT++ G TP+NI GRNLLT +G +LNF
Sbjct: 61  NVEIEVLGKRIRGTIMTGDTPINIFGRNLLTALGMSLNF 99


>gi|157836348|pdb|2SAM|A Chain A, Structure Of The Protease From
           Simian Immunodeficiency Virus: Complex With An
           Irreversible Non-Peptide Inhibitor
          Length = 99

 Score =  106 bits (265), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 49/99 (49%), Positives = 69/99 (69%)

Query: 17  PQITLYQRPLVTIKIGGQLKEALLKTGADDTVLEEMSLPGEWKPKLIGGIGGFIKVRQYD 76
           PQ  L++RP+VT  I GQ  E LL TGADD+++  + L   + PK++GGIGGFI  ++Y 
Sbjct: 1   PQFHLWKRPVVTAHIEGQPVEVLLDTGADDSIVTGIELGPHYTPKIVGGIGGFINTKEYK 60

Query: 77  QILIEICGHKAIGTVLVGPTPVNILGRNLLTQIGCTLNF 115
            + IE+ G +  GT++ G TP+NI GRNLLT +G +LNF
Sbjct: 61  NVEIEVLGKRIKGTIMTGDTPINIFGRNLLTALGMSLNF 99


>gi|1942089|pdb|1YTI|A Chain A, Siv Protease Crystallized With
           Peptide Product
 Chain A, Siv Protease Crystallized With Peptide Product
          Length = 99

 Score =  105 bits (263), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 48/99 (48%), Positives = 69/99 (69%)

Query: 17  PQITLYQRPLVTIKIGGQLKEALLKTGADDTVLEEMSLPGEWKPKLIGGIGGFIKVRQYD 76
           PQ  L++RP+VT  I GQ  E LL TGADD+++  + L   + PK++GGIGGFI  ++Y 
Sbjct: 1   PQFHLWKRPVVTAHIEGQPVEVLLDTGADDSIVTGIELGPHYTPKIVGGIGGFINTKEYK 60

Query: 77  QILIEICGHKAIGTVLVGPTPVNILGRNLLTQIGCTLNF 115
            + +E+ G +  GT++ G TP+NI GRNLLT +G +LNF
Sbjct: 61  NVEVEVLGKRIKGTIMTGDTPINIFGRNLLTALGMSLNF 99


>gi|494588|pdb|1SIV|A Chain A, Three-Dimensional Structure Of A Siv
           Protease(Slash) Inhibitor Complex. Implications For The
           Design Of Hiv-1 And Hiv-2 Protease Inhibitors
 Chain B, Three-Dimensional Structure Of A Siv Protease(Slash)
           Inhibitor Complex. Implications For The Design Of Hiv-1
           And Hiv-2 Protease Inhibitors
 Chain A, Siv Protease Complexed With Inhibitor Sb203386
 Chain B, Siv Protease Complexed With Inhibitor Sb203386
          Length = 99

 Score =  105 bits (261), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 48/99 (48%), Positives = 69/99 (69%)

Query: 17  PQITLYQRPLVTIKIGGQLKEALLKTGADDTVLEEMSLPGEWKPKLIGGIGGFIKVRQYD 76
           PQ +L++RP+VT  I GQ  E LL TGADD+++  + L   + PK++GGIGGFI  ++Y 
Sbjct: 1   PQFSLWRRPVVTAHIEGQPVEVLLDTGADDSIVTGIELGPHYTPKIVGGIGGFINTKEYK 60

Query: 77  QILIEICGHKAIGTVLVGPTPVNILGRNLLTQIGCTLNF 115
            + IE+ G +  GT++ G TP+NI GRNLLT +G +LN 
Sbjct: 61  NVKIEVLGKRIKGTIMTGDTPINIFGRNLLTALGMSLNL 99


>gi|157830152|pdb|1AZ5|A Chain A, Unliganded Siv Protease Structure
           In An "open" Conformation
          Length = 99

 Score =  103 bits (257), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 47/98 (47%), Positives = 68/98 (69%)

Query: 18  QITLYQRPLVTIKIGGQLKEALLKTGADDTVLEEMSLPGEWKPKLIGGIGGFIKVRQYDQ 77
           Q  L++RP+VT  I GQ  E LL TGADD+++  + L   + PK++GGIGGFI  ++Y  
Sbjct: 2   QFHLWKRPVVTAHIEGQPVEVLLDTGADDSIVTGIELGPHYTPKIVGGIGGFINTKEYKN 61

Query: 78  ILIEICGHKAIGTVLVGPTPVNILGRNLLTQIGCTLNF 115
           + +E+ G +  GT++ G TP+NI GRNLLT +G +LNF
Sbjct: 62  VEVEVLGKRIKGTIMTGDTPINIFGRNLLTALGMSLNF 99


>gi|443402|pdb|2MIP|A Chain A, Crystal Structure Of Human
           Immunodeficiency Virus (Hiv) Type 2 Protease In Complex
           With A Reduced Amide Inhibitor And Comparison With Hiv-1
           Protease Structures
 Chain B, Crystal Structure Of Human Immunodeficiency Virus (Hiv)
           Type 2 Protease In Complex With A Reduced Amide
           Inhibitor And Comparison With Hiv-1 Protease Structures
 Chain C, Crystal Structure Of Human Immunodeficiency Virus (Hiv)
           Type 2 Protease In Complex With A Reduced Amide
           Inhibitor And Comparison With Hiv-1 Protease Structures
 Chain D, Crystal Structure Of Human Immunodeficiency Virus (Hiv)
           Type 2 Protease In Complex With A Reduced Amide
           Inhibitor And Comparison With Hiv-1 Protease Structures
 Chain A, Crystal Structures Of Hiv-2 Protease In Complex With
           Inhibitors Containing The Hydroxyethylamine Dipeptide
           Isostere
 Chain B, Crystal Structures Of Hiv-2 Protease In Complex With
           Inhibitors Containing The Hydroxyethylamine Dipeptide
           Isostere
 Chain A, Crystal Structures Of Hiv-2 Protease In Complex With
           Inhibitors Containing The Hydroxyethylamine Dipeptide
           Isostere
 Chain B, Crystal Structures Of Hiv-2 Protease In Complex With
           Inhibitors Containing The Hydroxyethylamine Dipeptide
           Isostere
 Chain A, Comparative Analysis Of The X-Ray Structures Of Hiv-1 And
           Hiv-2 Proteases In Complex With Cgp 53820, A Novel
           Pseudosymmetric Inhibitor
 Chain B, Comparative Analysis Of The X-Ray Structures Of Hiv-1 And
           Hiv-2 Proteases In Complex With Cgp 53820, A Novel
           Pseudosymmetric Inhibitor
 Chain A, Crystal Structure At 1.9 Angstroms Resolution Of Human
           Immunodeficiency Virus (Hiv) Ii Protease Complexed With
           L- 735,524, An Orally Bioavailable Inhibitor Of The Hiv
           Proteases
 Chain B, Crystal Structure At 1.9 Angstroms Resolution Of Human
           Immunodeficiency Virus (Hiv) Ii Protease Complexed With
           L- 735,524, An Orally Bioavailable Inhibitor Of The Hiv
           Proteases
 Chain C, Crystal Structure At 1.9 Angstroms Resolution Of Human
           Immunodeficiency Virus (Hiv) Ii Protease Complexed With
           L- 735,524, An Orally Bioavailable Inhibitor Of The Hiv
           Proteases
 Chain D, Crystal Structure At 1.9 Angstroms Resolution Of Human
           Immunodeficiency Virus (Hiv) Ii Protease Complexed With
           L- 735,524, An Orally Bioavailable Inhibitor Of The Hiv
           Proteases
 Chain A, Crystal Structure At 1.9 Angstroms Resolution Of Human
           Immunodeficiency Virus (Hiv) Ii Protease Complexed With
           L- 735,524, An Orally Bioavailable Inhibitor Of The Hiv
           Proteases
 Chain B, Crystal Structure At 1.9 Angstroms Resolution Of Human
           Immunodeficiency Virus (Hiv) Ii Protease Complexed With
           L- 735,524, An Orally Bioavailable Inhibitor Of The Hiv
           Proteases
 Chain A, Potent Hiv Protease Inhibitors Containing A Novel
           (Hydroxyethyl)amide Isostere
 Chain B, Potent Hiv Protease Inhibitors Containing A Novel
           (Hydroxyethyl)amide Isostere
 Chain A, High Resolution Hiv-2 Protease Structure In Complex With
           Clinical Drug Darunavir
 Chain B, High Resolution Hiv-2 Protease Structure In Complex With
           Clinical Drug Darunavir
 Chain A, High Resolution Hiv-2 Protease Structure In Complex With
           Antiviral Inhibitor Grl-06579a
 Chain B, High Resolution Hiv-2 Protease Structure In Complex With
           Antiviral Inhibitor Grl-06579a
 Chain A, High Resolution Hiv-2 Protease Structure In Complex With
           Antiviral Inhibitor Grl-98065
 Chain B, High Resolution Hiv-2 Protease Structure In Complex With
           Antiviral Inhibitor Grl-98065
          Length = 99

 Score =  103 bits (256), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 46/99 (46%), Positives = 67/99 (67%)

Query: 17  PQITLYQRPLVTIKIGGQLKEALLKTGADDTVLEEMSLPGEWKPKLIGGIGGFIKVRQYD 76
           PQ +L++RP+VT  I GQ  E LL TGADD+++  + L   + PK++GGIGGFI  ++Y 
Sbjct: 1   PQFSLWKRPVVTAYIEGQPVEVLLDTGADDSIVAGIELGNNYSPKIVGGIGGFINTKEYK 60

Query: 77  QILIEICGHKAIGTVLVGPTPVNILGRNLLTQIGCTLNF 115
            + IE+   K   T++ G TP+NI GRN+LT +G +LN 
Sbjct: 61  NVEIEVLNKKVRATIMTGDTPINIFGRNILTALGMSLNL 99


>gi|443054|pdb|1IVP|A Chain A, The Crystallographic Structure Of The
           Protease From Human Immunodeficiency Virus Type 2 With
           Two Synthetic Peptidic Transition State Analog
           Inhibitors
 Chain B, The Crystallographic Structure Of The Protease From Human
           Immunodeficiency Virus Type 2 With Two Synthetic
           Peptidic Transition State Analog Inhibitors
 Chain A, The Crystallographic Structure Of The Protease From Human
           Immunodeficiency Virus Type 2 With Two Synthetic
           Peptidic Transition State Analog Inhibitors
 Chain B, The Crystallographic Structure Of The Protease From Human
           Immunodeficiency Virus Type 2 With Two Synthetic
           Peptidic Transition State Analog Inhibitors
 Chain A, Comparison Of The Structures Of Hiv-2 Protease Complexes
           In Three Crystal Space Groups With An Hiv-1 Protease
           Complex Structure
 Chain B, Comparison Of The Structures Of Hiv-2 Protease Complexes
           In Three Crystal Space Groups With An Hiv-1 Protease
           Complex Structure
 Chain A, Comparison Of The Structures Of Hiv-2 Protease Complexes
           In Three Crystal Space Groups With An Hiv-1 Protease
           Complex Structure
 Chain B, Comparison Of The Structures Of Hiv-2 Protease Complexes
           In Three Crystal Space Groups With An Hiv-1 Protease
           Complex Structure
 Chain A, Human Immunodeficiency Virus Type 2 Protease Mutant With
           Lys 57 Replaced By Leu (K57l) Complex With U097410 [4-
           Hydroxy-3-[1-[3-[[[[(Tert-Butyloxycarbonyl)
           Aminomethyl]carbonyl]amino]phenyl]propyl]coumarin
 Chain B, Human Immunodeficiency Virus Type 2 Protease Mutant With
           Lys 57 Replaced By Leu (K57l) Complex With U097410 [4-
           Hydroxy-3-[1-[3-[[[[(Tert-Butyloxycarbonyl)
           Aminomethyl]carbonyl]amino]phenyl]propyl]coumarin
 Chain A, Human Immunodeficiency Virus Type 2 Protease Mutant With
           Lys 57 Replaced By Leu (K57l) Complex With U096333 [4-
           Hydroxy-3-[1-(Phenyl)propyl]-7-Methoxycoumarin]
 Chain B, Human Immunodeficiency Virus Type 2 Protease Mutant With
           Lys 57 Replaced By Leu (K57l) Complex With U096333 [4-
           Hydroxy-3-[1-(Phenyl)propyl]-7-Methoxycoumarin]
 Chain A, Hiv-2 ProteaseU99294 COMPLEX
 Chain B, Hiv-2 ProteaseU99294 COMPLEX
 Chain A, Hiv-2 ProteaseU99283 COMPLEX
 Chain B, Hiv-2 ProteaseU99283 COMPLEX
          Length = 99

 Score =  101 bits (251), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 46/99 (46%), Positives = 66/99 (66%)

Query: 17  PQITLYQRPLVTIKIGGQLKEALLKTGADDTVLEEMSLPGEWKPKLIGGIGGFIKVRQYD 76
           PQ +L++RP+VT  I GQ  E LL TGADD+++  + L   + PK++GGIGGFI   +Y 
Sbjct: 1   PQFSLWKRPVVTAYIEGQPVEVLLDTGADDSIVAGIELGNNYSPKIVGGIGGFINTLEYK 60

Query: 77  QILIEICGHKAIGTVLVGPTPVNILGRNLLTQIGCTLNF 115
            + IE+   K   T++ G TP+NI GRN+LT +G +LN 
Sbjct: 61  NVEIEVLNKKVRATIMTGDTPINIFGRNILTALGMSLNL 99


>gi|4389337|pdb|1BAI|A Chain A, Structural Basis For Specificity Of
           Retroviral Proteases
 Chain B, Structural Basis For Specificity Of Retroviral Proteases
          Length = 124

 Score = 48.1 bits (113), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 38/90 (42%), Positives = 49/90 (54%), Gaps = 16/90 (17%)

Query: 38  ALLKTGADDTVLEEMSLPGEW------KPKLIGGIGGFIKVRQYDQILIEICGHKAIGTV 91
           ALL TGADDTV+ E   P +W       P+ I GIGG I VR+  + +IE+      G++
Sbjct: 34  ALLDTGADDTVISEEDWPTDWPVMEAANPQ-IHGIGGGIPVRK-SRDMIELGVINRDGSL 91

Query: 92  --------LVGPTPVNILGRNLLTQIGCTL 113
                   LV  TPVNILGR+ L  +G  L
Sbjct: 92  ERPLLLFPLVAMTPVNILGRDCLQGLGLRL 121


>gi|159162755|pdb|1NSO|A Chain A, Folded Monomer Of Protease From
           Mason-Pfizer Monkey Virus
          Length = 107

 Score = 34.3 bits (77), Expect = 0.010,   Method: Compositional matrix adjust.
 Identities = 27/94 (28%), Positives = 45/94 (47%), Gaps = 7/94 (7%)

Query: 23  QRPLVTIKIGGQLKEALLKTGADDTVLEEMSLPGEW----KPKLIGGIGGFIKVRQYDQI 78
           Q+P +T+ +  ++   L+ TGAD T+++    P  W        + GIG     +Q  + 
Sbjct: 8   QKPSLTLWLDDKMFTGLINTGADVTIIKLEDWPPNWPITDTLTNLRGIGQSNNPKQSSKY 67

Query: 79  LIEICGHKAIGTV--LVGPT-PVNILGRNLLTQI 109
           L         G +   V P  PVN+ GR+LL+Q+
Sbjct: 68  LTWRDKENNSGLIKPFVIPNLPVNLWGRDLLSQM 101


>gi|134104445|pdb|2HAH|A Chain A, The Structure Of Fiv 12s Protease
           In Complex With Tl-3
          Length = 116

 Score = 30.4 bits (67), Expect = 0.18,   Method: Compositional matrix adjust.
 Identities = 39/106 (36%), Positives = 51/106 (48%), Gaps = 12/106 (11%)

Query: 20  TLYQRPLVTIKIGGQLKEALLKTGADDTVLEEMSL----PGEWKPKLIGGIGGFIKVRQY 75
           TL +RP + I + G   + LL TGAD TVL           E   ++IGGIGGFI+   Y
Sbjct: 9   TLEKRPEILIFVNGYPIKFLLDTGADITVLNRRDFQVKNSIENGRQMIGGIGGFIRGTNY 68

Query: 76  DQILIEICGHKA-----IGTVLV---GPTPVNILGRNLLTQIGCTL 113
             + +EI           G V V     TPVNILGR+ + +    L
Sbjct: 69  INVHLEIRDENYKTQCIFGNVCVLEDNSTPVNILGRDNMIKFNIRL 114


>gi|230182|pdb|1MVP|A Chain A, Structural Studies Of The
          Retroviral Proteinase From Avian Myeloblastosis
          Associated Virus
 Chain B, Structural Studies Of The Retroviral Proteinase From
          Avian Myeloblastosis Associated Virus
          Length = 124

 Score = 30.0 bits (66), Expect = 0.21,   Method: Compositional matrix adjust.
 Identities = 18/48 (37%), Positives = 27/48 (56%), Gaps = 7/48 (14%)

Query: 38 ALLKTGADDTVLEEMSLPGEW------KPKLIGGIGGFIKVRQYDQIL 79
          ALL +GAD T++ E   P +W       P+ I GIGG I +R+   ++
Sbjct: 34 ALLDSGADITIISEEDWPTDWPVMEAANPQ-IHGIGGGIPMRKSRDMI 80


>gi|230722|pdb|2RSP|A Chain A, Structure Of The Aspartic Protease
          From Rous Sarcoma Retrovirus Refined At 2 Angstroms
          Resolution
 Chain B, Structure Of The Aspartic Protease From Rous Sarcoma
          Retrovirus Refined At 2 Angstroms Resolution
          Length = 124

 Score = 30.0 bits (66), Expect = 0.21,   Method: Compositional matrix adjust.
 Identities = 18/48 (37%), Positives = 27/48 (56%), Gaps = 7/48 (14%)

Query: 38 ALLKTGADDTVLEEMSLPGEW------KPKLIGGIGGFIKVRQYDQIL 79
          ALL +GAD T++ E   P +W       P+ I GIGG I +R+   ++
Sbjct: 34 ALLDSGADITIISEEDWPTDWPVMEAANPQ-IHGIGGGIPMRKSRDMI 80


>gi|157831103|pdb|1FMB|A Chain A, Eiav Protease Complexed With The
           Inhibitor Hby-793
 Chain A, Eiav Protease Complexed With An Inhibitor Lp-130
          Length = 104

 Score = 28.1 bits (61), Expect = 0.88,   Method: Compositional matrix adjust.
 Identities = 30/99 (30%), Positives = 42/99 (42%), Gaps = 7/99 (7%)

Query: 21  LYQRPLVTIKIGGQLKEALLKTGADDTVL-----EEMSLPGEWKPKLIGGIGGFIKVRQY 75
           L +RP   + I       LL TGAD +VL       +   G  K +  G  G    V  +
Sbjct: 5   LEKRPTTIVLINDTPLNVLLDTGADTSVLTTAHYNRLKYRGR-KYQGTGIGGVGGNVETF 63

Query: 76  DQ-ILIEICGHKAIGTVLVGPTPVNILGRNLLTQIGCTL 113
              + I+  G      +LV   PV ILGR++L  +G  L
Sbjct: 64  STPVTIKKKGRHIKTRMLVADIPVTILGRDILQDLGAKL 102


>gi|2624458|pdb|2FIV|A Chain A, Crystal Structure Of Feline
          Immunodeficiency Virus Protease Complexed With A
          Substrate
 Chain B, Crystal Structure Of Feline Immunodeficiency Virus
          Protease Complexed With A Substrate
          Length = 116

 Score = 26.9 bits (58), Expect = 2.1,   Method: Compositional matrix adjust.
 Identities = 14/35 (40%), Positives = 19/35 (54%)

Query: 20 TLYQRPLVTIKIGGQLKEALLKTGADDTVLEEMSL 54
          TL +RP + I + G   + LL TGAD T+L     
Sbjct: 9  TLEKRPEILIFVNGYPIKFLLNTGADITILNRRDF 43


>gi|6730067|pdb|5FIV|A Chain A, Structural Studies Of Hiv And Fiv
          Proteases Complexed With An Efficient Inhibitor Of Fiv
          Pr
          Length = 113

 Score = 26.6 bits (57), Expect = 2.2,   Method: Compositional matrix adjust.
 Identities = 22/67 (32%), Positives = 32/67 (47%), Gaps = 4/67 (5%)

Query: 20 TLYQRPLVTIKIGGQLKEALLKTGADDTVLEEMSL----PGEWKPKLIGGIGGFIKVRQY 75
          TL +RP + I + G   + LL TGAD T+L           E   + + GIGG  +   Y
Sbjct: 6  TLEKRPEILIFVNGYPIKFLLDTGADITILNRRDFQVKNSIENGRQNMIGIGGGKRGTNY 65

Query: 76 DQILIEI 82
            + +EI
Sbjct: 66 INVHLEI 72


>gi|2624481|pdb|3FIV|A Chain A, Crystal Structure Of Feline
          Immunodeficiency Virus Protease Complexed With A
          Substrate
 Chain B, Crystal Structure Of Feline Immunodeficiency Virus
          Protease Complexed With A Substrate
          Length = 116

 Score = 26.6 bits (57), Expect = 2.2,   Method: Compositional matrix adjust.
 Identities = 14/35 (40%), Positives = 19/35 (54%)

Query: 20 TLYQRPLVTIKIGGQLKEALLKTGADDTVLEEMSL 54
          TL +RP + I + G   + LL TGAD T+L     
Sbjct: 9  TLEKRPEILIFVNGYPIKFLLNTGADITILNRRDF 43


>gi|6730050|pdb|6FIV|A Chain A, Structural Studies Of Hiv And Fiv
          Proteases Complexed With An Efficient Inhibitor Of Fiv
          Pr
          Length = 113

 Score = 26.6 bits (57), Expect = 2.4,   Method: Compositional matrix adjust.
 Identities = 14/35 (40%), Positives = 19/35 (54%)

Query: 20 TLYQRPLVTIKIGGQLKEALLKTGADDTVLEEMSL 54
          TL +RP + I + G   + LL TGAD T+L     
Sbjct: 6  TLEKRPEILIFVNGYPIKFLLDTGADITILNRRDF 40


>gi|1127270|pdb|1FIV|A Chain A, Structure Of An Inhibitor Complex
          Of Proteinase From Feline Immunodeficiency Virus
 Chain A, Structure Of Feline Immunodeficiency Virus Protease
          Complexed With Tl-3-093
 Chain A, Fiv Protease Complexed With An Inhibitor Lp-130
          Length = 113

 Score = 26.6 bits (57), Expect = 2.5,   Method: Compositional matrix adjust.
 Identities = 14/35 (40%), Positives = 19/35 (54%)

Query: 20 TLYQRPLVTIKIGGQLKEALLKTGADDTVLEEMSL 54
          TL +RP + I + G   + LL TGAD T+L     
Sbjct: 6  TLEKRPEILIFVNGYPIKFLLDTGADITILNRRDF 40


>gi|213424552|pdb|3F1C|A Chain A, Crystal Structure Of
           2-C-Methyl-D-Erythritol 4-Phosphate Cytidylyltransferase
           From Listeria Monocytogenes
 Chain B, Crystal Structure Of 2-C-Methyl-D-Erythritol 4-Phosphate
           Cytidylyltransferase From Listeria Monocytogenes
          Length = 246

 Score = 26.2 bits (56), Expect = 2.9,   Method: Compositional matrix adjust.
 Identities = 13/30 (43%), Positives = 20/30 (66%)

Query: 24  RPLVTIKIGGQLKEALLKTGADDTVLEEMS 53
           RP +T +I  +  +A L+TGA DTV+E + 
Sbjct: 115 RPFLTHRIIEENIDAALETGAVDTVIEALD 144


>gi|2780904|pdb|2HRP|P Chain P, Antigen-Antibody Complex
 Chain Q, Antigen-Antibody Complex
          Length = 10

 Score = 26.2 bits (56), Expect = 3.0,   Method: Composition-based stats.
 Identities = 9/10 (90%), Positives = 9/10 (90%)

Query: 52 MSLPGEWKPK 61
          MSLPG WKPK
Sbjct: 1  MSLPGRWKPK 10


>gi|159164133|pdb|2DIV|A Chain A, Solution Structure Of The Rrm
           Domain Of Trna Selenocysteine Associated Protein
          Length = 99

 Score = 25.8 bits (55), Expect = 3.6,   Method: Compositional matrix adjust.
 Identities = 17/50 (34%), Positives = 19/50 (38%)

Query: 61  KLIGGIGGFIKVRQYDQILIEICGHKAIGTVLVGPTPVNILGRNLLTQIG 110
           +L G   G+  V   D    E C HK  G  L G TP      N  T  G
Sbjct: 46  RLTGIPAGYCFVEFADLATAEKCLHKINGKPLPGATPAKRFKLNYATYSG 95


>gi|114793631|pdb|2CU9|A Chain A, Crystal Structure Of Histone
           Chaperone Cia1
 Chain A, Crystal Structure Of Histone Chaperone Asf1 In Complex
           With A C-Terminus Of Histone H3
 Chain B, Crystal Structure Of Histone Chaperone Asf1 In Complex
           With A C-Terminus Of Histone H3
 Chain A, Crystal Structure Of Spcia1ASF1 COMPLEX WITH HIP1
 Chain B, Crystal Structure Of Spcia1ASF1 COMPLEX WITH HIP1
 Chain A, Crystal Structure Of Spcia1ASF1 COMPLEXED WITH CAC2
           PEPTIDE
 Chain B, Crystal Structure Of Spcia1ASF1 COMPLEXED WITH CAC2
           PEPTIDE
 Chain C, Crystal Structure Of Spcia1ASF1 COMPLEXED WITH CAC2
           PEPTIDE
 Chain D, Crystal Structure Of Spcia1ASF1 COMPLEXED WITH CAC2
           PEPTIDE
 Chain E, Crystal Structure Of Spcia1ASF1 COMPLEXED WITH CAC2
           PEPTIDE
 Chain F, Crystal Structure Of Spcia1ASF1 COMPLEXED WITH CAC2
           PEPTIDE
 Chain G, Crystal Structure Of Spcia1ASF1 COMPLEXED WITH CAC2
           PEPTIDE
 Chain H, Crystal Structure Of Spcia1ASF1 COMPLEXED WITH CAC2
           PEPTIDE
          Length = 161

 Score = 25.8 bits (55), Expect = 3.6,   Method: Compositional matrix adjust.
 Identities = 18/52 (34%), Positives = 23/52 (44%), Gaps = 13/52 (25%)

Query: 49  LEEMSLPGEWKPKLIGGIGGFIKVRQYDQILIEICGHKAIGTVLVGPTPVNI 100
           LE +    EWK   +G        + YDQIL          T+LVGP P+ I
Sbjct: 31  LEPLKSDLEWKLTYVGSATS----QSYDQIL---------DTLLVGPIPIGI 69


>gi|159163504|pdb|1X2L|A Chain A, Solution Structure Of The Cut
          Domain Of Human Homeobox Protein Cux-2 (Cut-Like 2)
          Length = 101

 Score = 25.8 bits (55), Expect = 4.1,   Method: Compositional matrix adjust.
 Identities = 18/63 (28%), Positives = 29/63 (46%), Gaps = 13/63 (20%)

Query: 26 LVTIKIGGQLKEALLKTG-------------ADDTVLEEMSLPGEWKPKLIGGIGGFIKV 72
          L T +I  Q+KE LLK               +  +V E ++ P  W+   + G   FIK+
Sbjct: 17 LDTAEIAFQVKEQLLKHNIGQRVFGHYVLGLSQGSVSEILARPKPWRKLTVKGKEPFIKM 76

Query: 73 RQY 75
          +Q+
Sbjct: 77 KQF 79


>gi|178847337|pdb|2VNU|D Chain D, Crystal Structure Of Sc Rrp44
          Length = 760

 Score = 25.0 bits (53), Expect = 6.9,   Method: Composition-based stats.
 Identities = 19/60 (31%), Positives = 30/60 (50%), Gaps = 5/60 (8%)

Query: 28 TIKIGGQLKEALLKTG----ADDTVLE-EMSLPGEWKPKLIGGIGGFIKVRQYDQILIEI 82
          T ++ G LK  +L  G    ++   LE  +SLP   KP LI G     +    DQ+++E+
Sbjct: 20 TARVXGGLKNGVLYQGNIQISEYNFLEGSVSLPRFSKPVLIVGQKNLNRAFNGDQVIVEL 79


  Database: pdb.fasta
    Posted date:  Jul 15, 2009  3:54 PM
  Number of letters in database: 9,620,218
  Number of sequences in database:  42,001
  
Lambda     K      H
   0.323    0.144    0.431 

Gapped
Lambda     K      H
   0.267   0.0410    0.140 


Matrix: BLOSUM62
Gap Penalties: Existence: 11, Extension: 1
Number of Sequences: 42001
Number of Hits to DB: 2,137,434
Number of extensions: 78447
Number of successful extensions: 324
Number of sequences better than 10.0: 152
Number of HSP's gapped: 318
Number of HSP's successfully gapped: 156
Length of query: 115
Length of database: 9,620,218
Length adjustment: 78
Effective length of query: 37
Effective length of database: 6,344,140
Effective search space: 234733180
Effective search space used: 234733180
Neighboring words threshold: 11
Window for multiple hits: 40
X1: 16 ( 7.5 bits)
X2: 38 (14.6 bits)
X3: 64 (24.7 bits)
S1: 41 (21.9 bits)
S2: 52 (24.6 bits)
